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This is an account of a 12-year search by
bacteriological methods to explain the cyles of the great
infectious fevers.
In a historical survey we see that epidemics have
shown long trends over the centuries and often shorter regular
waves, such as that every 2 years in measles, as well.
Exclusion of seasonal and other extraneous factors suggests
a rhythm in the microbe itself•
In Part II experiments with Escherichia coli show not
only that streptomycin-resistant mutations are mathematically
predictable for each type-strain, but that these variants
mutate in turn at regular rates, while "back-mutations" also
occur. Similar predictable and progressive mutations could
explain the sudden appearance and reappearance of new
characteristics such as exalted virulence or infectivity.
In Part III the origin and development of similar
streptomycin-insensitivity is considered in Mycobacterium
tuberculosis. Using a new method, Slope Diffusion, we see
the emergence of mutants over a number of years in 25 cases
and in 5 families or groups, culminating in what is virtually
a new disease - streptomycin-resistant tuberculosis.
There is a constant mobilis in mobile between
parasite and host as each adapts to changes in the other.
In Part IV it is suggested that the pre-determined frequency
of microbial mutations explain epidemic cycles, and that
evolution is no more fortuitious than the more successful





CHAPTER 1. THE HISTORICAL INCIDENCE OF EPIDEMICS.
INTRODUCTION
Although it would seem that the great infectious
diseases have always been with us it is axiomatic that
their incidence has been by no means uniform down the
centuries. History is made up of epidemic epochs. Plague
devastated Mediaeval Europe, smallpox pock-marked all
Christendom in the Eighteenth Century, and anginous scarlet
fever and diphtheria exterminated entire Victorian families.
In our own day worldwide pandemics of influenza remind us
of the scourges of the past.
Quite a superficial study soon shows that these
long-term trends are themselves fluctuating with a constancy
which is so remarkable as to seem at first inexplicable.
An annual rise and fall could, of course, be seasonal or due
to other climatic or even social factorsj but how are we
to account for the waves of measles every second year, or
of influenza pandemics returning twice or thrice in a century?
The aim of this thesis is to survey both these long trends
and the intervening recurring cycles, and to show that their
regular rhythm is not only explicable; but aiust in fact be
characteristic of mutations, which alone could enable a
living microbe to survive by constantly adapting to the
changes in its host.
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We will start by surveying the historical aspects
of epidemic cycles, culminating in a study of influenza,
whose vagaries are almost certainly mutational and afford
the best evidence for that purposeful adaptation described
as "epidemiological drift".
EPIDEMIC CYCLES AND THEIR IMPACT ON HUMAN HISTORY
It is often supposed that the unprecedented advances
in medicine of the present century are due to the same rise
in technology which has revolutionised other branches of
science. No organ remains inaccessible to modern surgery,
and the pathogenic bacteria, only discovered in the 1880»s
and since, have for the most part been miraculously conquered
by the antibiotics of the last twenty years* But whether
preventive medicine has appreciably influenced the vagaries
of epidemic disease is much more in doubt.
Nowhere is this better seen than with plague. The
World Health Organisation recently surveyed the whole globe
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except China and found only 300 cases for 1959# and yet
in historical times four pandemics of plague ravaged the
known world. The first in Trajan^ reign affected his
whole empire for half a century, the "Black Death" of the
14 th. Century killed perhaps 40 million - half the world.
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The "Great Plague" of the 17 th. Century which swept London
in 1665 was commemorated by Pepys, and the 1894 pandemic
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killed 12 million in India alone in the subsequent 43 years *
In Shakespeare's day the plague visited London
every summer and when the deaths rose to thirty a week the
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theatres were shut. But in "Timon of Athens" published
in 1623* Shakespeare makes Timandra voice a common belief
that disease transmitted to another left the infecter free;
"I will not kiss thee5 then the rot returns to thine own
lips again". So that it is hardly surprising that the lues
was rampant.
C)&
Chaucer says of the plague in his Pardoner's
Tale: "He hath a thousand slain this pestilence," and he
goes on to describe the prevalence of smallpox - 'the pokkes',
and 'mesel' or leprosy. Food-poisoning epidemics,
commonplace in the Middle Ages, covered the machinations of
TPA
the Borgia poisoners , and syphilis, "the strange disease"
TO fi
traditionally brought by Columbus' men from the Hispaniola ,
followed Charles the Eighth's army across Europe. Cromwell
6 f 3 6died of malaris then epidemic every autumn in the
marshes of Pall Mall, and plague, smallpox and dysentery can




Although measures for the control of leprosy and
other "unclean issues" had been given in the Mosaic law
including isolation of cases and contacts and washing or
burning of their clothes, no such enlightened prevention
i
prevailed in this country for many centuries. Thus Chaucer
in the fourteenth century wrote of the docteur: "He kepte
that he wan in pestilence," and Bullein in his "Dialogue
against the Pestilence" wrote in 1573s "And in such plagues
we poor people have mickle good ... Besides us pakers, many
more men have good luck, as the vicar, parish clerk and the
bell-manj we look for old cast coats, jackets, hose, caps,
batts and shoes, by their deaths which in their lives they
4.50
would not depart from, and this is our hap" .
Smallpox, unheard of before the time of James I,
killed 50*000 of the half million population of London in
the last 40 years of the 17 th. Century, and exterminated
tropical populations when it hod waned in Europe. Cholera
appeared in England in 1817 and disappeared in 1892
regardless of unchanged sanitation.
Scarlet Fever was notable only for a rash from its
first description in the 16 th. Century to Sydenham's account
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in the 17 th. . In the 18th. it raged as a fever all over
Europe, diminishing in the early 19 th. Century only to





1870 1880 1890 1900 1910 1920
Fig: 1. Deaths from Scarlet Fever had fallen strikingly from
144.6 per 100,000 of the population of England and
147
Wales in 1870 to 1.2 in 1936 , as shown by thts
291
diagram after Madsen . This decline, due almost
entirely to lowered fatality, and hardly at all to any
falling incidence, preceded the introduction of
sulphonamides and, penicillin.
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the death rate of 720 per million fell to 11 per million in
the 1930's, too soon to be influenced by chemotherapeutic
drugs (Fig: 1). Moreover the other manifestations of
virulent haemolytic streptococci - erysipelas and puerperal
fever - fell too with remarkable consistency. Clearly the
long-term fluctuations in the incidence of these, and the
other infectious diseases cited in this thesis, present an
enigma which has eluded men's understanding for centuries.
THE INFLUENCE OF OVERCROWDING
In Shakespeare's "Henry IV" we hear: "As men take
diseases one of another} let men take heed of their company,"
and again: "We are all diseased, and with our surfeiting
and wanton hours have brought ourselves into a burning fever" .
Sir Thomas Browne observed to a friend, half a century later:
"The small pox grows more pernicious than the great: the
king's purse knows that the king's evil grows more common.
Quartan agues are become no strangers to Ireland; more
common and mortal in England," antj Defoe 9* wrote
resignedly in 1720: "We were crowded enough to cause a
pestilence among us•" Nowhere was overcrowding worse than
among children, generally the most susceptible of all to
infectious diseases, - "and in the morn and liquid dew of
youth contagious blastments are most imminent," as we read
in "Hamlet" 391.
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Boarding schools offer the opportunity for studying
the fluctuations of diseases in more or less closed herds of
non~immtuies, and when one recollects that the English and
Scottish Public Schools have had unbroken histories extending
back, in some cases, over a period of five centuries, even
their fragmentary medical records assume importance. The
diet did little to maintain the boys' resistance, and both
yt 24.0
Coleridge and Charles Lamb have written of the hunger
of their schooldays at Christ's Hospital, while as late as
1846 the boys at Winchester rose at 5*30 a.m. and waited 4~k
hours for breakfast of bread and beer, of which the nurse
at the sick house disposed of three quarts a day.
Plague killed 26 boys and 11 masters at Winchester
in 1430* the dying boys being immediately replaced by others.
As a preventive Eton obliged all its boys to smoke in school
each morning under penalty of a whipping, and in 1450 issued
a paper asking whether a new boy had been exposed to the
Great Death. But the younger boys were still sleeping on
the floor of Long Chamber there a hundred years ago with the
rats eating their clothing and braces, while at Westminster
single beds cost £4 extra, a dubious luxury when fagging
began at 3*3° a.m. ^
During the 19 th. Century Christ's Hospital had only
one towel for every four boys, and ringworm was treated by
the boys themselves with ink. Children with fevers
traditionally received emetics and purges, and had their
temperatures lowered by bleeding and cold showers.
While admitting that more humane boarding schools
have reduced epidemics by increasing the boys' stamina it
seems certain that cyclic changes in virulence may have
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also occurred, and Lempriere 0 has shown that school records
reveal four periods of different predominant infectious fevers.
Thus 1400 - 1700 was a period of plague which usually led to
rustication or closure of the school, while from 1700 - 1800
small-pox covered Europe. 1800 - I87O was the hey-day of
diphtheria and the exanthemata, a time when anginous scarlet
fever and diphtheria were not well distinguished and equally fatal,
while from 1S70 influenza caused the major epidemics in schools
as elsewhere.
SPECULATIONS ON THE CAUSE OF EPIDEMICS
History asserts that Sennacherib lost 165,000 men in
one night on the eve of attacking Palestine in 711 B.C., and
the gratified Jews claimed divine visitation. Hippocrates,
three centuries later, described the reigning diseases through
successive seasons of the island of Thasos, associating their
onset with the changes of the weather: "About the equinox,
and until the season of the Pleiades, and at the approach of
winter, many ardent fevers set in" -*-95^ Tjie a{jvent Df
Syphilis in Europe was ascribed at tne time to the conjunction
10
of the planets Venus, Mars and Mercury in 1483 398^ aRd aboufc
1600 Galileo's telescope provided the credulous with many
astronomical phenomena suitable for appostion to the
recurrences of disease. Similarly the microscope with its
revelations of the microparasites of man, swept all medicine
before it in the '80's, so much so that it was in distinctly
bad taste to admit any other causative factor than Pasteur's
18A
Germ Theory of Disease •
Although the early microscopists overstated their
case to the point of ridicule, the full potentialities of
bacteria and viruses have still to be revealed and Pasteur
may yet be vindicated. To a biologist all living things
are the products of evolution, and to a microbiologist,
accustomed to the prodigious multiplication of bacteria,
mutations are a daily observation. But even he may scarcely
realise the full significance of such changes among organisms
which, in a single day, can complete as many generations as
the human race has achieved in the whole Christian era.
The doctrine of the "Epidemic Constitution" was
originated by Hippocrates, who, after describing the weather,
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argued that each season had a ruling disease , Sydenham
followed his classification remarkably closely and gave the
Great Plague of London the same place in his series of years
as the Fourth Constitution of Hippocrates, which was the
8G
Plague of Athens as described by Thucydides. Creighton
remarked that fevers proper to the climate of Thasos were
not likely to be identified in or near London except by a
forced construction, and Sydenham appears to have carried
back his records solely to accommodate the intention in view.
|C J
Similarly Ilamer attempted to draw an exact analogy between
epidemics in London between 1888 and 1928, and those of
Sydenham two hundred years before. He traced influenza to
the Milaires and Picardy Sweats of earlier centuries, and
likened its protean tendencies to Sydenham's "exceedingly
anamalous and irregular fever". He suggested comparison
of the epidemic wave of measles with the far less stable
influenza, and regarded typical influenza as the "spray on
the crest" of other fever waves, instancing pneumonia in the
•90's and meningitis in 1918. In short the Epidemic
Constitutionalists insist that there are periodic recurrences
down the centuries of like epidemic constitutions.
In 1918 the concurrence and resemblance of
cerebrospinal fever and poliomyelitis on the one hand, and
of influenza, bronchitis and pneumonia on the other,
*i27
encouraged some official recognition of the theory , and
Hamer asserted that all these diseases were but protean
manifestations of the one epidemic gu^. MCi$aity
dretv attention to the resemblance of the prodromata and
abortive cases of poliomyelitis and encephalitis lethargica
12
to the ubiquitous influenza, and Mall 1B2 ironically
remarked that, if there was any connection between the
diseases, it was unusually well concealed from the clinician.
The alternative theory of the "Epidemic Cycle" had
been postulated by Whitelegge in 1892, who had considered
that minor epidemics of measles became progressively
intensified into the big cycles of major ones, and Hirsch
gave similar explanations for influenza, and the less invasive
cerebrospinal fever, noting that an increase in sporadic cases
280
preceded and followed the main epidemics .
In 1928 Gill propounded the "Quantum Theory of
Epidemics" which purported to explain all epidemic phenomena
in terms of a change in the relationship between the infection
1 1A
and immunity 'quanta', and in 1935 Topley and Greenwood
interpreted their experimental findings in mice in terms of
an immunological constitution of the herd in relation to all
the parasites to which it was exposed. By intermittent
introduction of fresh mice into a herd heavily infected with
rodent typhoid, these workers were able to propagate waves
of fatality by low iiniuigrati on where high immigration gave
a steady death rate} but they admitted that virulence and
infectivity varied independently even in the course of a
single long epidemic, and the results do little to explain
fluctuations in incidence.
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The introduction of antibiotics provides a unique
tool for observing changes in the bacterial organism, for
resistance to these drugs is immediately conspicuous, and
usually follows a genetic distribution. The resulting
mutations make a fascinating study which may throw some
light on epidemic cycles, and perhaps on the origin of
sporadic cases of disease. Moreover the possibility of
a new menace from epidemics of drug-resistant organisms
cannot be dismissed.
Preliminary experiments suggested that various drug-
fast mutations were in fact constant for any species, and,
therefore, predictable, and in this thesis are described a
few experiments measuring the mutation rates. It soon became
clear that the number and diversity of mutations occurring
simultaneously are so vast that this could be the challenge
for almost any new circumstance, and go far to account for
the onset of disease. Before describing these laboratory
experiments, however, I would like to survey the astonishing
fluctuations in the prevalence of infections to show the
extent of the problem which they pose.
Quite a cursory study will show that all the common
infectious diseases shoxv one or more different types of
fluctuation, be it periodic cycle, seasonal prevalence,
irregular epidemicity or long-term trend • The periodic
14
cycle, so well seen in the biennial incidence of measles
and triennial of whooping cough raay be explained in
part at least by the accumulation of a susceptible
population exposed to sudden risk from cases or carriers -
"and by the hazard of the spotted die let the spotted die"
0Q2
as Shakespeare expresses it • The seasonal incidence
appears to derive in part directly from climatic exposure
and in part indirectly from the resulting enforced over¬
crowding or diminished ventilation or an infection due to
these factors may predispose to another. Moreover abnormal
weather may account for some irregular prevalences, for
instance the heat wave of 1921 was associated with a high
incidence of diarrhoea but a low rate for scarlet fever
Schools isolate 16% of the population in term-time,
at least for the greater part of the day, and school holidays
materially affect the spread of disease between different
places and different age-groups, and account for the timing
of some epidemics. Similarly the British Isles are unusually
well insulated against diseases from abroad - "this fortress
built by Nature for herself against infection and the hand
189
of war" - so that the introduction of exotic infections
is associated with a short meteoric career.
As regards long-term trends all the common infectious
diseases have declined in virulence in recent years, but the
15
most providential deliverances in historical times have been
from the "black" and "White" plagues, P, pestis and M.
tuberculosis. 1'he Great Plague or Black Death of the 14 th.
Century was by far the most frightful epidemic in history.
Beginning in China in 1346 it killed 13 million in less than
a year and then spread to Europe along the trade routes
depopulating the countries through which it passed, and even
in England and Norway, where the epidemic ended, more than
half the people were destroyed. Pope Clement VI ordered a
census in 1348, and awe-struck messengers whispered that
half the known world was dead, and offered a final estimate
of 42,836,486, which was probably exceeded. Three hundred
years later the second pandemic described by Pepys and Defoe
killed one-third of London before the Great Fire of 1666
stopped its spread.
Tuberculosis, even if it has not vanished like the
Plague, has markedly diminished in severity in this country
although the down-trend faltered during the war •
gPhthisis is now increasing in severity in India and the
396Far East generally just as it increased in this country
in former centuries, Browne ^ in I69G noted how often
unsuspected tuberculosis was found at post-mortem examination,
and everywhere its ravages were watched with the same
superstitious dread ^71 shown by the natives of Samoa and the
New Hebrides today. There seems little doubt, in fact, that
we in Europe are nteeting tuberculosis on the down-curve of an
exceedingly long epidemic cycle, a cycle whose wave-length must
be measured in centuries. The present decline began before the
53
introduction of sanatoria and other preventive measures , just
as the fall in diphtheria fatalities in 189C preceded the
introduction of antitoxin, that of scarlet fever in 187° the
general introduction of fever hospitals, and erysipelas and
/ \
puerperal fever the discovery of the sulpha- drugs•
How long these down-trends will continue none can at
X7A
present say, but Topley and Greenwood maintain on
experimental grounds that a disease will never normally die
out in a large community, and that, as active immunity merely
prevents overt disease not infection, even mass immunisation
would not eliminate a disease.
Centuries of co-existence have produced a balance
between living species which, in the case of man and his
parasites, must imply a constant mobilis in mobile phenomenon
between the two. Mutations in the parasite gross enough to
overwhelm the host will produce disease, and among communities
an epidemic can follow and persist until some compensation
restores the former equilibrium. Thus a distinction between
commensal and pathogenic flora is really quite untenable for
any parasitic micro-organism has in its protoplasm the key to
virulence, and dismissal of, for example, coagulase-negative
Staphylococci in a blood culture as harmless contaminants
O r ^ o
could be a quite unjustified assumption 39 .
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CHAPTER 2. CLIMATIC AND OTHER RECURRING EXTERNAL FACTORS,
SEASONAL INCIDENCE
Variations in disease incidence according to the
time of year have also attracted comment throughout history,
112
although the fatalistic "to everything there is a season"
10 c
discouraged the search for a cause. Hippocrates
repeatedly noted the greater frequency of dysentery during
the summer and autumn on Thasos, and the curious predominance
of fevers around the equinoxes, still seen to this day. Thus
while the majority of epidemic diseases in Europe are at their
height in the late winter and spring, scarlet fever and
poliomyelitis are autumnal in incidence, while typhus usually
occurs in midwinter and only the intestinal infections reach
their maximum prevalence during the summer. It seems possible
that sudden changes in climate are more weakening to both
humans and animal vectors than the relatively prolonged
exposure to cold and wet in midwinter} but one cannot ignore
social rhythms such as indoor and outdoor life, and the
opening and closing of schools
In the tropics the influence of climatic changes on
epidemics is, as one might expect, still more marked, and to
illustrate this malaria and dysentery incidence were surveyed
in the laboratory records of an Indian garrison town over the
18
SEASONAL INCIDENCE DISEASES
Fig: 2. Incidence of diseases among British troops in Ahmadnagar,
India, during the 1939 - 1945 War (Author's figures).
After high initial incidence due to the arrival of
infected troops in the spring of 1944, there were abrupt rises
in malaria, and to a lesser extent in bacillary and
amoebic dysenteries, each summer with the coming of
the monsoon.
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two year period 1943 - 1945* It will be seen that malaria
after an initial wave due to newly arrived infected troops,
reappears abruptly each summer with the coming of the
monsoons bringing breeding of its anopheline vector.
Intestinal infections show less variation, but again there
is a midsummer peak coinciding with increased flies (Fig: 2).
SIMULTANEOUS EPIDEMICS
There is no doubt too that one epidemic predisposes
to another, and as early as 1847 Farr noted the co-existence
of influenza, whooping-cough, measles and typhus all highly
prevalent together, and in 1887 Wellington School had
26*?
coincident scarlet fever and diphtheria, with influenza .
Scarlet fever is commonly associated with anterior nasal
223
diphtheria, chickenpox, erysipelas and erythema nodosum ,
129
diphtheria also occurs with measles 7 , measles with
236
whooping-cough J , C.S.F, with shingles, syphilis with
gonorrhoea, typhus tvith relapsing fever, and cholera with
influenza Both poliomyelitis and cerebro-spinal fever
preceded the influenza pandemics of 1890 and 1918 , and
a secondary broncho-pneumonia usually complicates measles
while herpes labialis is a well-known concomitant of other
infectious diseases. As Greenwood and Topley remark:
"The association of two bacteria or, more especially a
bacterium with a virus, may play a part in an epidemic no
less than that played by variations of a single parasite"
20
TABUS 1
FREQUENCY OP ORGANISMS ON FIRST ISOLATION IN SIGNIFICANT BACTERIVRIA
IN CASES WITH NO ABNORMALITY OP THE URINARY TRACT,
(personal communication from


















On the other hand one can but wonder at the purity
of so many diseases* For instance several
observers ls6' 2«' 358' 3W' 383' 387 have noticed that
mixed urinary infections are less common than simple ones;
but the implications seem to have been overlooked, or a
vain search made for some antagonism ^$7^ Even in chronic
cases of stasis from prostatititis ^ • 358^ paraplegia ^87^
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or cystitis , where a second pathogen could more readily
join the primary invader, cultures more often than not
yield a pure growth of one organism, usually a coliform
(Table !)• If mere lack of hygiene and lowered resistance
were alone responsible for pyuria one would expect to find
as a rule the full range of intestinal flora represented.
Presumably a mutation giving enhanced virulence to one
organism at the opportune moment plays a far bigger part than
is generally suspected.
Where no mutation is involved, as must generally be
the case among the larger invertebrate parasites, whose
reproduction rate is relatively slow, infection must just
reflect the local fauna. Thus where, as in India, helminth
parasites are plentiful cases of multiple infection are by
no means uncommon (Table 2).
Infants might be supposed to offer little resistance
to invading bacteria; but in fact even the youngest child
TABLE 2
SINGLE AND MULTIPLE HELMINTH INFESTATIONS IN
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presents a barrier demanding exalted virulence. This was
illustrated by investigating infantile gastro-enteritis due
to E, coli neapolitana in Edinburgh during six months
(January to July) 1952,
During this period 167 babies were admitted to the
Royal Hospital for Sick Children and the City Hospital for
enteritis. Slide agglutinations were performed on a
dozen E, colo colonies selected at random from each child's
stool. As shown in Table 3» 37 had initially pure cultures
of the Aberdeen o((0111.B4) serotype, 39 Aberdeen p> (055.B.5),
while only 1 had both. Both types of infection were
treated in the same tvards relying on barrier nursing,
confidence in which was generally justified by 3 healthy
babies remaining unaffected by a month's stay in the ward,
including the ttvin sister of a girl with the jl strain.
Sulphadiazine virtually sterilised the faeces, and
on stopping treatment E, coli communis reasserted its
predominance, occasionally preceded for a few days by
Proteus species, Enterococci or E, coli aerogenes. It is
interesting to speculate why the normal flora can be relied
upon to restore itself rather than a recurrence of the
pathogens after their transient elimination. Four 'relapses'
did indeed happen; but as a repetition of the agglutination
tests showed a change of serotype in three instances, complete
reinfection must have occurred in these cases.
TABLE S
INCIDENCE OF E. COLI SEROTYPES IN CASES OF INFANTILE GASTROENTERITIS
AT R.3.S.C. & CITY HOSPITAL, EDINBURGH, JAN. - JULY 1952.
'Aberdeen 'Aberdeen
a' c + Jb Neither
Uneventful
recovery 35 37 1 90
a I
jb a S
a —$* o 1
Totals 37 39 1 90
a « Serotype 0111.B4
ft m Serotype 055.B5
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Presumably the pathogenic serotypes of E. coli
neapolitana must be of low prevalence in humans until a
mutation offers exalted virulence. This could explain,
too, the replacement in Britain since 1952 of the 0111,B.4,
and 055.B5 strains by 026 and 0119. All these strains
are said to persist in farm animals ^61# 362 petg
Given such large reservoirs virulent mutants can constantly
menace babies, and that E, coli neapolitana has high mutation
rates is shown in Chapter 7*
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CHAPTER 3. HOVEL AND CJIANGING CHARACTER; Hi JitJMAN EPIDEMICS
Butler pointed out that an epidemic aight be a
great increase in a normally endemic disease* or a
relatively much smaller prevalence of an exotic disease
scarcely achieving the endemic heights of the other; but
quite as noticeable because of its usual rarity. Among
these more ephemeral infections are epizootics of animals*
whose occasional epidemics in man could be explained by a
121
mutation in the parasite enabling it to change its host •
INFECTIOUS DIEEASES TRANSFERRING FROM ANIMALS TO MAN
Undulant Fever
A27
Abortus fever is common enough in cows to affect
5'>- of British milk samples and 10# of American j but up to
1929 only 14 known human cases had occurred in England and
350 in the United State. 36' 58' »«• 18'' «28' «8'
°6
Even allowing for fallacies due to improved diagnosis ~ ,
sporadic and epidemic cases in man do seem to have become
increasingly frequent
byre believed that the corresponding melitcnsis
septicaemia was primarily a disease of goats in the Persian
hills and accompanied them in their world-wide wanderings*
Endemic Melitensis Incidence
Fig: 3, A geographical spread. Malta Fever, which affected 40ft
of the goata on that island in 1904 had spread! round the
Mediterranean by 1910; but the human cases were still
122
limited to the coastline (after Eyre ),
28
becoming modified for cows and other animals. A large
epidemic of "Mediterranean or Gastric Remittent Fever"
occurred in 1856 in British troops returning from the
Crimea, and the continued prevalence in Malta led to the
discovery in 1904 that 40$ of the goats there were healthy
carriers, few herds being innocent Compulsory boiling
of milk reduced the incidence of the disease in the forces
from 555# the annual average between 1900 and 1905, to 21
122in 1906 • In 1910 the disease was confined, so far as
existing knowledge went, to the coastline of the
Mediterranean the spread is now world-wide ^ 9 2^2> 481
(FigJ 3).
Ornithosis
Ever since 1879 when Dr. Ritter in Switzerland
observed an outbreak of sickness resembling both pneumonia
and typhus in the hoaie of a relative who collected exotic
22 176
birds, house epidemics and the association with parrots
had been recognised as the criteria of a strange disease.
Vast areas of the upper Amazon have never been explored and
it is possible that psittacosis, as the disease was first
called, is an epizootic among tropical birds in the wild
state, to which they readily succumb when herded in captivity.
201
Dead Brazilian parrots and their droppings , love
1 A C oQfi
birds , and African parrots J can all be infective, while
29
fulmar petrels in the Faroe Islands may carry infection
from the fledgling stage, so that "ornithosis" is a
preferable term for a whole group of epidemic viral
diseases. But whereas in over 30 species of birds gastro¬
enteritis results, in man the disease is essentially a
viral pneumonia, and in 1917 fi consignment of birds confined
in the basement of an American Departmental store caused an
epidemic among staff and customers clearly due to
(1C
inhalation • Similarly ladies carrying parrots on their
shoulders as part of a more than usually eccentric Parisian
fashion in 1930, may have provided uniquely close contact
between the human nose and the birds* execreta. But in
1897 a music professor in Florence bought a sick parrot,
recently imported from the Amazon, and he and two of his
family died while a child and the servant recovered. The
following year a green parrot infected nine persons in one
family at Cologne, only the youngest child escaping. In
fact children, even though they fondle birds, seem to be
A29
much less susceptible , and in the English 1929 epidemic
two-thirds of the cases were over middle-age, and the case
mortality was noticeably higher in the older age groups.
In this epidemic twelve birds caused sixty human cases, of
which ten were traced to one parrot given by a sailor to
the proprietor of a public house. Similar outbreaks were
almost world-wide during 1929 find 193° from Egypt to Honolulu,
in every case cage-birds being implicated, often solitary ones.
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Thus in Buenos Aires a dozen actors performing with a
parrot all fell ill with two deaths. One might speculate
that the epizootic virus underwent a highly virulent but
transient mutation capable of producing severe pneumonia
in those few humans, mostly adults, who contracted the disease.
CHANGES IN THE TROPISM OF PATHOGENIC MICRO-ORGANISMS
Herpes Zoster and Varicella
The possible relationship between shingles and
chicken-pox has excited discussion for thirty-five years
and is still undecided. Parallel epidemics occurred in
Budapest in 1912 and epidemics of chicken-pox succeeding
223
heroes zoster have been noticed in several instances .
Many adults with herpes give a definite history of chicken-
pox in childhood, second attacks of which are excessively
rare.
If one accepts the current view that shingles is
in fact chicken-pox in a person sufficiently immune to
localise the spread of the virus, there still remains the
problem of explaining the singular spread along a sensory
nerve. If a dermatropic mutant is involved the change is
short-lived, for children infected by Herpes Zoster get
chicken-pox not singles, and cases claimed to show both
236infections concurrently ° might be chicken-pox starting with
a fortuitous zonal distribution.
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Mumps
2When Hippocrates described mumps among the boys
"engaged in the exercises of the palestra and gymnasium"
on Thasos, orchitis commonly ushered in the disease. While
223
this may still be the only symptom ° or even occur
236
primarily in an epidemic , mumps is now almost always
an infection of the parotids and only shows secondary spread
elsewhere. Still showing a singular partiality for glands
as histologically distinct as the salivaries, sex glands,
breasts, pancreas and lacrimals, the virus during twenty-two
centuries has developed an overwhelming specificity for the
parotid gland of man.
Poliomyelitis and Polioencephalitis
In the 18 th. Century sporadic cases of poliomyelitis
occurred among children, and Sir. Walter Scott, who was
himself crippled at eighteen months old, described it as
"the fever which often accompanies the cutting of large teeth"2,
Underwood in 1784 ascribed the disease to teething or "foul
bowels" in children aged 1—4# and usually among those
debilitated by another fever. Shaw in 1822 saw the disease
in the same age group and considered it was related to
weaning. Four children were attacked simultaneously in
Worksop in 1835 and ten infants all under two in Iowa in
the autumn of 1841* ®h© disease was now realised to be
an affection of the spinal cord and quite unconnected with
32
Fig: 4. Paralytic poliomyelitis of left leg of Room, a priest of
the Temple of Astarte in Memphis, from a stele of the
18th. Dynasty (1580 - 1300 B.C.).
From the Carlsberg Glypotothek, Copenhagen,
33
teething or weaning, but neither the infectivity, nor, far
280
less, the epidemicity appear to have been observed .
Media, at the International Congress in Berlin in
189b, first drew attention to the epidemic character of
this disease, but it was still "infantile paralysis", an
illness which crippled but rarely killed Further
epidemics in 1911 and 1912 caused considerable alarm and
38
the compulsory notification of the disease. Bramwell
pointed to its growing incidence, especially in adults,
and that it had been a sporadic disease until the epidemics
in Scandinavia in the 1880»s.
Poliomyelitis increased prior to the "flu epidemic
in 1918 and was much cited by the "epidemic constitution"
theorists but a detailed investigation by McNalty
in Epsom revealed that an epidemic of 20 cases in and around
a boys' school was connected through a day-boy. A rational
explanation for both the epidemicity and higher age-group of
111
the modern disease has been given by Bodian and others.
The polio virus is spread in faeces and most primitive people
i O
possess antibodies , presumably the result of subclinical
attacks when young. Lack of previous exposure through
hygiene can explain the present outbreaks among adults; but
a further disquieting feature is the growing tendency for
the virus to attack the brain giving polioencephalitis with
34
a consequent increase in mortality. In the Broadstairs
epidemic of 1926 out of 55 cases, 32 were polioencephalitis,
17 poliomyelitis and six mild or abortive • Mid-brain
involvement continues to feature present-day outbreaks,
thus in the outbreak among troops in the Poona area in the
autumn of 1945, a marked incidence and a mortality from
polioencephalitis occurred among senior officers over 35
years of age, a far cry from the day when poliomyelitis was
described as a children's disease. It is difficult to see
how without postulating a mutant virus one can explain the
changing site for the disease.
Encephalitis lethargica
This disease is unique in having arisen, at any rate
as a major epidemic within our generation, and its evolution
and apparent disappearance have taken place in full view of
modern epidemilogical science.
Although Sleepy Sickness had been described at
Tubingen in 1872, in Italy in 1890# and in the Breach Army
in the winter of 1915 - 16, the first authentic epidemic of
fifty cases occurred at Vienna in the winter of 1916 - 17,
113
when von Economo gave the classical description of the
disease as a tendency to protracted daylight sleep and marked
squint lasting for weeks or months with 30% recovery, 30%
invalidism, and 30% mortality. He also noted the very low
infectivity which he put at 4%# and he suggested droplet infection.
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Next year encephalitis Icthargica appeared in
France, and in March-April 1818 in England, where it was
at first mistaken for botulism. Reports of 10 cases in
Sheffield by Hall and seven in London by Harris
were followed by diagnoses all over the country of cases
presenting increasing stupor ending fatally for
instance Kennington New Cross six cases with five
deaths at Lambeth Infirmary and even a 34" months' old
baby who presented typical mask-like facies, divergent
squint, stupor and spasticity. This baby being breast-fed
struck the death-knell to the botulism theory, while repeated
records of clear spinal fluid and the novel manifestations
ruled out any infectious disease such as cerebro-spinal
56
meningitis. Finally Buzzard suggested that a new virus
was abroad with a predilection for the mid-brain and brain¬
stem and two post-mortem examinations a few weeks later
57
helped to confirm this view , which was finally proved by
280
Mcintosh transmitting the disease to monkeys in 1924 c •
Throughout the winter of 1917-,18, the disease
183
occurred throughout Western Europe , and by 1924 it had
reached Japan with a mortality rise to 60%, Starting
apparently on the battlefields of Flanders, within a brief
seven years encephalitis lethargica had encircled the globe.
The increasing incidence and still more marked
increase in mortality and mental sequelae 37*337*4^3,464^
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caused wide concern in Britain and the appointment of a
government committee to investigate the outbreaks. The
investigations, involving the Ministry of Agriculture and
Fisheries, and the Ministry of Health besides numerous
unofficial articles by doctors and veterinary surgeons in
medical journals, became a trifle ludicrous when cases were
cited of two cats and two kittens suffering from lethargy
and squint in a Devon village, and of three horses with
catarrh at a farm at Abinger, Surrey, where a child lay ill
with encephalitis 337 #
McNalty in 1919 and Netter in 1920 suggested
that encephalitis lethargica was an epidemic and infectious
disease. Preveiously the apparent sporadicity and scanty
evidence of cace-to-case infection had occluded its
infectious character. For instance during 1919-'20 there
was only one contact-case among 206 in England and hales,
and none among 414 cases from January to May 1920 in France,
2 go
nor among 181 during the same period in the U.S.A. 7.
However in the celebrated Derby Girls' iloiae epidemic in
August 1919 287 twelve children out of twenty-two were
attacked with five deaths in fourteen days, and in the
Mulheim epidemic in the summer of 1922 there were 28 cases
in an asylum in three weeks including six nurses and three
1 Co
doctors. In the Sheffield outbreak of 1924 Professor Wynne
found contact in six instances involving thirteen cases - 40$
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of the total* In this epidemic, as at Liverpool in the
A(\0
preceding year , mild and abortive cases were seen
en i q<j 288
suggesting the existence of carriers * and in
126
1925 ha Fano demonstrated the virus nature of
encephalitis lethargica, and suggested its possible relation
to heroes febrilis. Whether or not encephalitis lethargica
was caused by a mutant of some such commonplace virus, the
disease in a recognisable epidemic form has now disappeared
unless we identify it with the much more benign outbreaks
of myalgic encephalitis whose assaults on the Hurses' homes
of several London hospitals were a clinical curiosity of
the 1950*3 34S* 377* 4°°.
Smallpox
That smallpox was formerly endemic in Europe is
shown by the fact that it is by far the most frequently cited
disease in Saint-Simon * s "Metnoires", and city children grew
up in Europe almost inevitably pock-marked, so that the
patches and powder used by the women in the 18th, Century
are said to have been introduced to disguise the scars.
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Hakluyt tells how smallpox aided the Spanish conquest
of Peru, and this extermination of the coloured races
culminated in the death of 5000 natives on Guam in 1856 396^
and the complete disappearance of the Easter Island
civilisation.
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Following the introduction of vaccination a steady
decline of the disease set in throughout Europe so that
smallpox is now more prevalent in the tropics than in
temperate zones, and experience shows that India is the
common source of such major infection as is conveyed to
2Q Cthis country by travel, and Massey points out that the
journey by air may now be accomplished well within the
incubation period and constitutes a new hazard especially
in a largely unvaccinated population. Widespread epidemics
occurred in the Sudan in 1939 due to infection from French
Equatorial Africa ^5^ an(j Korea in 1940^9^. That there
is still a risk in Britain was shown by the epidemics in
1901, 1931, 1942 9S, and 1958 476. The 1931 epidemic was
of limited spread and low mortality and was due to an
aberrant form of smallpox, Variola minor, which bred true
and was identified with African Alastrian or Kaffir milk-
pox, introduced into England for the first time
That there was a protective effect from previous
cowrpox seems to have been widely suspected in country districts
before the traditional Gloucestershire dairymaid enlightened
Jenner. There is the unequivocal nursery rhyme i "Where are
you going to my pretty maid? I'm going a-milking, Sir," she
said, and Jesty, a Borset farmer used cow's material on his
family in 1774, and Dr. Bragge of Axminster possibly seven
years before that. Modern vaccine lymph is the serum exudate
from vaccinia vesicles propagated in calves and periodically
exalted in virulence by passage through a rabbit.
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Vaccinia. variola major and variola minor viruses
are all morphologically and serologically identical, although
the diseases are so distinct. Whether modern vaccine lymph
originated in natural cowpox or artificially modified
smallpox is not really known as so many passages have now
occurred, including human, that the source is now forgotten.
The generalised pox of vaccinia virus in experimental animals,
and its necrotic lesions in chick embryos, contrast sharply
with the much milder effects in both of variola major and
still more variola minor. But after several transfers in
both animals and eggs variola major and minor assume the
pathogenic characters of vaccin ja and it seems clear that all
three forms are mutants of the same virus with varying
virulence and animal susceptibility.
Syphilis
Unlike gonorrhoea, which has been described in Europe
as a prevalent venereal disease from time immemorial, syphilis
seems to have been unknown before the middle ages and most
people blame Columbus for its introduction. According to
this tradition, which appeals to the romantics and moralists
alike, the lonely Spanish sailors found dusky companions
beneath the palm trees of Hispaniola, and certainly
Vincenti Finzon, the pilot of the flagship, was ailing all the
way home. Then, too, Columbus, as proof of his conquests
carried women aborigines as steerage passengers, and presented
40
them at the court of Ferdinand and Isabella. Spanish
mercenaries were fighting in the French army in Italy, and
to them is ascribed the first great epidemic. This was
appallingly disfiguring and reached its height in 1546 when
Fracostero with amazing foresight suggested that there was
an unseen "living contagion", and coined the name "Syphilis"
for the new scourge.
Milder non-venereal skin diseases such as yaws and
pinta, both of which are due to spirochaetes indistinguishable
morphologically from T. pallidum, have their home in Central
Americaj but bejel, another contagious spirochactal disease
even more like syphilis, is common among children in Arabis,
and similar milder "Syphiloids" occurred in Europe up to the
17th and 18th centuries, for instance the buccal ulcers
which assailed Cromwell's army in Scotland and were described
with coarse humour by the Scots as "sibbens" - wild raspberries.
It seems clear that around 1500 A.D., whether or not
the New World gave it to the old, a new mutant Treponema arose
which brought a devastating epidemic of syphilis to Europe,
and which persists as a world-wide venereal disease to this day.
EPIDEMICS ATTRIBUTED TO VARIATIONS IN VIRULENCE
Although the more ephemeral fevers just described
may afford striking evidence of mutations, for an indication
of the true power of such phenomena we must look at the rise
and fall of the more prevalent infectious diseases especially
among children.
Meningococcal Meningitis
Although some have identified this disease with
1q6
the "phrenitis" of Hippocrates and Galen 7 , and the
"petechial fevers" of Sydenham ^ ® and Huxham, the first
recorded outbreak of cerebro-spinal fever was in Geneva in
1805. The characteristic winter to spring incidence was
seen, namely February to April, and the typically high case
mortality, unchanged until the sulphonamide era.
Following the Swiss 1805 outbreak there is an
unbroken history of epidemics of the disease generally in
its favourite role as a camp-follower of Wars 331^
although its conveyance presumed to be by "healthy" carriers
was also well exemplified in Sweden in 1854. In that
epidemic the infection advanced steadily across Scandinavia
for seven years from the south to the north-west, beginning
each winter from the point at which it had been arrested
the previous summer. By 1861 4,158 deaths had occurred.
Meanwhile the American Civil War had broken out and
cerebro-spinal fever was present with the army of the
Potomac during the first winter, and then spread to the
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confederate troops and civil population. Outbreak®
continued up to 1911# when 2,800 cases occurred in Texas
among crowds listening to a popular gypsy preacher in
defiance of official warnings.
In 1914 Canadian troops brought a virulent strain
from the New World to camps on Salisbury Plain, and cases
traced to men on leave occurred all over south-east England
for the remainder of the %^ar. Thus in the 1917 epidemic
three-quarters of the civilian cases were south-east of a
line from the Wash to the Bristol Channel and two-thirds of
Welsh cases were in Glamorgan. 6,450 cases occurred in
England and Wales throughout the war, 4#238 being military
162
Glover ~ considered that the 1917'epidemic was
due to the severe winter and antecedent influenza lowering
the resistance of troops, with, in addition, gross over¬
crowding and a high carrier rate of epidemic strains of
meningococci in the population at risk. By increasing the
space between beds from l| to 2-$* he purged a depot of cases,
but a return of overcrowding raised the carrier rate to 30%
in a fortnight and brought an out-of-season epidemic in train
three weeks later. He considered that a carrier rate of 2
to 5% was normal in a community and that a rise above 20%
presaged an epidemic. Another potential danger noted at
370the time was the presence of ambulant abortive cases who
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had recovered in some cases within 48 hours. Between the
two wars epidemics occurred on a major scale in Korea in
1934-1935* in the Japanese Mandate Islands in 1926 with
389 cases in a population of 50,000 3^ and in the Sudan
in 1939 - 2,714 cases 350.
In 1940 and again in 1941 war brought major
epidemics to Britain, and they showed the traditional
seasonal incidence in the late winter and spring months,
the slight preponderance of males, and the chief prevalence
among those under five. Agglutination reactions showed
the homeogeneity of the epidemic, for example in Edinburgh
116 cases in a series were Scott's group I and only one
222
group II • In the year following the British epidemic
New Zealand in turn had the worst outbreak in its history
with an incidence rate of 56.8 per 100,000 whites and even
306
higher among the Maoris , suggesting the arrival of
carriers with a strain of exalted virulence from the
Home Country.
The existence of carriers and abortive cases also
explains a striking feature of cerebro-spinal fever epidemics,
namely the way in which even in cities most cases appear
quite unconnected both in time and space, so that areas of
simultaneous prevalence are separated by clear districts, and
an epidemic frequently seems to spread from many small centres
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rather than a single large one# Thus in the Texas epidemic
of 1912, out of 2,800 cases in only 5$ were two of a family
attacked, and in only one instance three in a family. On
the other hand the obvious infectivity of the disease was
269
shown by the deaths of a doctor and four nurses in 1917-J19 •
Cerefero-spinal fever has a very low incidence in
inter-epidemic periods, rarely exceeding 1-2 per 1000 even
in large cities, a figure much lower than the rate for the
exanethemataj but given suitable conditions such as a
severe winter and over-crowding of susceptibles with carriers,
a correspondingly steep rise occurs, and starting in the
New Year an epidemic of a new virulent mutant will reach its
acme in the spring and be burnt out by midsummer having
exhausted all likely contacts.
Diphtheria
Diphtheria was much more prevalent in the nineteenth
century, and as the "malignant angina or cynanche" was often
confused with anginous scarlet fever with which, as we now
know, it was often combined ' » fan j,n death-rate
began in 1880 and was attributable to a decreasing prevalence
of the disease, and especially of the more severe laryngeal
type, rather than to antitoxin which was only introduced some
fifteen years later, or to the immunisation campaign of
1941-'45 which merely accentuated a fall already far advanced.
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In Britain on the outbreak of war in September 1939
nearly one-third of the children under the age of fifteen
were evacuated from the citiee into the country, and this,
coupled with the closure of the urban schools, was followed
by a fall of over 4.0% in the diphtheria rates that winter
among the children who stayed In town. The influx of three
quarters of a million children however caused an immediate
rise of 60-70$ of diphtheria among the native children in
the reception areas, which fell back to the normal level in
six months. The epidemic prevalences occurred most
irregularly, and bore no relation to the number of immigres.
Stocks suggested that carriers had different strains of
the organism to which country children might or might not
have immunity, Greenwood likened the consequences to bad
shuffling of a pack of cards, where one village might get
more than its fair share of carriers and convalescents, while
Glover thought that thinning out of the children at risk
by billeting with adults, and double-shift classes in small
school-rooms, might explain the discrepant figures.
That the diphtheria bacillus was still ubiquitous
was shown by the immediate rise in faucial diphtheria in the
occupied countries of Europe so that the Pasteur
Institute in Brussels recorded 25,000 positive throat cultures
each year, while the Institute in Paris increased antitoxin
output six-fold In Lisbon laryngeal diphtheria was
46
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still quite common* representing one quarter of cases ,
and cutaneous diphtheria appeared on wounds in the Middle
and Far £ast seems clear, therefore, that
forecasts of big epidemics by dissemination during the war
were belied only by the low infectivity of diphtheria at its
present stage in the trough of its cycle#
Scarlet Fever
Following the demonstration by Lancefield and
Griffiths of the identical organism in other diseases,
scarlet fever must be regarded as but one manifestation
223
of epidemic streptococcal infection . Nevertheless it
is a clinical entity, and as such has been recorded distinct
from measles for four centuries, ever since Ingressio of
Palermo described his "Rossania" in 155° as "toturn corpus
ignitnm appareat" - the whole body appears on fire. In
1574 Ballonius contrasted the disease with measles, and in
1627 Boring of Breslau described the desquamation, sore
throat and dropsy ("abdomen intunescit" ) of a fatal ease.
Sydenham 2^° named the disease Scarlatina in I676, and his
immense prestige doubtless led to the adoption of the name
Scarlatine in France and Scarlach in Germany,
Throughout the eighteenth century scarlatinal
angina was widely confused with malignant angina or diphtheria,
just as the simple rash had been confused with measles in
47
preceding centuries. This severe anginous type of disease
reached its height in the first years of the nineteenth
century, tvaned until I83O, only to rise again the second
half of the century, as "the leading cause of death among
80
the infectious maladies of childhood" • Marlborough
College founded in 1843 had endemic scarlet fever almost
263
from its commencement , and in Liverpool at this time
scarlet fever and other infections killed nearly half of
the children before the age of five, (460,370 per million).
By the time a natural decline set in, in 1876, many personal
tragedies had occurred, such as that of Br, Tait, Archbishop
of Canterbury, who had lost five of his six children in
a single month.
There was nothing to show at the time that the decline
was anything more than the usual periodic descent which would
rise again in five to seven years' time. But the peak in
1878, when it came, was insignificant, and apart from some
excitement over the outbreak in Hendon in 1879 which revealed
a new hazard in milk-borne infection, and perturbation over
hospital 'return cases' in the '90's 313# 329 ^
there has been widespread gratification at the steady drop in
infectiveness and lethality of the disease (Fig: 1),
The lower mortality, which, even in the relatively
severe epidemic of 1921, only reached 1.04%, no longer
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Seasonal Incidence of Scarlet Fever and Diphtheria
in England and Wales from 1922-1929
Fig: 5, ( After Madsen 291,)
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justified hospitalisation, and attempts were made to lower
oo
the cost of big fever hospitals with large isolation wards ,
by gargling 316^ barrier nursing 378, 324^ cutjicies 39 ^
especially when it was realised that there was no danger
■t <5 <}
from vectors such as fleas , nor, as was long thought,
from desquamating cases. The main risk is, in fact, the
A lO
healthy carrier , with a haemolytic streptococcus which
can readily exalt its virulence. This is exemplified in
school outbreaks which usually do not begin until the second
or third week of term, suggesting a carrier in the school
299
rather than a child returning with the infection , while,
226
according to Kerr , out-of-season outbreaks are often due
to milk—borne infection from carriers.
Among additional reasons for supposing that we are
encountering a biological phenomenon such as a mutation are
the following - in cities in the temperate zones, where
scarlet fever is endemic, a marked seasonal wave is seen
each year with its zenith in October and nadir in the spring,
when the epidemic suddenly abates often without apparent
relation to the weather. Moreover there is an epidemic
prevalence at intervals of about five years, and it is said
to present an even better marked epidemic wave every thirty
236 223
years ^ , especially as regards severity . Although
this country has been favoured by a decline in severity,
Eastern Europe and the Far East still show fatality rates
Cases of Diphtheria and Scarlet Fever in the United States
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Seasonal Incidence of Scarlet Fever and Diphtheria
in the United States from 1920-1929
Ftg: 6. (After Madsen 291
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exceeding \0%t and so appear to experience a quite
asynchronous cycle. Among other curious features of
scarlet fever may be mentioned the almost complete
immunity of natives in the tropics, the preponderance of
200
infection among males which may be as high as 3 *1 ,
and the frequent association with anterior nasal diphtheria,
chickenpox, erysipelas and erythema nodosum.
Measles
Ever since Whitelegge remarked on the
periodicity of measles in 1892 men have been tantalised by
the inexplicable cyclic phenomena of this disease. That
there are singular peculiarities in the behaviour of measles,
recurring after both long and short periods, becomes obvious
on the most superficial scrutiny of the statistics, but the
explanation, and still less the correlation, of these changes
at once leads into realms of pure speculation. Brownlee's
conception of ttvo waves, one seasonal, and the other inherent
in the virus, and both nearly two years long, mutually
interfering in the manner of beats, was but one attempt to
fit into a single theory seasonal incidence, biennial waves,
long-term cycles and the skewness of the individual wave •
And if for the wave inherent in the virus be substituted a
mutation the theory might well fit the facts.
Hamer, facetiously suggesting that Brownlee's two
different waves coexisting in London implied different sorts
52
Fig: 7, The biennial wave of measles shown by Madsen's Graph
for Denmark from 1900 to 1927 29*,
t
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of measles at either end of Waterloo Bridge, may have
spoken more truly than he knew, for he interpreted the
biennial cycle as a periodic change in the constitution
of the populcTtion at risk, which leads after each epidemic
173
wave, to a gradual re-accumulation of susceptibles 'J,
and while Topley and Greenwood showed that, in fact,
widely spaced waves could be reproduced by slow immigration
of fresh susceptible mice into a herd surviving from an
epidemic, this still does not explain why although the
great infectiveness has remained constant to this day,
and defies all progress in preventive medicine, fatalities
have markedly diminished even from the eighteenth century
when the severity of measles led to confusion with smallpox.
The death rate is now one quarter of thirty years ago, and
the improvement cannot be entirely explained by the rise
to a safer age-incidence J .
Moreover the seasonal incidence of measles
epidemics was formerly summer and autumn; but a change to
late winter occurred quite abruptly in this country, in the
case of Glasgow, for instance, in 1904 In hot countries
such as Spain, Portugal and Egypt 22^, and also in India,
396
Burma and French Indo-China where the biennial cycle has
set in, the main incidence is still in the summer especially
in dusty weather, for instance just before the monsoon.
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BEAT BEAT
Fig: 8, Beats are heard in music, and particularly in bell-
ringing, when two notes almost, but not quite, in
tune sound together. Brownlee had suggested that
a similar "beat-wave" compounded of two lesser waves
Just out of phase could occur in epidemics as they
343
periodically augmented each other .
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However both the regular seasonal incidence and
the biennial wave are liable to be disturbed when measles
occasionally changes its stride# Thus no epidemic
appeared in 1861 or 1862 in Glasgow, in 1918 or *19 in
Manchester, *21 or *22 in Leeds, nor in 1936, '37 or '38
in large areas of Australia 343 Whixe the widespread
disturbance in the cycle in 1940, while doubtless due
218
partly to evacuation of children in Britain , had no
such explanation in New York 4*4. early '90's
Glasgow and Renfrew had epidemics in the odd years, but
in 1898 the even years received the waves which concentrated
on a midwinter biennial cycle in 1904* while London changed
step from odd years to even in 1918, and Manchester followed
in 1920, The long-term cycle, which really amounts to a
progressive flattening or increasing swing in the amplitude
of the biennial waves, w»as elegantly demonstrated in the
Renfrew statistics, the incidence waves rising uniformly
between 1904 and 1908, and falling as regularly between
1908 and 1912 343.
A curious phase of the measles cycle is the
autumnal trough occurring in August and September between
the consecutive minor and major measles epidemics, and
alternating with the long five months sub-epidemic level
occurring in other years. This is well seen in Butler's
super-imposed graphs of wartime epidemics ~*4 (Figs 9)#
0
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Fig: 9. Butler's superimposed graphs 53' of three epidemics
of measles shows the remarkable way in which the
successive biennial waves follow a common pattern.
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and Stallybrass has remarked that this deterrent effect
on the infectivity is also seen in influenza and may occur
in September when the dispersability of scarlet fever and
diphtheria are reaching their height.
Whooping Cough
In the winter of 1845 Farr recorded a big epidemic
of whooping cough occurring in London in conjunction with
measles, influenza and typhus. This close association
between whooping cough and measles has been noticed on many
occasions since, especially in the large cities of Europe
where the two diseases are epidemic every three years
during the winter and spring ^ (Fig: 10). Remarkable
changes have occurred in the rise and fall of the epidemic
waves, the troughs sinking so low by 1931-'40 that a large
part of the inter-epidemic periods were free from deaths,
and the overall death-rate between 1921-'30# while still
exceeding that of both scarlet fever and diphtheria
223
combined, was but a third of that half a century before .
Whooping cough has a predilection for girls and
299
twice as many epidemics occur in their schools as in boys* .
Moreover 99 »3'® of cases notified in four London boroughs
were children under the age of fifteen ^12, „nt? as^ even
on previously unexposed islands such as Samoa, Guam and the
396
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Seasonal Incidence oe Whooping Cough in Denmark
Fig: 10. The triennial wave of W.hooping Cough shown by
291
Madsen's Graph for Denmark from 1900 to 1927
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affected, one must conclude that adult resistance to the
H. pertussis is a change in the parasite-host relationship
and does not merely depend on previous subclinical attacks
as might be supposed.
SETTLING IN EPIDEMIC CYCLES
291
Madsen working in Copenhagen in 1937 used the
homogeneous and highly organised population of Denmark
to study cyclical changes in the common infections there.
His graphs cover a decade and show most elegantly how
remarkably uniform the recurring waves are both in wave¬
length, that is the duration of the epidemic, and in
amplitude representing its incidence. But they also show
a much more significant feature, that there are distinct
groups of epidemic diseases.
Group 1.
First there are, for example, scarlet fever and
diphtheria which have settled down over the centuries to
a strictly seasonal incidence with maxima in November and
January respectively, and minima in July. Year after
year they follow this seasonal channel unchangeably, so
that they are in a sense more endemic than epidemic.
Madsen's graphs for these are shown (Figs! 5 & 6}a
60
Group 2,
By contrast there are those diseases which also
recur rhythmically but whose waves of infectiousness
quite overcome the seasonal variations. Measles comes
round every 2-3 years and whooping cough every 3-5
^respective of the season, so that while the maximum
mortality for whooping cough may be, as if often stated,
in the spring, the maximum incidence may occur at any time
of the year (Figs* 7 & 10)•
Group 3#
Finally there is the peculiar example of influenza,
whose fluctuations appear so asynchronous on a graph that
they can only be due to several superimposed lesser waves
alternately potentiating or opposing each other (Fig* 11).
Madsen attributed his waves to alternating variations
in human resistance, citing Simpson and Clayson's ^97
observation that pus in tuberculous glands is greatest in
g
March, and his own discovery that the response of animals
to diphtheria toxin is greatest in winter. But a much
more likely explanation is a variation in the parasite, and,
if we accept this, it is hard to resist the conclusion that
recurring mutations are at work, and are more drastic in
some species than in others* It is the hypothesis of this
study that this is precisely what is happening. It is
suggested that there is a gradation in the epidemicity of
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Fig: 11, Incidence of Influenza in Copenhagen, 1917 - 1936
(after Madsen 29*),
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infectious diseases which depends on their mutability.
Measles and whooping cough, and still more influenza, are
still very actively mutating, and their abrupt transitions
cause a greater impact on the individual and on the
community. Such diseases as diphtheria and scarlet fever
long ago became more quiescent, and, while still mutating,
they have reached a stage of greater stability. If
successful parasitism is the objective of the species then
equilibrium with the host must be the measure of its
success. But perhaps the best evidence is, by contrast,
the extreme mutability and therefore instability of
influenza which is described in Chapter 4»
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CHAPTER 4. INFLUENZA PANDEMICS AND IMMUNOLOGICAL DRIFT
HISTORICAL INCIDENCE
Although this disease was ironically referred
to as the "Newe Acquayantance" at the court of Mary Queen
of Scots in 1562 , there seems little doubt that
epidemics of chills, coughs, langour and fever identifiable
as influenza have recurred for over a thousand years since
A.D. 877* Precise descriptions of the 1657 outbreak were
left by Willis, of that of 1675 by Sydenham, 1729 by
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Huxham and 1767 by Heberden, so that Creighton remarked
that influenza almost alone among infections diseases had
remained true to its type. But although this persistent
success has required no clinical change, remarkable
mutations of the antigen have occurred to evade the
antibody defences. Thus 1847 ushered in the era of modern
pandemics recurring at 30-4° year intervals, in which the
virus showed that it had evolved to complete supremacy of
infective power with a toxicity almost unrivalled by any
other infectious disease. This pandemic lasted six weeks
and at its height in the first three weeks of December
1847 the death rate for the elderly rose by 247$ due to
influenza and its complications of bronchitis and pneumonia.
After 1850 the disease almost disappeared until the
next great pandemic of 1889-'92. Once again a high death-rate
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from pneumonia was seen and for the first time the epidemic
revealed the successive waves separated by short intervals
characteristic of modern influenza. It was realised that
miasmatic and climatic causes were no longer tenable, and
that the disease had spread from person to person by direct
contagion, coming to this country from China and Russia,
and continuing westward to America and Japan.
In contrast to the previous inter-pandemic period
the next twenty-five years were marked by repeated minor
outbreaks culminating in the astonishing pandemic of
1918-'19 which exploded almost simultaneously all over the
world. In a few months influenza killed 10 million, more
than the greatest war in history had been able to achieve in
five years, and the disease fell as heavily on Samoa and
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other Pacific islands as on nations exhausted by the war •
Almost everywhere a characteristic tripe wave was
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seen. Thus in Great Britain the epidemic began at the
end of June with an abrupt onset of 3-day fevers, continuing,
mostly in the younger population, for six weeks. At this
stage the fever was followed by a rapid convalescence and
low mortality. But in October a second wave of much
graver illness arose, and starting insidiously it lasted for
twelve weeks. Three-quarters of the deaths occurred in
6 321
this wave, often due to secondary broncho-pneumonia '
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heralded by heliotrope cyanosis and haemoptysis on the
third or fourth day. In February 1919 the third phase
was seen as a final wave of intermediate virulence lasting
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eight weeks .
After 1918 influenza resumed its former role in
2X0 j 2
minor outbreaks (Fig* 11) which, Brownlee asserted,
tended to occur in a 33-week cycle or its multiples^
preceded in the previous week by pneumonia and a fortnight
earlier by bronchitis, diseases which, he suggested, had
become ancillary to influenza in the outbreak of 1889*
The seasonal incidence in January and February was seen in
the British epidemics of 1920 1936-,37» and 1940 2^»
and in Australia in 1939 » but Burma and Siam experienced
annual outbreaks in the cold season following the November
north-east monsoon.
In 1931 Shope showed that Swine Influenza was due
to simultaneous infection by a virus and Haemophilus influenzae
suis, neither being sufficient alone. However no such
symbiosis has been found necessary for the human disease, a
virus, now known to be one or other of two types 'A1 or 1B*,
sufficing alone. Whereas both types are clinically similar
being primarily respiratory infections with a 2-day
incubation period, and probably only a single day of
infectivity, *B« is a milder disease. A is on a 2-3 year
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cycle, B on a cycle twice as long. In addition however
to these regularly recurring waves there is a much bigger
cycle accounting for worldwide pandemics nearly half a
century apart.
Thus early in 1957 Chinese virologists in Peking
reported a new strain of A. The 1782, 1830, 1889, and
1957 epidemics all originated in China and the World
Health Organisation, of which China is not a member state,
believes that the disease is harboured there in horses,
pigs and wild animals 478^ TJie virus was found
to be infecting horses and pigs in many countries, and
Swine Influenza ^95 ifSeif first reached prominence during
the 1918 human epidemic even suggesting that it had arisen
from the human disease.
The new 1957 virus was found on arrival in
Singapore to be immunologically distinct from all previously
isolated strains, and it was realised at once that the
whole population of the world was potentially susceptible.
As expected Strain A/Singapore/1/57 as it was called spread
round the world westwards in 2 waves reaching the British
Isles in Autumn '57 and January •58 where 3#000 deaths were
recorded. The confident predictions concerning the 1937
epidemic were based on new knowledge of the structure of
influenza virus. The inner ribonucleic acid core is fixed
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and distinguishes the virus itself as 'A' or 'B'. The
surface protein which is concerned with the initial
infectivity is immunologically constant for that one single
epidemic only} but subsequent changes are of minor
character until a major variation occurs, roughly once in
a decade. Thus the virus of the spring of 1957 was
unraistakeably 'A* but the surface antigen marked a sharp
break from those of the previous large epidemic of 1946.
It was realised that the entire world might well be at
risk, and that Europe and America could count on up to 6
months delay to prepare their vaccines, but that Australasia
would be attacked imminently, and this in fact happened.
Many millions were vaccinated, particularly in the U.S.,
using inactivated virus grown on the allantois of chick
embryos. It is a measure of the exalted virulence that
pandemic *A' flu infects the allantois as well as the amnion}
ordinary inter-epidemic 'flu needs serial passage before this
is achieved.->2.
Observations in Australia 2^ showed that those over
25 years old had some degree of immunity, suggesting that
the 1935 epidemic, a quarter of a century previously, had
marked the appearance of a new variant virus. But neither
infection by this nor by the 1946 strain could ensure full
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protection in 1957• On the other hand Mulder and Masural
were able to show in Holland that survivors of the 1889-92
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epidemic still living were not only spared but gave
serologically evidence suggesting that they had encountered
virus A/Singapore/1/57 before This affords an
implication bordering on the bizarre - that Flu virus is so
mutagenic that in less than a century, it has exhausted the
available permutations even of major variants and inevitably
repeats itself.
Hirst "^7 ^ serological absorption tests showed
in 1952 that seven distinct types of Influenza A had
temporarily established predominance in the previous 20
years, and Burnet later detected almost annual changes
suggesting that there was very frequent discontinuous mutation.
Each mutation proceeds from the former ones so that immunity
will confer protection also to the earlier strains$ but not
to future ones unless back mutation occurs. Mulder's
immune octogenarians suggest that such a back mutation
occurred in 1957 and that therefore a long-term cycle may
well exist in the antigenic variation of Influenza A.
Similar cyclical changes are still more likely among the
minor mutations and could explain the biennial frequency of
interepidemic 'A' and the 4-yrly waves of 'B', while
superimposed mutations in virulence, and transmissability
226
which are always occurring must add further esoteric
effects. There is some experimental evidence too that




mutability. Burnet Fraser and Lind mixed large amounts
of the Melbourne Epidemic virus with another strain in
chick embryos, and claimed recombinants emerged with
character derived from both. Suffice is to say that
recent outbreaks continue to display the cyclical phenomena
of this historic disease and that the 1959 Influenza of 'B'
type showed serological resemblances to that of 1954 420^
GENETIC DRIFT
The principle of genetic drift is generally accepted,
whereby successful new characters replace the outmoded old
in a community by elimination and gradually become the normal
features, A similar Survival of the fittest* would appear
to be spreading with the 'flu viruses throughout ages, and
K2
Burnet J has suggested that they show an Immunological
Drift analogous to the genetic drift of higher species.
Hirst had disclosed the succession of antigenic
patterns evolved by Flu virus A, each in turn sweeping the
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world, Jensen , however, showed that there were three
marked discontinuities so that in the 40 years 1918 to 1957
there was a particularly abrupt change of the virus in 1929
after 11 years and again in 1946, with a final decade ending
in the 1957 epidemic. He suggested that 4 distinct families
of virus succeeded each other at these times, and persisted
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for one or tv,'o decades. Even if we accept this view, that
such major variations succeed each other, it would still
appear that minor variants similarly replace their
predecessors almost annually, and are no less successful in
spreading throughout the world. This is borne out by the
Davenport phenomenon °^, that the first fA» flu epidemic
in childhood largely determines one's immunological response
throughout life. Thus at present (1962) only those over 33
yrs. old have the antibodies to the pre-1929 epidemic strains,
and only these over 12 to that which followed, while present-
day children should have the 1957 "Asian" strain as their
dominant 'flu immunity. By the Davenport principle each new
epidemic will supersede all those previous to it, conferring
immunity to itself and also afresh to the strains previously
encountered, and thus preventing these strains returning to
the population a second time. Eventually all the permutations
having been exhausted, a major mutation of a lifetime ago will
be repeated so that, as Mulder found, the very elderly are
confronted by a familiar strain once again.
Owing to its intense infectivity and droplet spread
Influenza viruses have potentially the whole world for their
arena; and certainly all civilisation will be successively
assaulted by each new variant strain as it rises to replace
the last. There seems no real reason to doubt that a
similar continuous evolution based on successful mutations
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is operating with other parasitic organisms, and there is
evidence that this is so, for example with the enteroviruses
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particularly the ECHO infections ° and anomalous polio
strains. Cut whereas 'flu by its rapid spread can always
find outlying human communities in which its novel forms
can secure a new foothold, the enteroviruses depending on
faecal transmission and at the mercy of all modern man's
sanitary improvements, will only rarely mutate sufficiently
to succeed in the same population as that infected already
by the parent virus. Such a new variant is suggested by
the worldwide spread in the 20th century of paralytic polio
occurring in epidemic form. But in general the picture
with the enteroviruses is not one of world pandemics as
with 'fluj but of localised out-breaks in which dozens of
variants. - ECHO viruses, Coxsackie and true polio can co¬
exist without any one assuming temporary world-dominance.
PART II.
RHYTHM IN BACTERIAL MUTATIONS
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CHAPTER 5. THE NATURE OF BACTERIAL MUTATIONS
The ability of a proportion of bacteria in a strain
to withstand a drug depends on an adaptation. In theory
there are two such methods of adjustment to the adverse
environment. In "phenotypic adaptation" changes in the
cytoplasm occur in at least a few cells, such as the
production of the enzyme penicillinase whereby the toxic drug,
in this case penicillin, is neutralised. These phenotypically
adapted cells can coiae to outnumber their sensitive counter¬
parts as the drug continues to actj but they do not transmit
the nettf ability genetically, and removal of the stimulus is
believed to lead to immediate loss of the characteristic.
In "natural selection" or "genetic adaptation" the
chance occurrence of naturally resistant mutants enables the
race to survive, and by overgrowing the sensitive population,
as it is exterminated by the antibiotic, a new drug-resistant
strain appears capable of taking a permanent place in evolution.
Much discussion has centred on an apparent distinction
between two patterns of drug-resistant mutation. With
penicillin and most other antibiotics bacteria serially
subcultured with increasing amounts of drug gain resistance
in a regular step-wise manner. With streptomycin the
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increase in resistance can be abrupt, and, it is often
said, of unpredictably large or small degree. In fact,
however, as experiments in this thesis will show, there
is no real distinction except in the degree of mutation
rate. First-step and subsequent mutants of all degrees
can be shown alike to streptomycin and other antibiotics;
but with some drugs, and particularly streptomycin itself,
they all occur with much greater frequency.
While imitations confirming drug-resistance to
2 'i
insecticides seem to be possible to all insects , this
is not so with bacteria where certain species such as the
Haemolytic Streptococcus have failed through many thousands
101of generations to produce penicillin-resistant mutants •
Natural Selection is a preferable term to genetic
adaptation, which can have the unfortunate connotation that
creatures are deliberately adjusting not only their own
destiny, but that of their progeny. This of course never
happens. Either a species fits its surroundings or it
does not. If it does not it will fail to reproduce and
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the race will vanish J•
This process of screening occurs tliroughout nature
and examples of such apparently intentional sorting, which
are quite as remarkable, occur among inanimate objects
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subjected to physical forces regularly applied. An extreme
example is Chessil Beach in Dorset where the pebble© are
accurately graded for 18 miles from bo 6" in diameter
apparently by tidal drifting
With living creatures there will be mutations and
variations constantly occurring, and in a ceaselessly
changing environment these new combinations arising from
the astronomical numbers produced by living protoplasm will
be needecf merely to maintain a stable equilibrium. "Natural
Selection" or "Adaptation", call it what we will, is merely
a demonstration of a game of chance in which a species, by
its mutants, survives the ever-changing conditions through
time.
Microbes evolved early in the world's history, and
where there has been no call for any change in specific
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characters these have been fantastically immutable • Thus
a dental abscess has been found in a dinosaur skeleton 100
million years old, and cocci occur in pre-combrian limestone
18 5
five times as old again . Staphylococci have kept their
cluster formation of some twenty organisms for at least sixty
centuries as shown in serial sections through the gums of
an Egyptian mummy (Fig: 12). Similarly the production of
coagulase is evidently a very fixed characteristic of
virulent staphylococci* Strains of Staph, albus isolated
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Fig: 12. Transverse section of alveolar margin of tooth of
Egyptian mvmy of approximately 4000 B.C. The
cluster of Staphylococci near the centre was
seen in several contiguous serial sections.
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from urinary infections niay not possess this feature,
presumably because their parasitism was on the surface
of, for instance, the bladder mucosa. Four such strains
injected intraperitoneally into mice produced a purulent
ascitis still without invoking coagulase production. It
seems likely that possession of the enzyme would require
a mutation only likely to persist where invasiveness is
demanded of the parasite,
THE MECHANISM OF SPONTANEOUS BACTERIAL MUTATIONS
Hugo von Mohl in 1846 wrote: "The remainder of
the cell is more or less filled with a white fluid having
granules intermingled in it, which fluid I call protoplasm",
Tliis description applies to all living cells, and bacteria
are no exception; but in them the granules of protein and
ribonucleic acid are so numerous that they mask the sharp
distinction between nucleus and cytoplasm which we see in
higher organisms. If the ribonucleic acid granules are
dissolved by hydrochloric acid, nuclear bodies can always
be found showing the staining characters of desoxyribonucleic
acid (BNA), the characteristic component of true nuclei.
Unlike nuclei, however, the nuclear foodies of bacteria
divide asexually and not by mitosis.
Normally bacteria divide by simple fission of the
nuclear body, each half retaining round it its half of the
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cytoplasm, and the resulting progeny maintain their
characters unchanged through generation after generation.
In the nuclear body are genes believed to be molecules of
BHA, which determine these unchaning features, and there
must be fully a thousand, each reproducing itself and
controlling a distinct substance or enzyme figuring among
the inherited characters. Presumably at meiotic cell
division the genes align themselves along the axis of a
chromosome in regular order, ready to split into two
parallel sets, one for each daughter bacterium.
If a gene becomes altered displaced or lost, one
or both daughter bacteria will be mutants with a new
characteristic which they thereafter transmit to all their
offspring until some further mutation occurs, or still more
rarely, until a "back-mutation" reverses the first. Any
gene may suffer such a spontaneous mutation, and the rate
for any one gene is probably constant, although the different
genes differ widely from each other. Thus buguid has
pointed out that a large bacterial colony, resulting from say
a thousand million divisions, will have thousands of mutant
cells, most due to genes mutating at perhaps 1 in 10* per
generation, but a few to those with only 1 in 10^° mutation
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The mutant cells on the scale seen among bacteria
could be lethal to a higher animal if they flourished and
colonised its tissues. Is the incompatability of homografts
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an example of pr©-adaptation as Medawar has suggested?
In mammals, by making a mother shed the foetus and placenta
in their entirety, it can prevent the ongrovrth of foetal
tissues which could become hyperplastic. But the
incompatability of homografts also occurs in fish and
reptiles who originated 300 million years before the first
mammals•
Besides the actual phenomena of mutation the
existence of an 1ecological niche* appears to be essential
to evolutionary changes, because unless the new forms have
the opportunity to mix and exchange genes in relative
isolation, they will not dominate a species. Such a niche
occurs in hospitals where nasal carriers among the staff and
actual patient© enable the relatively rare penicillinase-
producing staphylococci to multiply in relative isolation.
1 e e
Gerard has called this micro-evolution * Thus
streptomycin-resistance is due to micro-evolution by a high
mutation rate in a single host while penicillin-resistance
is a slower micro-evolution due to a low mutation rate among
populations of bacterial strains in the ecological niches of
hospitals.
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As long ago as 1928 Griffiths showed that a
transfer of genes occurred between two pneumococcus variants
A and B# He mixed dead A and live B variants and injected
them intraperitoneally into a mouse* Subsequently living
A types were found in the mouse, showing that transformation
has taken place by A introducing genetic material into B,
This transfer cf protoplasm can also occur by transduction,
in which a bacteriophage virus successively invading A and
B can remove protoplasm from one to the other*
Thus in addition to the classical sexual union of
higher animals in which two partners contribute half-shares
to the genetic constitution of their descendents H'^, there
are at least two other possible processes for maintaining a
species in nature, transformation and transduction, and both
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may occur among bacterxa .
Another relatively rare mechanism giving mutations
which appear to be heritable, is lysogenic conversion* This
occurs when a parasitic bacteriophage contributes genes to
its host, and unlike transduction the entire infected
population of bacteria will exhibit and transmit the new
characters but only, of course, during the sojourn of the
parasite* Lysogenic conversion is known to explain toxin
production by hitherto avirulent diphtheria bacilli*
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The most remarkable of all phenomena conferring
new inherited characters is conjugation between bacilli*
Certain E. coli when in actual aposition fuse sufficiently
for genes to stream across from one cell into the other.
The recipient, now at least partly a diploid cell, undergoes
a reducing division to yield two haploid bacilli with
characters derived from both parents. The fertility factor
which predisposes to this phenomenon is itself thus passed,
and also that controlling colicine production, but for other
genes this must be quite exceptional, although Xalabarder
by studying serial electron photomicrographs has suggested
that it is the rule, rather than the exception as is
generally supposed 483 ~ 488? 49°» 491. This will be
further discussed in Chapter 12.
Not only are all these four mechanisms probably
rarities, they are also necessarily haphazard in their
incidence, and we are looking, of course, for a regular
cyclical phenomenon capable of explaining the systematic
wave-like rise and fall of epidemic diseases. This thesis
is intended to show that spontaneous gene mutations by their
essential constancy could offer a mechanism which would
fulfil this role.
The alternating "phase variations", among, for
example, Salmonellae, by which fimbriae and flagella are
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lost on solid media only to be regained in liquids, have
been regarded as arising from exceptionally prolific
mutations; but whether they ore indeed genetic seems
doubtful.
ARTIFICIAL INCREASE OF MUTATION RATES
mutation, it is tempting to suppose that the environment
was itself the cause of the change rather than merely
selecting organisms from the results. Certainly there
are mutagenic agents in the environment such as radiations
and chemicals which can increase mutation rates thousands
of times, and some are used, for example in the propogation
of antibotic-yielding moulds. But mutagens cannot do more
than increase the overall mutation rates for all the
exposed genes. They cannot promote one selected character,
although the same agent might presumably provide also the
environmental conditions for subsequent selection.
THE CONSTANCY OF BACTERIAL MUTATIONS
be quite frequent among bacteria because of their enormous
multiplication, and among the best known are the dwarf
'L-forms1 in many species. These variants, often only 200
Since natural selection may first disclose a
It is now generally appreciated that mutants must
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in size are said to be stimulated by antibiotics
and so may be part of a cyclic change to withstand adversity^S
though Tulasne and Brison have also suggested that they
persist ^52^
The species Escherichia coli mutabilis is remarkable
for its instability, and Zamenoff has shown that the
strain contains, in fact, two main mutants, one long-chained
and less active than the discrete type, which alternate
every 1,000 to 5,000 divisions. There have been occasional
calculations of the frequency of various other mutations:
A*71
thus Wltkus observed that white colonies appeared among
the yellow of Sarcina lutea in a fixed proportion of 1 in
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40,000, and Elek found that streptomycin-resistant
mutants in a strain of Staphylococcus aureus were constant
at 1 in a 100 million before the drug itself disturbed the
equilibrium. Illemann-Larsen showed more precisely that
matiiral resistance to 4 g» of streptomycin distinguished 1
colony in 14,600 of a strain of tubercle bacilli20^. At a
medical conference in Moscow in 1962 pale colonies were
described among the red in Scrratia marcescens appearing as
mutants with a constant rate of 1 in 10 .
then we look for reasons why such counts have not
been made more often, we find that the apparent simplicity of
the calculation is misleading, because, in fact, a single
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isolated character which is also conspicuous like the colour
of the colony is exceptional. Much more commonly the mutant
is one of many, differing either in degree or controlling quite
distinct characters.
THE HETEROGENEITY OF A BACTERIAL POPULATION
Thus even such an apparently uniform characteristic
as the drug-resistance of Pseudomcmas species is, in fact,
possessed by only some of the bacilli Welsch
showed that Staph, aureus No. 126 had two distinct mutants
both resistant to 5 of streptomycin but one with full-
A21
sized colonies, the other with much smaller ones. Szybalski * °
in a classic experiment using penicillin gradient plates
seeded with Staph, aureus N.R.R.L. No. 313 found among its
resistant mutants 1 in 20,000 which not only survived themselves;
but also allowed a halo of faint general growth around. He
showed that these were, unlike all the other resistant mutants,
penicillinase-producers rather than outrightly insensitive, in
fact they only just withstood penicillin themselves. They
differed, too, from other penicillin-resistant mutants in being
as fast-growing and virulent as the parent sensitive strain,
so that clinically they could eventually become dominant even
if initially they were the rarest of the rare.
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PROGRESSIVE MUTATIONS
Drug-resistance is not, however, a mere matter of
the simple accumulation of these insensitive mutants. Thus
Tompsett ^9 explained relapses in his tuberculous cases by
observing that bacilli resistant to l^g., isoniazid had
become a third of their Mycobacterial populationj but Wallace
and his colleages in Edinburgh showed in a similar series
that in spite of back mutations there was a steady rise in
absolute resistance reaching the maximum strength tested
(50 ^vg.) in less than five weeks. It seems quite clear that
such mutations are not only cumulative but also progressive
and that, as Demerec suggested with penicillin-resistant
staphylococci, higher potency genes emerge at every step.
Experiments with specific strains of Escherichia coli will be
described to show that drug-resistant mutations are not only
regularly occurring but that these in turn are the progenitors
of regularly occurring resistant mutants of higher and higher
degree. We will then go on to study similar regular mutations
recurring among the tubercle bacilli multiplying in anindividual
patient as an ecological niche over months or years, and finally
we will consider the implications of such periodically emerging
mutants in the cycles and evolution of infectious disease.
The particular mutants chosen throughout these studies were
those conferring resistance to streptomycin for the reasons
given in the next chapter.
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CHAPTER 6. DRUG-RESISTANCE AS A VISIBLE MUTATION
To a biologist all living things are the products of
evolution, and to a bacteriologist there is the additional
fascination of watching his organisms pass through a score
of generations in a single day. Among the prodigious
numbers of organisms involved, mutations are sufficiently
numerous to be seen happening before our eyes. A drug-
resistant mutation is only one of these manyj but it is
conspicuous, and may provide a new tool for studying the
frequency of bacterial mutations in general.
Drug-resistance may appear during any chemotherapeutic
regime, and is almost certainly due to the selective breeding
of a few resistant bacteria present in the original stock of
infecting organisms 2^, Thus in prolonged therapy as in
tuberculosis the gradual onset of resistance in cultures
isolated during the first few weeks, the increasingly rapid
progress from the second or third month, and the final
attainment of an apparently permanent level of high resistance
provides in many cases strong presumptive evidence that we are
dealing with the cumulative effects of multiplying variant
bacteria.
The experiments which will be described in this thesis
suggest that this selection of variants is indeed occurring,
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though it would appear from the continuing superior count
of the control plate that not all the progeny remain
genetically stable. If it could be shown that the
frequencies of occurrence of drug-resistant mutations are
constant for any one strain of a species, both initially,
and as regards the progressive mutations producing a
cumulative effect in successive generations, the knowledge
could be of clinical significance.
Garrod has pointed out that apparent
superinfection during antibiotic therapy could be due to
the emergence of resistant organisms already present, to
the drug actually stimulating them, to disturbance of the
natural antibiotics which supposedly maintain their
equilibrium, or to a new opportunist organism which chances
to find the vacuum. Of these much the most likely is the
firsts resistance due to the multiplication of an existing
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mutant clone. Eagle in the case of penicillin-resistance
suggested that several alternative mechanisms could confer
such survival# They could produce penicillinase extra-
cellularly, or intracellularly, or avoid binding the drug
altogether, in which case, as he showed, unaltered penicillin
itfould remain present.
The team-workers of Finland *^6 ant| Barber
have shown that penicillin-resistant staphylococci have
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multiplied from a few variant strains which originally happened
to possess the neutralising enryme penicillinase* The
actual individual mutation from penicillin-sensitivity to
penicillin-resistance has not yet been observed and it must
be of exceedingly rare occurrence. By contrast, resistance
of staphylococci to the other antibiotics appears to have
come about by current mutations. Evidence of these mutations
is seen clinically most often with streptomycin, and less
frequently with erythromycin, novobiocin and the tetracyclines,
while with chloramphenicaol they seem to be rare 460.
This apparent rarity of chloramphenieol-resistant
staphylococci is not, as might be supposed, related to the
amount prescribed 400^ Sp£^e Qf ^he heaviest use
of the antibiotic the phenomenon still holds true ^7/t 476^
and is partly due to a low mutation rate but still more
to a relatively high back-mutation rate restoring the
staphylococcus to its original status of chloramphenicol-
sensitivity 166, 234^ This is readily seen in surgical
wards, where stopping the use of chloramphenicol allows the
rapid return of sensitive organisms Cessation of
penicillin, by contrast, confers no such immediate benefit
because the penicillin-resistant strains must be actually
replaced by the slow regrowth of sensitive stocks unhelped
by mutations. The other antibiotics, streptomycin and
the tetracyclines, lie intermediate in this respect between
these two extremes.
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Since Rammelkamp and Moxon 355 first postulated
the existence of these mutants there has been much speculation
as to their origin, and Fairbrother suggests that
penicillin-resistant staphylococci represent a survival from
a primitive or saprophytic type. Inherently high drug-
resistance is certainly more common among some of the less
parasitic organisms such as Staoh. albus. and species of
Proteus and Pseudomonas. and it has even been found in
175
Staphylococci from the jungle of New Guinea .
The pattern of drug-resistant mutations varies with
A "I
the species of organisms as well as with the antibiotics
170
and their dose ' a great deal more than is generally
supposed. There has never been an authentic report of any
strain of true haemolytic streptococci gaining resistance to
penicillin, chloramphenicol or erythromycin 23# 135, 359, 3/6
271
though a few strains have achieved tetraeycline-resistance «
H. influenzae has remained consistently sensitive to
176 502
chloramphenicol ' j but species of the genus Proteus
158
resistant to this antibiotic are increasingly encountered .
The enormous reproduction rate of bacteria would
allow even the rarest variants to replace the normal
population, strains of Staphylococcus aureus resistant to
penicillin and other antibiotics are now notoriously
prevalent 17' l8' 124' 131* 137' 158' 242» 355» 385' 4°°> 4°S#
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and although their daily exposure to almost universal therapy
is often cited as the cause ^70^ this cannot be the
whole explanation as Strept. pyogenes and Strept. pneumoniae
have similar opportunities without comparable deterioration.
It seems likely that a new factor, mutation-rate, must be
taken into account 1st the choice of an antibiotic, Such a
217
criterion would for example favour novobiocin and
cOi
vancomycin of the newer drugs, as resistance to them is
slow in onset, but would disqualify cephalosporin, nicroccccin
and albamycin to which resistance develops with unparalleled
rapidity.
THE MECHANISM OF ACQUIRED RESISTANCE TO TUBERCULOSTATIC DRUGS
In the case of the drugs used for tuberculosis the
very long period of treatment is especially conducive to the
emergence of resistance. When streptomycin was first
introduced and given alone, about one in four cases initially
sensitive showed resistance towards the end of the second month
of treatment 30°» 068^ ancj this may well have accounted
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for many relapses • Indeed it seemed only a matter of time
before infections resistant from the start to streptomycin
o o 2 CI
and other tuberculostatic drugs would be reported ' .
Some reassurance from these forbodings was gained by
the extensive trials conducted by the Medical Research Council
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using two or more drugs at the same time. As the mutations
confering resistance to the different tuberculostatic drugs
are quite distinct it was expected that the frequency of two
or more such mechanisms occurring simultaneously in an
on
individual bacillus would be of extreme rarity ~ . While
in practice the onset of resistance in tuberculosis, as in
other infections ^33# 351# 410, 482^ cer^a^niy retarded
by such devices, they do not appear to abolish the risk
indefinitely 434# 224^ perhaps because the dose of one
of the drugs, p-aminosalicylic acid (P.A.S.), is so formidable,
or its deterioration to meta-amino phenolis such, that
patients may fail to take what is prescribed 341# 433^ Doubly-
resistant mutants should in theory arise at a frequency
equalling the product of the single mutation rates, and if we
knew these we could calculate the risk.
STREPTOMYCIN-RESISTANCE AS A SPONTANEOUS MUTATION
One must not exaggerate the dangers, particularly with
in vitro tests which cannot comprehend the patient's own powers
of recovery, and in other respects may not be strictly
referable 101# 267# 369^ por ^stance extreme
streptomycin-resistance induced experimentally in cultures can
lead to actual streptomycin-dependence as described in Chapter 8.
The antibiotic# far from inhibiting the strain, encourages its
growth 409# 492^ Such anomalies do not appear so far, however,
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to have affected human cases, perhaps because they are readily
reversible ^34 # Synergism, the pronounced mutual benefit
sometimes seen to occur among pairs of antibiotics2"^' 220»240, 349# 322,
and its opposite - antagonism, do not seem to be demonstrable
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with tuberculostatic drugs J , while the phenomenon of cross-
112
resistance which occurs in other fields of chemotherapy
has not been a problem in the treatment of tuberculosis,
except of course with analogues derived from the same parent
drug. Moreover Linz and Lecocq showed that in cultures
from recovering tuberculous meningitis cases that streptomycin
sensitive bacilli will outgrow resistant bacilli when the
drug is discontinued? an example of the "Welsch Phenomenon"
which is doubtless life-saving on occasions.
Paine and Finland 334 had shown experimentally some
years earlier that both streptomycin-resistant and
streptomycin-dependant clones actually grew slower than their
sensitive counterparts, which may account for their relative
rarity in nature. But they also showed 335 that these rare
streptomycin-resistant and -dependant organisms could be
recovered from strains of E. coli, Staph, aureus, and Proteus
and Pseudomonas spp., given large enough inocula, and moreover
that given the opportunity they would breed true. Working
with Murray and Wilcox, Finland 323 had maintained thirteen
strains of resistant Gram-negative bacilli through a hundred
subcultures observing occasional sensitive colonies re-appearing
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in two after 28 and 59 transfers. But it mu$t be the
steady ascendancy of such sensitive organisms by overgrowth
from the start, rather than those only occasional back-
mutations, to which we must look for their predominance in
nature and presumably they possess a metabolic superiority,
although Stubblefield could detect no biochemical
difference in streptomycin-resistant E. coli even when they
also differed to a coccoid shape.
The advantage of using streptomycin-resistant mutants
is that they demonstrate quite clearly that they owe their
emergence and continued appearance entirely to the drug which
is under our control. In fact we are dealing with selective
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breeding, and, as Klein showed with resistant
staphylococci, a high concentration of streptomycin is
sufficient to disclose them, whereas successive more gradual
concentration are needed with penicillin. In three subcultures
he obtained Staph, albus 125® times more streptomycin-resistant,
and Price et al in fourteen transfers raised the
streptomycin-resistance of typhoid bacilli no less than 226,000
«| /La
times. Later Goldstein showed that a similar natural
selection explained the emergence of streptomycin-dependant E.
coli from rare mutants already present.
The irrefutable proof that streptomycin-resistant
organisms pre-exist for the looking was obtained by the elegant
94
261
replica plates of the Lederbergs . By making identical
impressions of colonies on both streptomycin-containing and
plain agar plates with a pad they showed conclusively that
particular colonies were streptomycin-resistant though they
had never been in contact with the drug until finally tested.
Doubts raised by Stenderup on the grounds that higher
levels of streptomycin-resistance, e.g. 512 ^.g,, only arose
in his experience from initial resistances of from | to 2
by successive cultures over a fortnight or a week respectively,
are really further evidence of continued natural selection and
not adaptation, as will be shown in Chapter 8 * In fact
12
Blondel showed that by restricting the chance of mutations
by deliberately keeping a Staphylococcal population below
loVnil., ®he was able to prevent streptomycin-!-resistance
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emerging altogether, Elek ' tentatively suggested from
early experiments that similar drug resistant mutants pre¬
existing in a typical E, coli population were likely to be
of the order of 1 in 2 million for streptomycin, 1 in 5 million
for chloramphenicol, and 1 in 15 million for oxytetracycline,
which would explain the relatively greater frequency with
which streptomycin resistance appeared clinically,
THE CONSTANCY OF STREPTOffYC IN -RESISTANCE MUTATIONS
From time to time there had been experiments suggesting
that streptomycin-resistances of various degrees appeared with
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a mathematical precision among multiplying bacteria. Thus
Miller and Bohnhoff 3*4 1947 had shown that a strain of
meningococcus had two such variants, one like the parent
but resistant to from 1 to 10,000 ^g., the other vary variable
in appearance and actually dependant on 100 - 400^g,, of
404.
streptomycin. The following year Yegian and Vanderlinde
counted streptomycin-resistant colonies of Myco. tuberculosis
H37R.V. by plating out liquid growths. Counts of the order
of 1 per million were obtained resistant to l^_g., with
decreasing counts to 10 |<Ag., and 100 ^Ag., and they confirmed
that the resistant to 1 |u_g., clone bred true. Moreover a
strain of tubercle bacilli from a patient responding to
streptomycin had similar counts, while a strain from a case
relapsing after a month's treatment had a higher count of
these resistant bacilli. This gave us prima facie evidence
that streptomycin-resistant mutation rates would prove as
predictable for Myco. tuberculosis as for other species.
CUMULATIVE AND PROGRESSIVE STREPTOMYCIN-RESISTANT MUTATIONS
Mitchison showed in 1950 that the proportion of
streptomycin-resistant among sensitive tubercle bacilli
needed to give a resistant culture varied directly with the
time available for incubation. Thus among his six strains
proportions of 1 : 440 or even 1 t 180,000 could suffice
given a fortnight, while rates of from 1 ; 6 to 1 J 130 were
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needed when only a week was available for their
multiplication. This is of course, largely a reflection
of the geometrical progression by which bacteria multiply.
But not entirely; because, although on the average as little
as 3^ of resistant bacilli will overgrow a Bubos culture of
^17
tubercle bacilli in 10 days , there are considerable
variations with the strain, and this is borne out clinically.
For instance Mitchison had among 18 cases of resistant
tubercle bacilli, 10 which persisted six months, 8 of which
rose to higher levels; but this very rarely reaches the
extreme of streptomycin-dependence seen with E. coli and
Pseudomonas sp*
Demerec, who first showed the mutational origin of
penicillin-resistant Staph, aureus in 1948 118^ aiso
demonstrated what Bryson and Szybalski ternaC the
"Obligate Multi-step Pattern" of such resistance. By this
was meant that the original strain had apparently only
resistant mutants of low degree, - 4 per 100 million
tolerating 0.12 units of penicillin in the case of Demerec's
staphylococcus. With each subsequent subculture of the
mutant clone in the presence of the drug, higher and higher
resistance was built up. This is also the pattern with
100 ooi 20A
staphylococci and erythromycin or carbomycin ' ' ,
20?
with Mycobacteria and neomycin , Esch, coli and
62
chloramphenicol , and in fact with most bacteria and
antibiotics.
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With streptomycin-resistance in staphylococci,
however, Demerec was able to show a contrasting
"Single-step Mutation Pattern". The very first culture
isolated already contained resistant mutants of all degrees,
and subsequent subculture continued to show a similar range.
A like "Single-step Pattern" of streptomycin-resistance was
shown for Esch. coli by Ushiba and Watanabe and it is
confirmed by the exjjeriments described in Chapter 8.
Ushiba's and others and Tsukamura's team ^48, ^49 s[lowetj
that Myco. tuberculosis behaved similarly in the presence of
streptomycin, and this would explain the relatively abrupt
onset of streptomycin resistance seen both clinically and by
in vitro tests (Fig: 47).
There seems no reason to d oubt that the more elaborate
heredity mechanism described in the last chapter can also take
part in drug-resistance such as that to streptomycin. When
Griffiths transferred genetic material between pneumecccci
his discovery concerned the capsular polysaccharide giving
virulence; but it is now known that other inherited characters
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including drug-resistance can be so transformed, and Ilotchkiss
conveyed streptomycin-resistance to a previously sensitive
pneumococcus with desoxyribonucleic acid from a resistant strain
in a matter of minutes in this way.
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ISONIAZID
Resistance to isoniazid develops as rapidly as to
streptomycin when the drug is given alone, in fact of the
cases in the first British trial of the drug 11% had
resistant cultures after one month, 52% after two months
*?12
and 71% after three. Middlebrook and Dressier showed
that the resistance to isoniazid developed in a single-step
manner like that to streptomycin, but they confirmed that
^<1 n 1 J f>
the two drugs were not synergistic , and Fisher
showed that haemin was required as a growth factor by the
isoniazid-resistant bacilli, in fact without it the 'one-
step' resistance did not occur. It is generally believed
that isoniazid inhibits mycobacterial nutrition, though
Pope thought oxidation to be vulnerable. She points out
that metabolic effects must bear no relation to loss of
virulence. As mentioned later in Chapter 10 isoniazid-
ooj} AI o *590
resistant mutants lose their pathogenicity for mice
71 311
and guinea-pigs ' j but they are still virulent
unfortunately to higher animals including man 2^1» 252, 306^
and it is clear that the mutations giving isoniazid-resistance
must be very complex involving several genotypes.
FARA-AMINOSALICYLie ACID
As regards P.A.S.-resistance TsuJkamura has
suggested that there are two genotypes, one of low resistance
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(1 - 2 jxg,/ml,) with a rate of about 1 in 50,000 and one high
(5 - 100j^g,/ml.) of a frequency of 1 in 100 million. Here
we have some supporting evidence. In Slope Diffusion Tests
as described in Chapter 10 this drug gives two zones of
inhibition, one partial and the other complete. These are
seen in Fig* 43» and enlarged in Fig: 44, where the more
complex sensitivity pattern seen with P.A.S. in the right
two tubes contrasts with the simpler inhibitory zones due to
isoniazid in the three tubes on the left. Schmiedel1s
modification of the Slope Diffusion Test has been used,
that is to say long tubes instead of bottles cover the bigger
inhibitory zones given by these very diffusible drugs.
There is another curious observation made by
Tsukamura • By studies of the size and number of surviving
colonies of H37Rv strain of Myco. tuberculosis subjected to
streptomycin and P.A.S., he was able to confirm what had been
previously supposed, that the survival mutation rate to the
two drugs was just the product of the survival mutation rates
to each drug separately. Thus if the mutation rate to
streptomycin is 1 X 10 "*ra and to P.A.S. 1 X 10 ~"n, that to the
two is 1 X 10 ""(ra+n^t With isoniazid and P.A.S. however
there is a complication • P.A.S. «. resistant strains are
characteristically heterogeneous with bacilli of varying
sensitivity and resistance present, and this heterogeneity of
P.A.S.-resistance is still present in strains resistant to
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both streptomycin and to P.A.S. But strains resistant to
both isoniazid and P.A.S. are homogeneous, the bacilli being
now all P.A.S.-resistant# If the isoniazid-resistant mutation
removes heterogeneity, a characteristic of P.A.S-resistance,
21
the two mutations must be in some way linked• Barreto
quotes Eagle as saying that such mutual linkage should make
it very rare for the combined resistance to appear, and
certainly when it does it is of high degree to both drugs.
However that may be, P.A.S.-resistance seems no more suitable
than isoniazid-resistance for simple experiments on mutation
rates.
THE CHOICE OF STREPTOMYCIN-RESISTANCE AS A MEASURABLE MUTATION
Quite a number of substances can neutralise
streptomycin 100' 139' 144 ' 264' 353, 366, 382> particularly
reducing agents, and those bacteria which are naturally
resistant such as Pseudomonas aeruginosa have been shown
to have a protective enxyme 'streptomycinase* analogous to the
penicillinase of naturally resistant staphylococci} but it
does not seem to participate in mutant resistance any more
than the latter. Unlike isoniazid streptomycin inhibits
2J.C
growth without gross morphological changes and it is now
agreed that the interference is xvith bacterial respiration3"*9»*4-,143
rather than protein metabolism *54* as case Gf
penicillin. All Mycobacteria are aerobes though tubercle
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bacilli seem to be more tolerant than others *92 which may
explain their ability to grow interstitially 97» 282^
The 195° International Conference showed that
streptomycin reduced the oxygen consumption of sensitive
organisms six times as much as resistant rautante, and there
seems no reason to doubt that acquired streptomycin-
resistance depends on some such compensatory respiratory
mechanism whatever the species of bacteria, and that it is
a relatively common mutation* We have therefore adopted
it as the mutant for study in this thesis and have used
strains of Esch* coli to observe the regularity of mutation
rates while Myco* tuberculosis was more suitable for long-
term e pid e miological studies*
Tsukamura, observing cultures from 32 patients in
Japan over 2 or 3 years, concluded that tubercle bacilli
could achieve unlimited heights for streptomycin-resistance
but not for resistance to P.A.S. or isoniazid * Thus
nearly half his cases reached a resistance to 1,000 ^g*/ml.
streptomycin; but the upper limit for P.A.S, was 60^g*/ial»
in about 60%, while for isonaizid there was a wide variation,
12% resisting 10 ^g./ml. and 47% l|ag,/ml., while 41% stayed
sensitive to 0,1 ^g./ml. This could explain why
streptomycin-resistance is relatively common and P.A.S,-




IN STRAINS OP MYCO. TUBERCULOSIS
20.11.61 - 19.11.62
Reatatant to >5^g./ml. 52 86.0
Restatant to > 1 ^g./ml.
but < 5 i^g./ml. 8 13.0a
Total 60
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not noticed such heterogeneity for isoniazid-resistance,
in fact of 60 resistant strains tested during 1962 against
isonaiazid 1 and 5^g«/ml»# 52 were resistant to both and
only 8 resistabt to 1 y~g. only (Table. 4).
Tsukamura also showed that the survival curves of
populations of the H37Rv strain were discontinuous at two
points, betiveen 2 and 5 ^ug. streptomycin, and again between
20 and 50 and he suggested that in Myco. tuberculosis
separate genes controlled low and high resistance respectively^^.
As there was quite a variation in colony size among the lower
strength mutants but uniformity among those at the higher
strength he suggested a further distinction between the tivo
genes, that the lower resistant one controlled other
characters while the higher one did not But Ushiba
has shown both in the case of Myco. tuberculosis and in
Esch, coli that streptomycin-resistance probably depends on
J r 4
a number of genes The picture produced by the resulting
cumulative mutation rates is the subject of our experiments
in the following chapters.
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CHAPTER 7. PREDICTABLE DRUG-FAST MUTATIONS AMONG
PYOGENIC BACTERIA
TECHNIQUES FOR CALCULATING MUTATION RATES
PART A, EVERYDAY EVIDENCE OF DRUG-RESISTANT MUTATIONS
If bacterial mutations are so prolific why are they
not seen more often in laboratory cultures? Routine drug-
sensitivity tests with discs or tablets of antibiotic added
to plate cultures have accustomed bacteriologists to clear-
cut patterns of sensitivity and resistance. Not only are
the zones of inhibition, which indicate a sensitive organism,
usually sharply defined from the continuous growth elsewhere}
but the zones themselves may be bounded by a luxuriant band
of growth, where metabolism is apparently actually stimulated
by the drug near its critical level. Sometimes this simulation
is seen without the corresponding inhibition (e.g. round
polymyxin in Fig: 19).
This failure to see mutants more often is not
altogether surprising in view of their low incidence on any
one plate, and the closeness of sensitivity of most to the
parent strain. In clinical practice, where the tissue
concentration of drug may only slightly exceed the minimum
for general inhibition, their appearance will be much more
favoured 423^
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Fig' 13, A Staphylococcal Drug-sensittvtty Plate(No: 27858/60)
showing complete resistance to svlphonamide (square
patch) and many resistant mutants to oxytetracycline
(first disc on left). Sensitivity is complete to
the remaining discs, from left to right - streptomycin,
penicillin, chloramphenicol, and erythromycin.
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Fig: 14. An example of synergism, between framycettn (the central
disc on the plate) and, sulphonamide (the square patch).
The latter has no inhibitory effect except on the side
facing the framycetin disc, whose gone it 'draws out'.
The other antibiotic discs are, reading clockwise:-
oxytetracycltne, streptomycin, penicillin chloramphenicol,
and erythromycin. Strain Staph, aureus No. 23858/60.
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Sometimes, however, isolated colonies are quite
conspicuous in the inhibitory zones, betraying the emergence
of resistant variants, and a repetition of the test especially
169with a heavier inoculum , will show that it is a feature
of that particular organism. Some strains are more prone to
mutate than others, the tendency is a constant one, and only
strains with a relatively high mutation rate are likely to
show the phenomenon within the confines of a 4" Petri plate.
Fig, 13 shows mutants resistant to oxytetracycline, Fig: 16
to chloramphenicol only, while in Fig: 18 mutants resistant
to several antibiotics are seen.
In Figs 14 growth of a strain of Staph, aureus is
shown on an agar plate in actual size with zones of inhibition
varying from 4 to 1" round 7 antibiotics (see legend). There
is, in addition, a zone of inhibition adjoining the square
patch of sulphonamidej but only on the side facing fraraycetin «
an instance of synergism between these two drugs.
Fig: 15 shows another strain of Staph, aureus
sensitive only to chloramphenicol and eythromycin. The two
larger colonies in the inhibitory zone round erythromycin and
the few similar large colonies scattered round chloramphenicol
are coliform contaminants. The most striking feature,
hoivever, is that the areas of no growth are abrupt, except
round chloramphenicol where three distinct zones occur -
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Fig: 15. A drug-sensitivity test on a strain of Staph, aureus, No.
27074. Reading clockwise the antibiotic discs are
oxytetracycline, streptomycin, penicillin, chloramphenicol,
and erythromycin, with sulphonamide in the square patch.
The Staphylococcus, characteristic of a hospital infection,
is inhibited only by the chloramphenicol and erythromycin
discs (the occasional larger colonies are a coliform Note,
however, that while the erythromycin sone is clear-cut,
round the chloramphenicol there is an intermediate sone,
which is generally considered to represent a bacteriostatic
level of drug giving only partial inhibition. Unlike the
growth seen with resistant mutants, it occurs in a band
which is itself sharply defined from fall growth on the
one side and no growth on the other.
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Fig: 16, Drug-sensitivity test on Staph aureus strain No, 4161/61
from a shin lesion in a man of 21, The antibiotic discs
here are, reading clockwise, oxytetracycline, streptomycin,
penicillin, chloramphenicol, and erythromycin, with
sulphonamide in the square patch. The organism is a
typically resistant hospital strain of Staph, aureus.
Only erythromycin and chloramphenicol are inhibitory, and
the zones of both, but especially chloramphenicol, contain
resistant mutant colonies scattered haphazardly within the
'inhibitory zones'.
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complete clearing, partial growth, and full growth. The
middle zone in such a case is generally agreed to indicate a
bacteriostatic level of the antibiotic contrasting with the
bactericidal zone of full inhibition. Contrast this with
Fig: 16 where a strain of Staph, aureus, again showing-
sensitivity only to chloramphenicol and erythromycin, has a
very small proportion of the colonies persisting throughout
these inhibitory zones and in the apparently haphazard manner
characteristic of true mutants. Fig: 17 shows that the
chloraiaphenicol-resistance, for example, of these is an
isolated phenomenon, because, when tested in parallel to a
dozen other antibiotics, the mutants in all other respects
resemble their parent strain.
Sometimes, however, a strain shows mutants resistant
to a number of antibiotics, and Fig: 18 is an example of this
in a Staphylococcus from a chronic varicose ulcer. Many
years' intermittent treatment has produced a strain wholly
insensitive to oxytetracycline and sulphonamidc, while
currently mutants are appearing resistant to streptomycin,
penicillin, chloramphenicol and erythromycin. Matching
sensitivity tests in Figs: 19 and 20 compare the subsequent
behaviour of the streptomycin-resistant mutant with the parent
growth. In Fig: 19, after overnight incubation, they are
identical except that the former has mutants also against
kanamycin. In Fig: 20 a further day's incubation has produced
Ill
Fig: 17. A drug-sensitivity test in parallel with the parent strain
of the hospital Staph. aureus from the culture seen in
Fig: 16, and its chloramphenicol-resistant mutant (below)
shows that both are identical in response to twelve other
antibiotics:-
Framycetin Bacitracin Oleandomycin Ristocetin
Streptomycin Vancomycin Spiramycin Oxytetracycline
hexagonal patch
Chloramphenicol Polymyxin Novobiocin Neomycin
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Fig: 18, A culture (23883/60, Elisabeth Mungall) of a 20-year old
varicose ulcer showing a strain of Staph, aureus with
multiple resistant mutants. The drugs and their layout
are the same as in Fig: 16. It will be seen that in
this case none are completely effective. Probably as
a result of years of intermittent treatment there is
now total tnsensitivity to oxytetracycline (extreme left)
and sulphonamides (square patch), while mutants are
widespread in the zones round all the other drugs.
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a crop of mutants also against neomycin in the streptomycin-
resistant variant. Kanamycin and neomycin are known to
exhibit some cross-resistance with streptomycin an(j this
would seem to be evidence of this.
MULTIPLE INFECTIONS BY DIFFERENT BACTERIA
An incidental use of drug sensitivity tests is to
distinguish the various genera and species of organisms.
Thus penicillin and erythromycin have virtually no effect on
coliform bacilli, so that if a zone of partial inhibition is
seen in a urinary culture there is evidence of some co¬
existing sensitive organisms such as a Gram-positive coccus.
The reverse picture is seen in sputum cultures, for if
Neisseria catarrhalis or Haemophilus influenzae are present,
their existence will be most conspicuous where they are
growing without competition from the pneumococcus, round
penicillin for ii. influenzae, and round both penicillin and
erythromycin for the Neisseria. In pus haemolytic streptococci
can be outgrown by staphylococci; but the much greater
sensitivity of the latter to neomycin and framycetin enables
Strep. pyogenes to be distinguished inside the inhibitory zones
round these antibiotics.
In view of the frequency of such simultaneous infection
by two or more species of bacteria, there is no inherent
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Figs: 19 and 20. Demonstrate probable cross-resistance between
streptomycin, kanamycin and neomycin.
Fig: 19 Additional drug-sensitivity tests performed in
parallel on the parent strain of Staph. aureus
seen in Fig: 18 (upper half of plate), and on
a representative sweep of its streptomycin-
resistant mutants (lower half of plate) show
that they are not also otherwise identical.
Reading clockwise (upper half of plate), framycetin
is effective, spiramycin only very weakly so,
kanamycin shows three mutants, novobiocin and
neomycin good sones, polymyxin no effect.
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Fig: 20. The additional drug-test in Fig: 19 was read and
photographed after overnight incubation. But here
we see the same plate after a yet further day's
incubation. It will be noted that, in contrast to
the parent strain (lower half of plate) the
representative resistant mutant strain (upper half)
which already differed in having three colonies
insensitive to kanamycin, has now also late resistant
mutants to neomycin. Both these antibiotics are
known to exhibit cross-resistance with the streptomycin
already seen to be ineffective.
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Fig: 21. A Double Staphylococcal Infection with Mutants.
Fig: 21 shows the complex picture produced by tin strains
of Staph, aureus with differing drug - sensitivity
patterns, the inhibitory zones being invaded by resistant
mutants derived from each. It will be nottced that one
strain, represented by hollow circles labelled 'a' in
the hey, Fig: 22, has paler and more discrete colonies
than 'b' represented by solid circles, and 'phage typing
differentiated the two as (a) 52A+ and (b) 6/47/53/54/81w.















Fig: 22. Diagramatic explanation of the photograph in Fig: 21,
P = penicillin, St. = streptomycin, 0 = chloramphenicol,
T = oxytetracycline, E =■ erythromycin,
square patch = sulphonamtde.
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improbability of similar mixed infections with different
strains within a species. Hitherto these would generally
have passed unnoticed or been regarded as mere variants in
colour or other naked - eye characters; but antibiotic
sensitivity tests give, in effect, a second biological
classification superimposed on the traditional one of colonial
morphology. The very complicated picture which can ensue
when there are two strains of one species which, in addition,
are both mutating is seen in Figs: 21 and 22.
A double Staphylococcal infection which presented
almost chimerical features on culture is illustrated in
Fig: 23. The main growth of Staph, aureus is sensitive to
streptomycinj but within the inhibitory zone, and adjoining
the antibiotic tablet '3% is a paler growth of Staph, albus,
which is also Coagulase-positive. Clearly the albus strain
is drug-resistantj but what remains to be explained is the
intervening clear zone between the two. A subculture growing
without streptomycin excludes streptomycin - dependance, which
would be the simplest explanation, and Waterworth has shown
that such rare anomalies are due to staphylococcine production
by the predominant growth masking the subordinate culture,
except where it lies protected near the antibiotic. The
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^0: 23. .4 curious anomaly. Two mixed strains of Staph, aureus
fraue been revealed by streptomycin:- (a) streptomycin-
sensitive (b) streptomycin-resistant. The zone
between the two is explained by the fact that (a) is
producing a staphylococcine against (b), which, in fact,
is only able to grow when (a) ts not present. This is
proved by a streak plate with the two strains showing their




The inhibitory zones round the drugs in the
sensitivity-tests which we have so far described may be
regarded as miniature gradient plates on which, as described
4,2*1
by Szybalski , variants have the opportunity to appear
in isolation, freed from all competitors except those sharing
their degree of resistance, those nearest the diffusing
antibiotic having to withstand the highest concentrations
and so on in proportion to their distance outwards. In
Chapters 10 and 11 a technique, Slope Diffusion, is described
for studying the mutants with different degrees of resistance
arising in strains of Myco. tuberculosis. Ordinarily those
very scanty mutants are seen which are of relatively high
resistance, and they appear as discrete colonies on the drug-
incorporated slopes of the solid culture sensitivity-tests
(Figs: 39 and 40). Cutter-plates are unlikely to provide
enough clear zones (Fig: 41) and sensitivity-tests in liquid
medium will not show the frequency of mutants at all.
THE CONSTANCY OF BACTERIAL MUTATIONS
If a pure culture of a bacterium such as Escherichia
coli is spread equally on plates of media with and without
known amounts of antibiotic, the drug-containing plates will
grow only isolated colonies whose number, even though small,
is remarkably regular. In Fig: 24 is seen a comparison of
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Fig: 24, The in vitro effect of streptomycin. The left-hand plate
contains plain MacConkey Agar, the right-hand, one similar
medium incorporating 5 j\g,/ml, streptomycin at the time
of pouring. The plates were each uniformly spread with
the same inoculum, 0,1 ml, of a broth culture of
5
Escherichia coli N,T,0, 1094 diluted 10 , Over 2,000
colonies as shown by the left-hand plate are reduced to
1 by the 5 i^g,/ml, streptomycin in the right.
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Fig: 25, The proportionate effect of incorporating increasing amounts
of streptomycin in MacConkey Agar on the growth of a strain
of E, coli neapolitana. Over 5,000 colonies on the normal
plate 'A' are reduced to 235 by 1 ^g,/ml, in 'B', and to
1 colony by 2 j^g./ml, in 'C',
colony counts of E. coli National Type Culture No: IO94 on
MacConkey Agar and on similar medium containing 5 ^xg/ml. of
streptomycin. The single conspicuous colony on the latter
is derived from the sole survivor of some 2000 bacilli
placed on the plate, and the experiment can be repeated again
and again with impressively consistent results.
Moreover if a series of plates are prepared with
various known amounts of the antibiotic the mutants will
fall off in numbers in direct proportion to the strength of
the drug, the numbers surviving at each concentration being
remarkably constant. In Fig: 25 are shown the numbers of
a laboratory isolated strain of E. coli neapolitana with¬
standing 1 and 2jo-g/ml. streptomycin respectively.
PART B, A TECHNIQUE FOR CALCULATING MUTATION RATES
Principle
It seemed clear that, if a reliable quantitative
method of estimating the proportion of these mutants could
be devised, then the mutation rates at various drug levels
could be determined for strains of any species of organism.
Experiments will be described showing that such rates are
constant for individual strains, and that drug-resistant
mutant clones will mutate in turn at constant rates so that,
where a drug is constantly applied, progressive mutations
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will occur at mathematically predictable rates* The actual
time of their emergence will, of course, be the product of
these mutation rates and the generation time which is also
a constant for any individual organism in the log phase as
we shall show* Expressed mathematically this can be
summarised :-
Time of Emergence = Mutation Rate x Multiplication Rate,
and there will theoretically be an equation such as this for
each degree of antibiotic resistance, all acting cumulatively
and in unison. Natural selection by the continuing action
of the antibiotic will then ensure that the resulting galaxy
of mutants replaces entirely the original sensitive 'population1.
Serial Decimal Dilutions
The essential requirement for accurate plate counts
of bacteria is a reliable method giving known dilutions of the
inoculum* Collecting too few colonies precludes any
reasonable assessment of the actual numbers of mutants present
in nature, while too many immediately introduces counting
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errors* But besides this Elek has pointed out that a
heavy inoculum will actually use up the antibiotic, and he
quotes calculations that, in the case of the Staphylococcus
and penicillin, each coccus binds 75° molecules of the
drug 110' 211' 274' 275.
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EXPERIMENT 1.
PRELIMINARY STUDIES OF RELIABILITY OF DILUTIONS
The test organism was a laboratory-isolated strain
of Escherichia coli var. neapolitana (duleitol-fermenting +
and motile)* This tvas grown overnight in nutrient broth
incubated at 37°C. in two cotton-wool-plugged tubes. The
resulting cultures were checked for comparable growth, and
complete dispersion ensured by two hours' mechanical shaking
in a Kahn shaker with two glass beads in a bijou screw-
capped bottle. Poured back into a single §" diameter test-
tube, the turbidity was adjusted to Brown1s Opacity Tube No: 4
(approximately 3»000 million bacilli per ml.) by sampling and
adding sterile normal saline by pipette in appropriate amounts.
Serial tenfold dilutions of this standardised inoculum
were now made down to 1/million by setting up a rack of §"
sterile test-tubes each containing 9 ml. sterile saline, adding
1 ml. of standarised culture to the first with a 10 ml. pipette
and thoroughly mixing by twenty rapid withdrawls and expulsions.
This was repeated six times down the line of tubes using five
separate 1 ml. pipettes for the subsequent transfers and mixing.
Statistical analysis ^99 simws that pipetting errors
are small provided a fresh oven-sterilised 1 ml. pipette is
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used at each stage to avoid carrying over undiluted inoculum
on the outside surface of the glass or possibly from the
upper bore. Experience soon showed that this use of dry-
sterilised pipettes was preferable to those silicone-treated
for the same purpose, and the same 1 ml. pipettes can remain
upright each in its own test-tube of diluted culture for
the subsequent inoculation of the plates.
sqq
Snyder showed that 0.1 m. spread with a glass
<i "JQ
rod gave reliable counts of dysentary bacilli, and Novel
counting bacteria in sea water showed that 2 plates were
useless for significance, 10 plates were excellent and 5
aO i
almost as good. Therefore well dried nutrient agar was
used in 15 4" Petri plates, and 0,1 ml, of the l/million
dilution was placed in the centre of each of 5 plates, 0.1 ml.
of 1/100,000 dilution on each of the next 5 plates, and 0.1 ml.
of 1/10,000 dilutions on the last 5» The inocula were then
rapidly spread by revolving the plates under an angled glass-
ros previously sterilised by flaming and then cooling. There
is no need to repeatedly resterilise the rod throughout the
procedure provided the spreading is done progressively from
the weakest concentration upwards and is lightly flamed after
each 5 plates, i.e. on actually changing inoculum strength.
Any carry-over within each group of 5 plates will be compensated
by subsequent averaging.
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Fig: 26, An experiment showing that 10-fold dilutions are an
effective technique for making measurable counts if
fresh ptpettes are used at each step:-
5 plates averaging 200 colonies each in the top row
are reduced by ten-fold dilution to 5 averaging 20
in the middle row, and by further ten-fold dilution
to 5 averaging 2 colonies each in the bottom row.
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The results of this method of serial decimal
dilutions are shown in Fig* 26. It will be seen that the
5 upper plates average approximately 200 colonics, the next
5 average 19* and the last 5 average 2.4. Ideally, it
might be supposed, one would want to count the maximum number}
but it will be clear from Fig: 20 that it is not feasible to
use more congested plates than the middle set. In practice
it is best to aim at counts of about 20 colonies, and this
has meant prefacing all the experiments which follow with a




PREDICTABLE RESISTANT MUTATIONS IN A STRAIN OF E.COLI
VAR. NEAPOLITANA
Materials
The same laboratory-isolated strain of E. coli var.
neapolitana was used as in the previous experiment, as that
experiment could be taken as a guide for the inoculum.
Moreover its discrete colonies had been easy to count, and
such separation of colonies varies considerably between
species and even strains. The tubercle bacillus is so
cohesive that it is extremely difficult to keep individuals
apart, and Klebsiella confuses by the tendency of its colonies
to coalesce.
Streptomycin was chosen as the antibiotic. It is
effective on both the genera Escherichia and Mycobacteria
which we wished to study as examples of fast and slow growing
organisms. Its mode of action is generally believed to be
an interference with the enzyme controlling the final stage
of bacterial respiration *42, *43 ^ possibly by the oxidation
of benzoic acid *0^ or some amino-acid *^4# 175^
Presumably at least one alternative respiratory enzyme system
is available, and this could explain the relatively high
mutability of many bacteria, especially these two genera,
to this drug.
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MacConkey's bile-salt neutral red lactose agar was
used as medium 2^# £s true that the pH of the medium
is important, and that at 7«& the alkalinity increases
1 310 "JAR
streptomycin's potency twelve times ' * J . As against
this peptone in the medium antagonises the antibiotic
though far less actively. Fortunately we are not so much
concerned with the absolute numbers of surviving bacilli but
with their ratio to the total bacterial population, so that
with the proviso that our final drug strengths are nominal,
\ve can make deductions about high and low strength mutations.
Method
The test strain of Escherichia coli was grown
overnight in nutrient broth at 37°C, dispersed by agitation
as before, and standardised by turbidity again to approximately
3,000 million bacilli per ml. The resulting suspension was
again found to be adequate, and shaking was therefore adopted
for all subsequent experiments in preference to using
emulsifying agents such as sodium isono-oleate C'Tween 80"
which can reputedly exaggerate the effects of streptomycin
as much as a thousand times » *39 giving the risk, of a
wholly disproportionate result, even if the bacilli are partly
protected by adding protective bovine albumin 1°3# 382^
A 250-ml. bottle of MacConltey agar was melted and
sterilised in the autoclave, and allowed to cool to 60°C.
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TABLE 5
FREQUENCY OF RESISTANT INDIVIDUALS
IN VARIOUS STRAINS OF ESCHERICHIA COLI
E. eoli var. neapolttana, Laboratory source (dulcttol +, mottle)
Cone. of Dtln: of Colony counts at 3 days Average Rate per
Streptomycin Inoculum 100 million
in j^g/ml,
0 106 98 105 99 104 101.5 100 million
1/8 106 77 130 109 99 103.75 102.2 million
1 106 109 107 105 102 105.75 104.2 million
| 106 91 98 97 83 92.25 90.88 million
1 106 11 13 12 12 12 11.82 million
2 104 2 5 3 4 3,5 34f490
5 10 2 3 2 2 2.25 2.217
10 1 0 0 0 0 0 0
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Streptomycin hydrochloride solution, freshly prepared in
its vial, was added to the plates at the time of pouring#
each plate getting 5 ml• of medium and streptomycin to
give final concentrations of 0, 4# a# 1# 2, 5 and I0^g/ml.
Four plates were prepared of each strength.
0.1 ml. amounts of the appropriately diluted
inoculum Mere pipetted on to each plate, the 1/million
dilution being used for the 1 |ug/ml. plates and all weaker
concentrations while 1/10,000, 1/10 and undiluted inocula
were used for the 2, 5# and 10 ^g/ml. concentrations
respectively. Well-dried plates were used as in the previous
experiment, and quick spreading ensured by revolving the
plates under a sterile angled glass-rod as already described.
The 32 plates, 4 of each strength of antibiotic, were
incubated for three days at 37°C with the results shown in
Table 5.
It will be seen that no effect appears on the two
lowest concentrations of streptomycin compared with *0*
(the control), and very little from 4 Rg/ml. About 10$
of the strain can survive 1 wg/ml., and 1 in 3#000 bacilli
survive 2 pig/,ml., but higher doses produce a sharp
diminution in the count to 1 in 50 million at 5 ^g/ra1.# and
a complete inhibition with 10 ^g/ial.
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TABLE 6,
FREQUENCY OF RESISTANT INDIVIDUALS
IN VARIOUS STRAINS OF ESCHERICHIA COLI.
E, colt var. neapolttana Laboratory source (dulcitol +, mottle),
Confirmatory experiments Resistant to l^g/ml, - (a) 10,9 (b) 10,76
gave respectively:'- (c) 12,01 millions per 100 million,
Resistant to 2^g/ml, - (a) 32,360 (b) 33,900
(c) 44, 740/100 million
Reststant to 5 t^g/ml, - (a) 1,69 (b) 2,58
(c) 2,66/100 milHon,
Reststant to 10 i^g/mL, - (a) 0 (b) 0
(c) 0/100 million.
134
But even more significant than the precise ratios
is the mathematical certainty with which each level of
mutation rate is regularly reproduced. The whole of
Experiment 2 was now repeated three times with no change in
any detail, and the four sets of mutation rates, each set
calculated as in Table 5* are summarised in Table 6. It
will be seen that in spite of variations of some 10$ in each
rate, the mutation rates are in fact quite distinct and,
within the limits of experimental error, reproducible
apparently indefinitely and therefore predictable.
CUMULATIVELY PROGRESSIVE MUTATIONS
Regularly repeating mutations of this sort must
account for the gathering accumulation of mutant bacteria
from which overall resistance can be confidently expected
in a certain time. For example in the days of single-drug
therapy of tuberculosis a quarter of the patients had
streptomycin-resistant strains by the end of the third month1^'2'7®,
What now remains to be explained is the abruptness of this
transition. Although patterns of resistance vary from
the single-step of streptomycin through intermediate types
to the multi-step of penicillin , these differences are
only matters of degree. The essence of mutational change
is its suddenness.
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If mutations continued in series at precisely the
same rate a relatively gradual change would occur. But
50
the mutants are themselves mutating, for as Burnet says:
"growth, reproduction and mutation are the fundamental
characteristics of life". If we can show that the mutants
in turn mutate at fixed rates we will have a possible
mechanism, a mobilis in mobile, whereby myriads of more or
less successful individuals will all emerge together to give
the explosive outbreak so typical of the recurring epidemic.
In the next chapter detailed experiments with
progressive mutations will be described} but a simple test
with our present culture will show that resistant variants
not only maintain their resistance but can yield still more
resistant progeny in their turn.
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EXPERIMENT 3 *
"STREAK-PLATES" AS EVIDENCE OF BACTERIAL VARIANTS
SHOEING FURTHER MUTATION
Materials and Method
A series of drug-resistant clones were obtained by-
picking off isolated mutant colonies, one from each of the
various antibiotic-containing plates, and one from the control
plate, of Experiment 2 and similar experiments. Each was
grown overnight in a tube of nutrient broth at 37°G, the
tubes being labelled with the reputed degree of resistance
in micro-grammes. The resulting cultures were adjusted
with broth to a uniform turbitity (Brown No s 4 ** 3»000 million
E. coli per ml.).
Single uniform loopfuls, yielding approximately 0,01 ml.
of each broth culture, were streaked in parallel on each of a
duplicated series of MacConkey agar plates to which streptomycin
hydrochloride had been added at the time of pouring to give
final strengths of 0, 1, 10 and 100 ^g/ml.
Results
The eight plates, 2 each of 4 concentrations of drug,
were incubated at 37°C for 6 days to ensure the appearance of




'STREAK-PLATE* EVIDENCE OF DRUG-RESISTANT MUTATIONS
Clones of E, coll, N, T. C. 1094, derived from the previous
experiments were Inoculated in parallel on fresh drug-containing
plates with the following results after overnight incubation at 37°C
Nominally Sensitive
* Resistant to 1 f^9.
* • 10 rg.
* " 1001^9.
MacConkey Agar Plates












It will be seen that the degree of overall
resistance in each streak is at least as high as in its
parent inoculum, so that the clones are to that extent
"breeding true"* But in addition the nominally "Sensitive",
and "Resistant to l^Ag/ml." clones are each yielding a few
colonies also resistant to 10^-g/ml*
DRUG-RESISTANT MUTATIONS IN A TYPE STRAIN OF B* CCLI COMMUNIS
The possibility remained that such regular and
progressive mutagenicity was exceptional if not peculiar
to the particular strain of E* coli neapolitana chosen.
A similar simple "streak plate" experiment was therefore




Drug-resistant clones of various degrees were
obtained as follows. Streptomycin hydrochloride was added
to MacConkey's agar medium at the time of pouring to give
plates with concentrations of 0, 1, 5, 10, 5b and 100 pxg/ml.
respectively. Large inocula of the order of 3b million
E« coli communis, N.T.C. No. 1094, were placed ori each plate
as loaded loopfuls of an overnight broth culture. The
inocula were spread by a succession of parallel strokes of
the loop repeated three times at right angles round the
periphery of the plate.
off from the surviving resistant mutants. This was cultured
in turn by overnight incubation at 37°C in nutrient broth.
The set of six broth cultures, each representing a distinct
clone, ivere all adjusted to uniform turbidity (Brown No. 4 -
3,000 million E» coli per ml.) and loopfuls of each,
approximately 0.01 ml., were streaked in parallel on a series
of antibiotic-containing plates. These again were of
streptomycin added as solution of the hydrochloride at the
time of pouring.
From each plate a single isolated colony was picked
MacConkey's agar medium with 5» 10,
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A 3treak plate technique providing evidence of mutation,
Resistant mutant colonies of various degrees are obtained
by putting large tnocula on antibiotic-containing plates
and picking off the survtvors. These colonies are grown
overnight in broth to uniform turbidity (Brown No, 4 = 3000
million E, colt per ml,), and loopfuls are streaked in
turn on plates containing the antibiotic in the seme and
higher strengths.
In the photograph cultures from mutant colonies of E, colt
1094 resistant to 0, 1, 5, 10, and 100 ^g,/ml, streptomycin
respectively, are seen to have not only held their
resistance but to have mutated still higher as shown by
the isolated mv.tant colonies along these streaks.
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Results
The growth after 3 days' incubation at 37°C is
seen in the photograph (Figs 27)• It will be seen that
each clone has not only maintained its resistance at the
appropriate level; but has also mutated again to higher
levels. Thus the so-called sensitive clone "0" gives
scattered colonies right up to 50 ^g/ml., and the reputed
"Resistant to l^g/ml.," similarly appears sparsely even
on 100 ^g/ml. The nominal "Resistant to 5"# and
"to 10 ^Ag/ml." are very comparable to "1", while "Resistant
to 50 pg/ml." gives confluent growth on the 2 lower strength
plates, and semiconfluent thereafter, while "Resistant to
100 jmg/ial." gives confluent growth throughout.
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THE REGULARITY OF MUTATIONS IN OTHER GENERA AND SPECIES OF
BACTERIA
Although various mutants have been described in
118
strains of Staphylococcus aureus , notably the dwarf r,G"
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variants which are still pathogenic and occur naturally
iOq
at a rate of 1 in 50,000 , preliminary experiments with
drug-resistant variants of staphylococci suggested that
their relative infrequency would make them much less suitable
for our studies than Escherichia coli.
Staph* lactis, N.T.C. 8340
Formerly known as Sarcina lutea because of its canary
yellow colonies, is a very sensitive organism* It is
inhibited by discs of penicillin 1 ^g, erythromycin 5 ,
tetracyclines 25^*g»j and chloramphenicol 25 ^g*, is partially
sensitive to 10 |^g., of streptomycin but resists sulphonamides
200 M-g, In fact, as A.T»C»C, 9341# it is used for the
commercial assay of Aureomycin, Chloromycetin and penicillin,
being sensitive regularly to 0.003 u. of penicillin as compared





EXPERIMENT 5 Staph, lactis, N.T.C. 8240, overnight broth culture.
Cone: of Penicillin I)iln: of Colony counts at 6 days
u/ml., agar inoculum
0 - control 10° 64 148 104 100 402 72
1 1 0 0 0 0 0 0
10 1 0 0 0 0 0 0
100 1 0 0 0 0 0 0
i.e. Sarcina's penicillin-reststant mutants are extremely rare, none
resistant even to 1 u., could be detected in 100 million cocci.
Streptomycin
TABLE 9
EXPERIMENT 6 Staph, lactts, N.T.C. 8340, overnight broth culture.
Cone: of Streptomycin Dtln: of Colony counts at 6 days Average
l^/ml., agar inoculum.
0 -- control 10° 287 270 282 222 292
1 10s 18 10 17 12 14
5 10 12 8 7 14 10
10 1 0 0 0 0




(a) EXPERIMENT 7 Staph, lactts. N.T.C. 8340, "Resistant to 1 1^7.'
subcultared in broth overnight.
Cone: of Streptomycin Diln: of Colony counts at 6 days
g./ml., agar inoculum
0 - control 106 849 281
1 104 486 443
i.e. only 1 in 50 breed true "Resistant to 1
TABLE U
(b) EXPERIMENT 8 Staph, lactis, N.T.C. 8340, "Resistant to 5 t^g."
subcultured tn broth overnight. '
Cone: of Streptomycin Dtln: of Colony counts at 6 days Average
j^g/ml; agar inoculum
0 - control 106 332 565 360 460 429
5 106 1 0 2 1 1
i.e. only 1 in 429 breeds true "Resistant to 5 j*g."
One may conclude that Sarcina is sensitive to penicillin
because of scanty mutants, and to streptomycin because, though
mutants occur they are transient, readily back-mutating to
streptomycin-sensitivity.
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Staph. aureus, N.T.C, 7447
A typical pathogenic strain with coagulase + golden
colonies, was also tested. It was known to be sensitive to
antibiotic discs identically to the previous strain, namely
sensitive to penicillin, erythromycin, tetracyclines and
chloramphenicol, with partial sensitivity to streptomycin and
resistance to sulphonamities. The following experiments
confirmed this general sensitivity to antibioticss-
Streptomycin
TABLE 12





Colony counts at 6 days Average







1 104 160 222 230 171 196
5 10 34 25 14 19 23
10 10 2 2 6 10 5
100 1 0 0 0 0 0
i.e, 1 in 2,000 are resistant to 1 ^g., 1 in l£ million are resistant
to 5f^g,, and 1 in 750 million are resistant to 10pg.
Streptomycin-resistant clone
TABLE 13
EXPERIMENT 10 Staph aureus, N.T.C. 7447,
overnight in broth,





Colony counts at 6 days Average
0 - control 107 232 222 277
1 107 205 223 213
10 10^ 213 225 219




EXPERIMENT 11 Staph. aureus, N.T.C. 7447, overnight broth culture.
Cone: of Pentcilltn Ptln: of Colony counts at 6 days Average
u/ml., agar. inoculum
6790 - control 108 725 607 629 756
1 1 0 0 0 0
10 1 0 0 0 0
100 1 0 0 0 o
Streptomycin-resistant clone
TABLE 15
EXPERIMENT 12 Staph. aureus. N.T.C. 7447. "Resistant to 10 p..





Colony counts at 6 days
0 - control 10 406 345
1 1 0 0
10 1 0 0
100 1 0 0
i.e. there are no resistant to 1 u. or higher penicillin mutants in at
least 67,900 millton of the original strain, nor in at least
37,500 million of the "Resistant to 10 ^g., streptomycin" clone
There is therefore no evidence of cross-resistance between
the two drugs. The comparative scarcity of drug-resistant mutants
in both the strains of Staphylococcus tested precluded their use
for further mutation rate experiments, and it was therefore
decided to confine these to the three strains of Escherichia coli
described in the next chapter. Later Mycobacterium tuberculosis
will be used for more prolonged laboratory and epidemiological
studies. Streptomycin-resistance being the particular mutation
or group of mutations which they have in common.
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MEASUREMENT OF THE MULTIPLICATION RATE OF BACTERIA
Bacterial reproduction is not just a geometrical
progression as the population continually doubles itself by
binary fission. In the first place some 10 to 20% of
individuals do not survive reproduction; but still more
important there is the complexity of the growth curve. The
log phase of true multiplication is preceded by a lag phase
for cell adjustment, and is followed by a stationary phase,
in which congestion limits the numbers and from which autolysis
leads to their decline. With pneumococci this occurs in two
or three days; but E. coli persist for months.
However, the true generation time, the average life
in the actively multiplying period, is constant under optimum
conditions. For coliform and anthracoid bacilli 20 minutes
is quoted 4^8^ for cocci about half-an-hour, and for
Corynebacteria and Clostridia some 40 minutes. Shepard
showed that the reproduction rate in tissue cultures for
Myco. tuberculosis was no less than 48 hours for the first
1-3 days and thereafter 24 hours, and comparison of the
visible increase in colony size with that of, say, a
diphtheroid suggests that tubercle bacilli do indeed produce
a generation a day.
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Direct counting of bacteria to estimate their
generation rate can be done by incubating a diluted broth
culture in a chamber such as is used for blood cells, and
counting fields periodically. This is only likely to be
accurate if oxygenation is maintained, and also the
temperature for a 10°C. fall from 37°C. is said to halve
the multiplication of B. coli . It is more practicable
to incubate a broth culture at 37°C. with aeration by shaking,
which incidentally also disperses the cells. At intervals
diluted samples are put in the chamber for counting. This
is the method we adopted.
EXPERIMENTS ON MULTIPLICATION TIME
a. EXPERIMENT 13.
Escherichia coli communis, N.T.O. No. 86
Method
Two loopfuls of a culture grown overnight at 37°C.
in nutrient broth were inoculated into 3 cc of broth in a
bijou screw-capped vial. Incubation at 37°C. continued
with the vial gently agitated 100 times per minute in a
mechanical shaker.
After I-4 hours a 1 in 8 dilution was made, the
diluting fluid consisting of 1% phenol and 0,01% methylene
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blue, and counts were made in a Neubauer Chamber using a 1/6"
objective. Successive large squares containedj-
74 87 84 99 97 97 114 92 Average 93
Two hours later a 1 in 16 dilution gave counts
261 304 318 301 276 296 Average 293
Therefore, multiplication is 3 x 2 (the extra dilution)
in 2 hours = 3 per hour - 20 mins. per generation.
(The Neubauer large square contains 16 small squares
each of 1/400 sq. mm. x 0.1 ram. deep «* 16 x 10 crrua. — I/25O cram.
400
Therefore, in these 2 hours 200,000 organisms per cmra. have
become 1,200,000.)
b. EXPERIMENT 14
Escherichia coli communis, N.T.C. No. IO94
Method
The inoculum again consisted of 2 loopfuls of an
overnight broth culture incubated in 3 cc. of broth at 37°C.
in an agitated bijou vial.
After hour a 1 in 2 dilution was made in diluting
fluid and counts made in the Neubauer Chamber.
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Three large squares containedj-
28 30 31 Bacilli respectively. Average 30
Incubation and shaking continued, and one hour later
a 1 in 16 dilution gave counts
28 29 29 Average 29
Therefore, 8 divisions have occurred in 2 hours = 15
minutes each. 24 generations will occupy 6 hours and in 10
hours the progeny could theoretically number a million million.
c. EXPERIMENT 15
Staphylococcus aureus. N.T.C. Mo* 7447
Method
The test organism was grown overnight at 37°C. in
Dubos detergent-containing medium 105, 116 an<| microsc0py
showed a general dispersion of the cocci. Pour loopfuls were
inoculated into a bijou vial containing 3 cc. of equal volumes
of nutrient broth and Dubos medium. Incubation continued at
37°C. with the culture gently shaken 100 times per minute.
Two hours later a 1 in 2 dilution was made with
diluting fluid and counts made using the 1/6" objective of
3 large Ncubauer squares as follows
55 58 60 Bacilli Average 58
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2£ hours later a 1 in 16 dilution gave counts of s-
71 70 57 62 64 74 Average 66
Therefore, the multiplication time of this strain iss
Ji x 60 (time in mins.) x 1 (the diln.) x 66 (the count) 855 21.2
2 ¥ 58 minutes
CONCLUSIONS
Theoretically the onset of resistance for any organism
exposed to an antibiotic could be calculated from the formulas-
Frequency of resistance = Mutation Rate X Multiplication Time
Multiplication in the log phase varies fairly widely
between genera, so that a single staphylococcus can yield a
visible colony in 8 hours while a tubercle bacillus may take
a full day to complete its first division. Even within a
species there may be variation so that strains of Mycobacterium
tuberculosis range in reproduction rate from 16 to 24 hours in
liquid medium, and 18 to 27 hours on solid slopes. The fast-
growing H37Rv. produced a visible colony from a single bacillus
in 8 days, and, though this speed is partly due to its having
less lag phase, the rote of multiplication must be only about
9 hours. Nevertheless these differences in generation time
within a species are only some two-or three-fold, whereas the
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mutation rates vary, as we have seen, far more greatly. It
therefore seems likely that mutagenicity, this tendency to
mutate, is the over-riding consideration deciding the
likelihood of a micro-organism to produce new epidemic types#
In a chronic disease such as tuberculosis there is
the opportunity to study this proneness to mutate in
individual strains over many years. The Slope Diffusion Test
described in Chapter 10 by providing an even gradient of drug-
potency enables mutant tubercle bacilli of varying strength
of resistance to be seen as well as the broad picture of the
sensitivity of the rest of the bacterial population.
In fact, of course, the development of drug-resistance
is not quite such a simple matter of the sequence of straight¬
forward naifcations. Not all the progeny survive, say one in
five bacilli dying. Some mutants revert resistant to
sensitive by "back-mutation"} while probably the majority not
only breed truly resistant but provide mutations in their turn,
so that the picture of drug-resistance is cumulatively
progressive. To illustrate these points is the purpose of the
next Chapter.
153
CHAPTER 8. PROGRESSIVE MUTATIONS IN THREE TYPED
STRAINS OF ESCHERICHIA COLI.
SUMMARY
The principle employed throughout these experiments
was to make serial ten-fold dilutions of a 24-hour broth
culture of the organism to give measurable counts on plates,
appropriately higher dilutions being used for those plates
containing nil or low strengths of streptomycin, ranging to
undiluted culture for the highest drug concentrations. The
plates contained MacConkey•s medium with streptomycin
solution added at the time of pouring, and eight plates
were used of each concentration, and the average count taken.
A typical count, that of E. coli N.T.C. 1094* showed
that this strain regularly produced
1 in 45*000 individuals resistant to 5^g«/ml«, of streptomycin,
1 in 4 million resistant to 10 ^g./ml., and
1 in 900 million resistant to 100 ^tg./ml. of the drug.
If we then repeat the experiment with these resistant
mutants in turn as inocule, progressively higher counts are
obtained.
a. The "Resistant to 5 j,ig." clone reproduced its
resistance to 5 p.g«, and yielded 1 in 1^ million
resistant to 10 |Ag., and 1 in 28 million resistant
to 100 (M.g./ml«
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b. The "Resistant to 100^ug." clone eventually achieved
resistance to no less than 25,000 ^Ag./m1. of
streptomycin, and became streptomycin-dependant
with only scanty growth on those plates with little
or no antibiotic. The fact that such growth was
obtained at all, of the order of 1 in 3 million
bacilli, was ascribed to •back-mutation'.
Counts were made of the proportion of resistant
bacilli in the strain E. coli var. neapolitana N.T.C. 414
in a similar manner and taken two stages. Streptomycin
concentrations of 2 1 ^cg./ml., and 0 (control) were
used; the broth culture being diluted ten times for the 2 g.,
plate, 1,000 times for the l^g., plate, and 100,000 times
for the control plate, these dilutions having been found by
previous trial to give manageable counts. It was found that
E. coli N.T.C. 414 contained initially 12.2% of bacilli
resistant to 1 ^g., and 1.8% resistant to 2yug./ml. When,
however, the experiment was repeated with a 24-hour broth
culture from a colony chosen at random from the plate contain¬
ing l^g./ml., and spreading a dilution of 1,000 X on fresh
2 j^g. plates, and 10,000 X on 1 g. and control plates, it
was found that there were now 43.8% resistant to 1 *vg., and
8% to 2 ^g., a rise in frequency of the resistant variants
of approximately fourfold.
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The third strain studied was the original type
species of Escherich, N.T.C. 86* Here again mutants
occurred overnight in fixed numbers diminishing with the
drug strengtht-
1 in 4 resisting 1 ^<-g.,
1 in 60 «' 5 ^ug.,
1 in 2,00G »■ 10^g., and
1 in 25 million «100 ug.,
and once again they could be 'stepped up' by subculturing
clones so that that "Resistant to 5 ^3»" bred 6% true, and
gave 5 times as many mutants resistant to 100 ^g., as the
parent strain.
Mutant counts with N.T.C. 86, however, are
complicated by a second range of colonies appearing two
days later at all stages of the experiment. Vvhile these
too were predictable, there were quite twice as many, if
not more. It is suggested that these late-comers were
adaptive rather than mutant in origin.
STRAINS
Three National Type Cultures were chosen for their
discrete colonies, and conspicuous lactose-fermentation on
MacConkey's medium. Simple tests with sensitivity discs
showed that they had initial overall sensitivities to
streptomycin:-
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E • coli comiminis
N.T.C. 86




Escherichia coli var. neapolitana N.T.C. No. 414
was grown in nutrient broth from a freeze-dried culture
and tested for any abvious contaminants by spreading on
blood agar.
Twelve 500 - ml bottles of MacConkey Agar were
prepared according to the formula of Mackie & MacCartney
10th Edn., p.216| and streptomycin hydrochloride added in
bulk at 55°C to give two bottles each of 10, 5, 2, 1,
and 0 jug/ml of antibiotic. 4" petri plates were poured
from the drug-containing medium and stored refrigerated
in cans until required.
Method
Preliminary Experiment
The optimum dilution of culture giving countable
colonies, below 250 and preferably below 25, was first
determined for each strength of streptomycin as follows.
An overnight broth culture of the strain was
brought to uniform turbidity by 2 hours' agitation in a
mechanical shaker with glass beads, and, after standardising
to Brown's opacity Not 4 (3000 million bacilli per ml.),
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decimal dilutions were made in sterile saline to 1/million
using fresh pipettes at each transfer of 1 ml. into 9 ml.
to avoid carrying over undiluted inoculum. 0.1 ml amounts
of appropriately diluted culture, as shown in Table la,
were pipetted onto sets of 4 streptomycin - containing
MacConkey Agar plates at each strength of drug. Careful
spreading on well-dried plates with an angled glass rod
sterilised by flaming is essential not only to avoid
colonies becoming uncountable through coalescencej but
also to avoid overcrowding producing zones of diminished
streptomycin potency, which would allot* secondary crops of
weaker colonies to confuse the count. The results after
overnight incubation at 37°C showed that the optimum
dilutions of inoculum for each concentration of streptomycin
would be those shown in the second column of Table 16.
Experiment Proper
An overnight broth culture of E. coli neopolitana
No. 414 was shaken, standardised, and decimal dilutions made
as before. 0.1 ml amounts of culture were taken using the
appropriate dilutions indicated by the pilot experiment,
and were pipetted, each by its own 1 ml. pipette onto plates
of MacConkey Agar with their previously added 10, 5, 2, 1,
2 or 0 jug/ml. of streptomycin. After incubation at 37°C
for six days the results shown in Table 16 were obtained.
4
table:16
FREQUENCYOFRESISTANTINDIV DU LSVARIOUSST AIESCHERICHIACOLI





Multiplying the average of the colony counts by
the dilution* and dividing by the average number on the
control plates, the number of resistant colonies present
per 100 million was calculated for each strength of
streptomycin in turn. It will be seen that approximately
0.7$ of the bacilli can tolerate ■§ ^ug/ml. Streptomycin,
about 1 in a thousand can withstand 1 ^g., 1.8 in a
hundred thousand 2 ^g., while 5 and 10 ^.ig. reduce the
bacterial population more than a million times - these
larger doses being much closer together, however, in the
magnitude of their effects.
EXPERIMENT 17.
In order to appreciate fully the progressive
development of resistance to streptomycin by this organism
it is necessary to see what happens to subsequent
generations of these mutants on further exposure to the drug.
In this simple streak-plate experiment colonies
of varying degrees of resistance were subcultured in neutral
broth from the various plates of the above experiment, and
after overnight growth at 37°C were streaked in parallel
using a standard loop on MacConkey Agar plates containing
higher doses of streptomycin with the results seen in the
photograph in Figj 28.
The progressive breeding of still more resistant
mutants among the progeny of each resistant clone is
clearly seenv The three resistant clones have not only
maintained each their own level of resistance but have
produced mutants in turn to higher levels shown by the
scattered colonies on the streak lines.
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O^g./ml. streptomycin
Fig: 28. Progressive mutations in E. coli neapolitana, No.: 414.
Three resistant and one nominally sensitive colony from
earlier experiments are incubated as parallel streahs



















To confirm the fact that the resistant mutants are
mutating in turn, and that their numbers are again
quantitatively determined, the whole of Experiment 16 was
repeated using as inoculum a pure resistant clone.
Materials
A single colony was chosen at random from a plate
of E. coli var neapolitana N.T.C. 414 "Resistant to l^ug/ml.
of streptomycin" and was grown in nutrient broth. MacConkey
plates containing 10, 5# 2, 1, | and 0^vg/ml, streptomycin
were prepared in bulk as before.
Method
Decimal dilutions in saline of an overnight broth
culture, shaken and standardised, were made to l/million and
0.1 ml, inocula of various dilutions spread on plates in sets
of 4* Using the plates yielding optimal counts of between
25 and 250 colonies as a guide, the experiment was repeated
definitively using undiluted overnight culture (Opacity
Brown Nos 4) for the 10^ g plates, one-tenth dilution for
5 Kgi one-thousandth for 2 ^-g, and one-ten thousandth for the
remaining drug strengths. Incubation of the plates was for
6 days at 37°C.
TABLE17
FREQUENCE0FRESISTA TINDIVID LSVA OUSST AINO 1ESCmfyC'IOLI
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The results are shown in Table 17« It will be
seen that both ^ and 1j^s/ml. can now do little more than
halve the population of bacteria, while 8$ survive 2jxg,
1 in 3,000 survive 5^g, and 1 in 100,000 resist 10It
appears that mutations are occurring with increasing
frequency, therefore, giving greater degrees of drug-fastness
to high concentrations of streptomycin as well as to low.
To bring out this feature, Composite Table 18 compares the
resistant mutation rates at each level of the original
"sensitive" strain with the clone nominally "resistant to lu-g".
COMPOSITETABLE18•
INCREASEDERECVENCYCPRESISTANTINDIV DU LS,OLI NEAPOLITANA,T.C.414EXP SEDTSTR P MY IN
Cone,fstreptomycin"Sensitive""R a tto1




Escherichia coli var. communis obtained from
National Type Cultures - Strain N.T,C. No. 1094* This
was tested for streptomycin-sensitivity using "Sentest"
(Evans) tablets, and also for discrete lactose-fermenting
colonies on MacConkey's Medium.
MacConkey Agar 4" plates (Maekie and McCartney
10th Edn p.216) containing streptomycin hydrochloride
(D.C.(B)L) added to the medium in bulk prior to pouring.
For the purpose of the preliminary experiment, 10 500.ml
bottles of MacConkey Agar were melted in a Koch*s Steamer,
and streptomycin solution added while shaking to give the
following respective final concentrations:- 2 each of
0, 1, 5, 10, and 100 ^g/ml, The ^ litre bottles were
distributed in each case into 8 plates, giving 16 of each
strength•
For the definitive experiment which followed, a
similar range of streptomycin - containing MacConkey medium
was prepared} but only in single 500-ml bottles giving 8




This was a pilot experiment to discover the
dilutions of inoculum which would be optimal for giving
countable colonies*
1 ml was taken by pipette from a 12-hour broth
culture of E. coli communis N.T.C. IO94, grown in a bijou
vial and shaken for 2 hours with 2 glass beads before
sampling to ensure a uniform suspension* Ten-fold
dilutions of this were made in a series of 5 x f" test-tubes
by adding 1 ml to 9 ml saline in succession, a fresh oven-
sterilised 1 ml pipette being used for each transfer. The
same pipettes were used to inoculate the corresponding sets
of plates with 0.1 ml each which were then evenly spread by
rotating rapidly against a right-angled glass-rod spreader.
Table 19 shows the resulting colony counts from empirically
chosen dilutions after overnight incubation at 37°c« Those
underlined were selected as the most practicable counts for
the subsequent experiment*
Experiment Proper
Again the inoculum was an overnight broth culture
shaken in a Kahn-agitator for two hours in a bijou vial with
two glass beads to ensure a homogeneous suspension. This
was standardised to Brown's Opacity Tube No: 2 (1500 million
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TABLE 19
PILOT EXPERIMENT TO DISCOVER DILUTIONS YIELDING COUNTABLE
COLONIES ON VARIOUS STRENGTHS 0? STREPTOMYCIN
Inoculum: 0,1 ml of 12-hour broth culture of E, colt oar, communis
N,T,C, No, 1094 shaken 2 hours with glass beads.
Colony counts are averages of 4 plates.
Log dtlutton Streptomycin concentrations in
of inoculum. MacConkey Agar
0 1 5 10 lOOfg/ml.
0 <250 J3
1 00 < 25 0
2 oo <5 0





8 <5 < 5
9 0 0
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E. coli per ml.) by adding drops of saline with a Pasteur
pipette and re-shaking. Ten-fold dilutions were then made
in tubes of saline, and using the pilot experiment as a
guide 0,1 ml amounts of appropriate dilutions were pipetted
onto the surface of the plates and quickly spread with the
angled glass-rod starting from the greatest dilutions and
working upwards to minimise carry-over of organisms.
As will be seen from Table 20, the 1 in 10 million
dilution sufficed for the 0 (Control) and 1 jig/ml
streptomycin plates, 1 in 10 thousand for those with
5 jug/ml, 1 in 10 for 10 ^g/ml plates and undiluted broth
culture for the plates with 100 ^g/ml.
Results
The resulting colony counts are given in the final
columns of Table 20 as a proportion of the count on the
untreated media. In every case 8 plates were used, counted
separately and averaged, allowance being made for the relative
dilution of the inoculum. It will be seen that virtually
all the population can survive 1 ^g/ml of streptomycinj but
that 5 j^g reduces the number to 1 in 45*000, while only
1 in 4 million can withstand 10 ^g, and the rare mutant
enduring 100 ug numbers only 1 in 900 million.
table:20
FREQUENCYOFRESISTANTINDIVID LSVA OUSST AINFESCHERICHIC LI


















A single colony was picked off a 5^-g/ml streptomycin-
containing plate of the last experiment, and inoculated into
broth. This in turn was subcultured in broth the night
before the new experiment, and the new culture known as
E. coli communis N.T.C, IO94 "Resistant to 5 j-<Sn used as
the next inoculum*
Methods
A pilot experiment was again conducted precisely as
before to discover the most suitable dilutions of inoculum*
These based on the averages of 4 plates and chosen to yield
not more than 25 colonies5 but as near that number as
possible, urere found to be 1 in 1 million for all streptomycin
strengths upto 5 |xg, while 1 in 10 dilution could be expected
to suffice for 10^g, and pure culture would evidently barely
suffice to give resistant mutants on 100^xg. See Table 21.
In the subsequent definitive experiment performed
as in Experiment 19 using 0.1 ml inocula from ten-fold
dilutions in saline of an overnight broth culture, only 5
plates were spread for each strength. Incubation at 37°C
was continued for 1 week, the colony counts being found easiest
on the sixth day.
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TABLE 21
PILOT EXPERIMENT TO DISCOVER OPTIMUM DILUTIONS OF INOCULUM
Inoculum: 0,1 m, of 24-hour troth culture of E, colt comvnta N,T,C,
1094 "R to 5* shaken 2 hours with glass beads,
Log dtlutton Streptomycin in MacCorikey Agar












These were again averaged, adjusted for their
dilutions, and the mutation rate of resistant individuals
expressed as a percentage, or rate per million respectively,
in the total population given by the count on the control
plates*
It will be seen from the final column in Table 22
that the whole of this clone of B» coli are now not only
surviving 1 ^g but also 5 |vg of streptomycin, in other words
the mutation conferring this degree of resistance is breeding
true* In addition there is a progressive rise in the
mutation rates giving higher degrees of resistance, the rate
for 10 of streptomycin being now 1 in approximately
1^ million, and that for 100 ^ug/ml occurring once in 28 million*
TABLE22
FREQUENCYOFRESISTANTINDIVID LSVAR OUSST AINOFESCH RICHIAC LI
E,coltvan,commnis,N,T,C,1094"Resista ttSyufl/ tf*. 0,1wl,inoculumfvernightbrothcult reshaken2ho swi hbead . Cone,fstreptomycin tnug/ml, MacCohkeyAgarPl tes, 1 5 10 100Dtln:of Inoculum insaline. 1U~ 10 106 10 1.6
Colonyc untsa 6days.
SO322748 296732 2243158 720125 0








A single colony of E. coli communis N.T.C. 1094 was
now taken from the 100 ^ug/r.il. streptomycin-containing
plate of the last experiment, and was grown in nutrient broth
for a week. Half-litre bottles of MacConkey Agar were melted
as before, five being required for the pilot experiment and
five for the experiment proper, streptomycin being added in
each case to four of the bottles as 1, 5, 10 and 100 ^g/ta1
shaking meanwhile and then expeditiously pouring the 16
plates needed for the pilot experiment and 5 for the experiment
proper at each strength. The fifth bottle of medium provided
a parallel set of untreated control plates.
Method
The pilot experiment was conducted exactly as in
Experiment 20 with 0.1 ml pipetted inocula from a well-
shaken 12-hour broth culturej but it was found, after two
abortive attempts with heavily overgrown plates, that
dilutions of 1 in 100,000 to 1 in 100 million would be needed
in every case to give a scatter of colonies which could be
counted. The results read after 3 days* incubation at 37°C
are shown in Table 23*
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TABLE 23
PILOT EXPERIMENT TO DISCOVER OPTIMUM DILUTIONS OF INOCULUM
Inoculum: 0.2 ml of 12-hour broth culture of E. colt communis N.T.C,
1094 "R to 100" shaken 2 hours with glass beads.
Counts are averages of 4 plates•
Log dilution Streptomycin in MacConkey Agar





5 <25 <25 <25 <25 oq
6 <5 <5 <5 <£_ <250
7 0 0 0 0 <25
8 0 0 0 0 <5
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Basing the experiment proper on this the saline
dilution chosen for the inoculum was 1 in a million for all
the plates. The overnight broth culture of E» coli communis
N.T.C. 1094 "Resistant to 100^g/ml was adjusted to Brown
No. 2 opacity, and then diluted tenfold by transferring
1 ml to 9 ml saline six times using 5 x §" tubes each with
its own oven-sterilised 1 ml. pipette. The final pipette
was used to drop 0.1 ml inocula onto the 25 MacConkey plates -
5 of each strength - which were then quickly spread, inverted,
and incubated at 37°C.
Results
Table 24 shows the resulting colony counts six days
later. It will be seen that this streptomycin-resistant
clone gives virtually identical counts at all concentrations
up to 5 |\Ag/ml, while 10 ^.g/ml and 100^-g/ml give not fewer
colonies as might be expected} but more - approximately
half as many again as the 10 and no fewer than 17 times
as many on the 100 ia£. In other words the colony count is
now rising rather than dropping with increasing streptomycin,
and we are now dealing with a mutant which is not only drug-
resistant but streptomycin-dependant.
TABLE84
FRECfJENCYOFRESISTA TINDIVIDUALSVA IO SST AINOPESCHE CHIACOLI
E,coltoar.communis,N.T.C.1094"Resistantt2 0f^g/ l". 0,1ml,inoculumfvernightbrothcult reshaken8ho rswithbeads. Cone,fstreptomycin inixg/ml. MadConkeyAgarPl tes, 1 5 10 100Dilmof inoculum, insaline, 106 1&- lcr 10 10
Colonyc untsa 6days. 11838 3113 3182 1352
4526343
Average 1,8 1.8 1.8 2.8 30.8
Rate
X1.5approx. X1?





In order to confirm that the mutation was truly
streptomycin-dependant, and thus largely irreversible, a
further experiment was planned.
Materials
A broth culture of E» coli communis N.T.C, 1094
"R to 100 , subculture*! from a 100 ^vg plate of the last
experiment, was grown overnight to bring it into the log
phase, and used as inoculum.
Twelve plates each of MacConkey Agar with
streptomycin incorporated in strengths of 0, 100 and 1000
ijig/ml* were prepared.
Methods
Serial tenfold dilutions brought the inoculum down
to 1 in 100,000, 1 in a million, and 1 in 10 million
respectively, ana 0.1 ml amounts of these, pipetted each
with its own 1 ml pipette, were dropped onto 4 plates each
of the control 'O', and the 100^g. plates. For the 1000^ug.
plates 4 received hundred-fold dilution, 4 ten-fold, and 4
undiluted broth culture. Spreading was done in every case




EXPERIMENT WITH E, COLI COMMUNIS N.T.C. 1094 *R TO 100^g/ml*
TO CONFIRM STRFPTOMYCIN-DEPENDANCF,
Log dtlutton Streptomycin tn MacConkey Agar
of inoculum. .
0 100 1000 f+g/ml •
0 OG CO CO oo




5 0 0 0 0 °c oo oo oo
(about 600 +)
6 0 0 0 0 68 81 79 63
7 0 0 0 0 8 10 11 9
OO CO CO oo
(about 20,000)
Conclusion: Survival count without streptomycin ■<! In 4,000,
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Results
It will be seen that the clone has now become
virtually wholly streptomycin-dependant, there being no
survivors on the streptomycin-free plates when plates
containing 100 jxg/ml of drug and receiving the same inoculum
showed uncounted colonies but certainly several hundred.
Moreover plates containing 1000pg/ml of streptomycin also
showed vast numbers of colonies, the number being so
unexpected that the plates were overinoculated. Comparison
of the two sets of streptomycin plates and consideration of
the relative dilutions of inoculum, however, suggested that
the counts were probably very similar. The conclusion
reached was that the strain had achieved resistance to
streptomycin even of the order of 1 |umg/ml, combined with
overwhelming dependence on the drug.
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EXPERIMENT 23.
It was now planned to investigate in more detail
both the extent of the streptomycin-resistance and also
the completeness or otherwise of the streptomycin-dependence,
after 3 weeks' continuous culture of the strain "1094
Resistant to 100 ^g/ral Streptomycin" on 3 successive 100^ g/rrtl
plates.
Materials
It seemed likely the broth culture used for the
inoculum would itself now need streptomycin to maintain this
strain, and this proved to be the case. Overnight broth
cultures of E« coli, N.T.C. 1094 "Resistant to 100yug" were
maintenance culture. Three cultures were made with 0, 20
duplicated. The degree of turbidity showed unmistakeably
that growth increased proportionately with increase of drug,
and the culture in 80 ^ g/5 ml showing the greatest growth
was adjusted to Brown Not 2 opacity with saline and used
as inoculum.
Bottles of MacConkey Agar 0.5 litre were melted and
streptomycin added prior to pouring in concentrations of
made from a single colony
and 80 ^g of streptomycin in 5 ml. of broth, each being
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TABLE 26
PILOT EXPERIMENT TO DISCOVER OPTIMUM DILUTIONS OF INOCULUM,
PRIOR TO INVESTIGATING IN THE CLONE E. COLI N,T,C, 1094 "RESISTANT TO 100 f^g/ml,
STREPTOMYCIN" AFTER THREE WEEKLY SUBCULTURES IN THAT CONCENTRATION:-
1, Extent of resistance,
2, Any reversal to sensitivity and non-dependance,
Inoculim; Onernight broth cultures were grown with 0, 20, and 80in
5 ml, broth. 80^g/5 ml, showed greatest growth, and 0,1 ml,
of it was used.
Counts are averages of 4 plates.
Log dilution Streptomycin in MacConkey Agar
of inoculum
Q JQ0 JQOO jotO0O 25,000^-g/ml
0 <_5 oo co
1 0
2 0 <25 <5
S 0
4 <5 0
5 < 250 < 250
6 <25 <25 0 0
7 0 0
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Oj lOOj lOOOj 10,000} and 25#000p,g/ml. For the
preliminary experiment 20 plates of each strength were poured.
Method
Tenfold dilutions of inoculum up to 1 in 10 million
were made in 5 x §" test tubes using a fresh oven-sterilised
1 sal pipette for each successive transfer of 1 ml into 9 «al
saline. The pipettes were left in the tubes and used in
reverse order to place 0,1 ml of their appropriate dilutions,
well shaken, onto sets of 4 plates as shown in the table 26.
After immediate spreading the plates were incubated at 37°C
for 24 hours with the results shown.
Using this pilot experiment as a guide the dilutions
of inoculum chosen for the definitive experiment were \% for
the 10,000 and 25#000 ^g/ml plates, 1 in a million for the
100 and 1,000 jxg/ml plates and undiluted inoculum for the
plain untreated plates. An overnight culture in 5 ml
broth containing 80 ^g/ml streptomycin tvas again prepared,
shaken 2 hours with tivo glass beads in a bijou vial, diluted
to Brown No: 2 opacity, and then passed through serial
tenfold dilutions to obtain those required. 250 ml amounts
of MacConkey Agar received the streptomycin in bulk for each
concentration, and 4 plates poured for each strength 0| 100j
1,000} 10,000} and 25#000 ^g/ml. The 0.1 ml inoculum was
quickly spread, incubated at 37°C for 6 days, and colonies
TABLE37
FREQUENCEOFRESISTA TINDIVIDUALSVA O SST AINSOFESCHE ICHICOL Tosh w1,Extentofre ista ce, 8,Anyreversaltosensitivitya dnon-d pendence













































Conclusions:Only1i3millionhaverevertedR,&D.->S. NearlyallreR,to100andlsot1,0 0^g, 1in10,000areR,to10,0 ^g,a din100,areRto25,0 ^g, "Rmesistant,D»epend ,S-Sensitive"
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resulting counted and recorded in Table 27 • After averaging
and making allowance for the dilution factor in each case
the mutation rates shown in the last column were obtained.
It will be seen that if we use the 100 ^g/ml
streptomycin now as the control plate, no less than 83^ of
these bacilli are also resistant to 1,000 ^g/ml, and mitants
are occurring resistant to 10,000 and 25#000 ^,vg/ml at rates
of 1 in 10,000 and 1 in 100,000 approximately, which are
far higher than the back-mutation rate to streptomycin-
sensitivity, which is only of the order of 1 in 3 million.
The Composite Table 28 summarises Experiments 1 to 5#
and shows clearly the progressively higher mutation rates
occurring in the already resistant clones of E. coli surviving
streptomycin. Back-mutation, while it does occur, is
obviously relatively much less frequent, and with the
natural selection which will happen so long as the drug is
administered, it is easy to see how antibiotic resistance
occurs in a rapidly steepening curve so characteristic of
streptomycin, and how only prolonged cessation of treatment
will give reversal to sensitivity again.
J!
COMPOSITETABLE28























STREAK-PLATE DEMONSTRATIONS OF STREPTOMYCIN-DEPENDANCE
To demonstrate graphically the reality of the
streptomycin-dependance achieved by this strain of E. coli
some simpler experiments were done using streak-plates and
these were photographed by transmitted light to show up any
trace of growth as a silhouette.
EXPERIMENT 24.
streptomycin-sensitive or resistant E. coli communis N.T.C.
1094, each derived from a single colony growing on a
MacConkey plate containing the appropriate concentration of
the drug, were suspended in 5 ml of broth and a loopful of
the suspension used as inoculum in each case. The inocula
were streaked in parallel on MacConkey plates containing
G, 1, 5# 10sand 100 j^g/ral streptomycin, two rows of such
plates being used to duplicate the whole experiment.
respectively" grow on all the three lower strength plates,
those containing 0, 1, and 5 j^S* but there was no growth
beyond this point. (N.B. The plates unfortunately read
from right to left. The labelling on each plate is correct
however, having been made to read by transmitted light
In the first experiment, FigJ 29, five clones of
It vd.ll be seen that the three least resistant
clones, those "Resistant to0,
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through the plates). The "Resistant to lOyug/ral" clone,
as might be expected grows on a plate higher to reach its
own level of 10 ^g. But when we come to the "Resistant
to 100 ^vg/ml" clone of E, coli, 1094 we find the very
different picture of no growth at all on any lower strength
plate than 100 ^g/ml streptomycin, showing the necessity
of the antibiotic for its continued growth.
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Fig: 29, Demonstration of the Streptomyctn-dependance of the strain
"E, colt, No: 1094, Resistant to 100^g, streptomycin",
Resistant clones from previous experiments were incubated as
parallel streaks on the following streptomycin-containing
plates:-
Nominal resistance Concentration of streptomycin in plate
of clone lo0 10 5 1 0 ^g/ml
0 i^g, __. + + +
1 IA-i7* — — + + +
5 ^g, - - + + +
10 ^\.g. — + + + +
100 j^g.
It will be seen that the three "weaker" clones grow only up to
5 j^g,/ml,f that the "Resistant to 10 f^-g.", grows on a plate
higher i,e, up to its nominal level of 10jmg./mL,; but that
the "Resistant to 100 ug," clone is only able to grow on the
100 i^g,/ml streptomycin plate.
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Comparison o£ 6treptormjoin- dependence Streptomycin-









Fig: 30, This simplified diagram, based on the phenomenon seen in
the foregoing Fig: 29, shows the complicated picture which
results when graduated resistance to streptomycin is
superimposed on dependence operating in the reverse
direction (shown in red). The superimposition of multiple








FigJ 31 is a still more conspicuous demonstration
of this streptomycin-dependance phenomenon# The clone
E. coli. 1094 "Resistant to 100^ g." was suspended in broth
and diluted 1 in 1 million with saline from the suspension
adjusted to Brown 2 opacity. 0.1 ml amounts were inoculated
onto three MacConkey plates containing 10, 100 and l,000yuvg/ml
streptomycin, each plate being repeated in triplicate. It
will be seen that the colony counts increase progressively
as the drug concentration rises, the fact that there is any
growth at all at the lower levels suggesting that some back
mutation is occurring; but being probably exaggerated by
the crudity of the method.
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Fig: 31, Another demonstration of streptomyctn-dependance.
The clone "E, colt No, 1094, Resistant to 100 ^xg, Streptomycin",
obtained from previous experiments, is now giving progressively
higher counts with increasing amounts of streptomycin,
Reading from left to rtght:-
A uniform inoculum yields 1-3 colonies on agar with
1° l^g,/ml, streptomycin,
" 3-6 colonies on agar with
100 p.g,/ml, streptomycin,




It is interesting to speculate whether the
administration of streptomycin could actually lead to a
relapse of infection in a subject harbouring a strain of
E, coli. which had become drug-dependant as in the in vitro
tests described above. The following in vivo experiment
was an attempt to detect this.
Nine white mice of average weight 10 G, were marked
distinctively with dyes and distributed into one group of 5#
and a control group of 4* The group of 5 each received
1 mg. Streptomycin hydrochloride dissolved in 0.5 ml
distilled water by intraperitoneal injection on each of
three successive days. One of these mice received nothing
more. The remaining 4# and the control group of 4» were
also injected intraperitoneally with suspensions of an over¬
night streptomycin-broth culture of E, coli. communis No.1094
"Resistant to 25,000 ^g/ml" harvested from Experiment 23•
This was adjusted turbidimetrically to Brown Opacity Tube Nos
4 (3,000 million organisms/ml) and then serially diluted so
that pairs of mice, one untreated, the other pre-treated
with streptomycin, received respectively 150 million E. coli.,
15 mil., 1.5 mil., and 0.15 mil. As no disease was yet
apparent in any of the mice, all the 8 infected animals
(both treated and untreated with streptomycin) were given
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a massive dose of 1,50° million E. coli. i.p. Three out
of four of both groups, those having streptomycin and those
not, succumbed in 24 hours# The survivor in each group
was the mouse which had previously had the biggest innocula
of 150 mil. organisms. The experiment was therefore
inconclusive, largely no doubt because attenuation during
the successive in vitro experiments had made all but over¬
whelming infection abortive, and even that could be withstood
by the two survivors whose previous injections had presumably
been adequate to pre-iramunise them# But while no
streptomycin-dependance had been demonstrated, the
streptomycin-resistance of this strain of E# coli., which we
have seen in vitro, had had suggestive confirmation in vivo
also, for 3 daily doses of 1 mg. (i.e. 1/10,000 of the entire




Under natural conditions, of course, it must come
about that quite a number of different mutations are
occurring in any one strain of bacteria simultaneously, and
this muct be particularly so with a drug such as streptomycin
to which resistant mutations so readily occur. The
following experiment gives an indication of how complex the
cumulative effect can become.
Materials
Colonies of E» eoli. communis N.T.C. IO94 picked off
drug-containing plates of the previous experiments 1-5
were grown separately in broth overnight, 80 jug/ml of
streptomycin being added to the clones from 1,000} 10,000}
and 25*000 |^g plates to satisfy their drug-dependance. The
resulting cultures provided inocula nominally "sensitive" and
"resistant to 1} 10} 100} 1,000} 10,000 and 25*000 ^g/ml
drug respectively". Hates of MacConkey Agar were prepared
containing all these strengths of streptomycin.
Method
The seven inocula were all streaked in parallel on
all seven plates, incubated overnight at 37°C &nd photo¬
graphed in silhouette (Figs 32) to show up any trace of
growth. The 1 pAg/m1 plate has been excluded as it proved
identical to the control (0 f^g/ml streptomycin).
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Fig: 32, Resistant mutants of various degrees of E, colt 1094
streaked on drug plates to show diverse properties:-
Plate:- 0 5 10 50 100 25,000
Clone:-
'Resistant to 0' +++ +++ 0 0 0 0
t if to 1' +++ +++ 0 0 0 0
I it to 10' +++ +++ 0 0 0
1 it to 100' 0 0 0 +++ +++ +++
t # to 1000' +++ +++ +++ ++ +++ +++
t a to 10,000' 0 0 0 ++ + +++ +++
1 n to 25,000' + ++ ++ •f-f +++ +++
streptomycin
This suggests:-
"R to 0 & 1" are alike R to 5 and no farther.
"R to 10" ts R to 10 and no further,
"R to 100 & 10,000" are Strep-dependant & R between 50 - 25,000,
"R to 1000 & 25,000" are similarly R but not completely dependant.
N,B, R = Resistant cr
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Results
A study of the photograph (Figi 32) will show that
the three less resistant mutants are unable to survive more
than small amounts of streptomycin, the limit being^g for
the 'sensitive' ana 'resistant to 1^ g' and 10 ^g for that
'resistant to 10 jug*. The more resistant mutants on the
other hand grow as well or better on the more strongly
dosed plates, the 'resistant to 100^g1 and 'resistant to
10,000 |Ag* clones being fully dependant so that they do not
survive below 50 jxg concentration of streptomycin, while the
'resistant to 1000 ^g' strain shows a suggestion of a
biphasic curve with least growth at the intermediate point
between sensitivity and dependence, while the most resistant
clone of all, that to 25»000 ^g, has been back-mutating
sufficiently to give some growth on all plates but diminish¬
ing inversely to the drug-concentration. The bewildering
overall picture which could emerge from all these, and no
doubt many other, diverse mutants all superimposed is obvious.
All that we can say clinically is that our drug is introducing
bias into the normal to and fro mutations so that, temporarily
at least, more pro-resistant mutations than others will be
encouraged, and to progressively higher levels, by a process
of natural selection.
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COMBINED ADAPTATION AND MUTATION
EXPERIMENT 28«
The previous nine experiments with the type culture
E, coli* communis Noi IO94 show clearly that drug resistance
to the highest degree can result from the selective breeding
of a few resistant organisms present in the original stock*
Even those variants which are excessively rare could, with
the enormous reproduction rate of bacteria, periodically
get the chance to replace the normal population.
But the wide-spread emergence of drug-fast strains,
including some apparently initially resistant, and also those
resistant to more than one antibiotic and even several
simultaneously, suggests that with some bacteria another and
additional factor contributes, namely that some individual
bacteria are capable of adaptation of their enzyme systems
to nullify the effects of the antibiotic* The time needed
for such adaptations, however short, can never be quite so
instantaneous as a mutation and it seemed possible that in
this way a distinction could be made between the two phenomena*
Materials
E* coli* communis N.T.C. No* 86 was selected as it
had been noticed with this organism that plate counts of
202
Fig: 35. Plates showing that drug-resistance in the strain E. coli,
N.T.C. No: 86 , is probably due to both adaptation and
mutation.
Left: A control plate of agar with no streptomycin.
It has grown 17 colonies all alike.
Right: An agar plate with 2^g./ml. streptomycin.
This has one large colony, which appeared at 6
hours and is probably a mutant.
But there are also 17 small colonies which appeared
only at 3 days, suggesting adaptation to the drug.
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streptomycin-resistant colonies had been increasing
inexplicably over the passage of several days. MacConkey
Agar 3*" plates were used incorporating 2 ^g/ml streptomycin
hydrochloride added at 5S°C just before pouring* Plain
MacConkey Age r plates provided controls.
Method
An overnight broth culture incubated at 37°C of
E. coli. 86 was shaken for 2 hours with 2 glass beads in
a bijou vial and diluted 1 in 10 million with saline.
0.1 ml of this was spread on the 2 iAg/atl streptomycin and
the plain plates with a glass rod and the plates incubated
at 37°C for 1 week with careful daily examination.
Results
Figs 33 shows photographs after 3 days of a pair
of equally inoculated plates, that on the left containing
no streptomycin, that on the right 2 ^Ag/ml. Both plates
show comparable numbers of colonies (17 and 18 respectively)}
but on the streptomycin plate the colonies are of two sorts -
a single large colony which had been visible to the naked eye
since the first day, and was therefore presumably a true
mutant, while the other 17 colonies on this plate were late
developers only appearing after three days, and therefore
considered to be adapters.
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EXPERIMENT 29.
It is possible of course, that the ability to
modify an enzyme system and thus avoid inhibition by an
antibiotic, is itself conferred by a mutation at least
when demanded in high degree by greater concentrations of
streptomycin than that with which we were dealing in
Experiment 10, If this be so drug-resistant 'adaptors',
and 'mutators1 pure and simple, should both be occurring
at fixed rates* The following experiment shows that
this is so*
Materials
B, coli. communis N.T.C, No, 86 groxm overnight
in nutrient broth to bring it into the logarithmic phase
of growth was shaken for 2 hours with glass beads and
adjusted to Brown No: 4 opacity tube (3*000 mil organisms
per ml), MacConkey Agar was prepared in litre bulks and
streptomycin hydrochloride added at the time of pouring to




To discover suitable dilutions of inoculum to give
practicable colony counts the broth culture of E, coli. No:
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TABLE 29
PILOT EXPERIMENT TO DISCOVER OPTIMUM DILUTIONS 0E INOCULUM
Inoculum.: 0,1 ml overnight broth culture of E, colt communis N,T,C,
No, 86 shaken 3 hours with glass beadst
Counts are average of 4 plates.








5 < 35 < 5
6 <350 <350 <5 0
7 < 35 <35 0
8 <5 <5
9 0 0
Plates were read after 4 days, and it was noticed that about half
the colonies took 3 days to become visible to the naked eye.
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Q
86 was taken through serial tenfold dilutions to 10 using
fresh oven-sterilised 1 ml pipettes for each transfer into
9 ml sterile saline. The same pipettes imoculated the
plates with 0,1 ml inocula in the manner shown in Table 8a,
and the entire set of plates was in quadruplicate. The
plates were spread rapidly by rotating an angled glass-rod,
and were then incubated at 37°c*
Results
Table 29 shows the approximate colony counts,
averaged from each 4 plates, after 4 days. It was noticed
even at this stage that about half of all these colonies had
not appeared during the first two days' incubation. Counts
of about twenty colonies gave the inoculum dilutions chosen
for the definitive experiment.
Experiment Proper
Method
Using the same materials as the previous pilot
experiment, and it as a guide, the broth culture of E, coli
86 "Sensitive to streptomycin" was diluted 10 for the
control and 1 ^g plates, 10 ' for the 5 plates, 10^ for
10f^g and used undiluted for those containing 100 ^g, Four
plates of each strength of streptomycin - containing MacConkey
Agar were used, and after incubation at 37°C colony counts
TABLE30
FREQUENCYOFSISTANTINDIVIDUALSIVARIOUSST INOFESCHERICHIAC LI
E.coltvan,communis,N,T,C,o86Sensi ivetstrep omycin", 0,1ml,inoculumfovernightbrotcultureshaken2h swithb ds. Cone,fstreptomycinDiln,finoculumC onyo tsa1da(u pern ,)AverageRat




were made at 24 hours and again at 3 days. These were
averaged, adjusted for the dilution factor, and two separate
rates obtained.
Results
These are shown in Table 30, the black being the
immediate number of resistant colonies, and therefore
straightforward resistant mutants, while the red totals
representing a quite different but nonetheless equally
regular rate suggest a slower adaptation, possibly itself
inaugurated by a mutation. It will be seen that this
second mechanism conferring streptomycin resistance on the
strain E. coli 86 is occurring more frequently throughout
than the straight mutation, being 4 times commoner to 1^ g,




PILOT EXPERIMENT TO DISCOVER OPTIMUM DILUTIONS OF INOCULUM
Inoculum: 0,1 ml overnight broth culture of E, colt communis N,T,C,
No, 86 "Resistant to 5 a/ml, streptomycin", shaken 2
hours vtth glass beads.
Counts are average of 4 plates.
Log dilution Streptomycin in MacConkey Agar
of inoculum
0 1 5 10 50 100





e <250 < 250 <25 <25
7 <25 <25 <5 <5
8 <5 <5 0 0
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EXPERIMENT 30*
This was a limited experiment with a "resistant to
5 clone from a true mutant colony on the 5 f^g plates of
Experiment 11 to see whether both simple mutation and
adaptation continue at fixed but still greater rates on
further subculturing.
Materials
An overnight broth culture of E, coli communis
N .T .C. 86 "Resistant to 5 streptomycin" was the
inoculum, and MacConkey Agar plates were poured with
streptomycin added in only 5 ^g/ml and 100 yug/ml
concentrations•
Methods
A preliminary pilot experiment showed that optimum
dilutions of the inoculum in saline would be 1 in 10 million
for the control plates, 1 in a million for the 5 ^g plates
and 1 in 10 for 100^g. (See Table 31 )•
In the actual experiment 4 plates were used at each
of these strengths and uere spread with an overnight broth
culture dispersed with beads and serially diluted with saline
to these amounts. After incubation at 37 0 colony counts
were made at 1 day and 3 days and separately recorded.
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Results
Table 32 shows that separate "mutation" and
•adaptation1 rates continue to operate regularly, and are
progressively rising in frequency at both the 5 end 100 ^-g.
levels, suggesting that both mechanisms depend on natural
laws and may well both in fact originate from mutations*
Thus the two rates at the 5 j,\g» level have risen from
scarcely 2% and 3$ to t% and 90% respectively, while those
at the 100level, formerly 1 in 25 mil. and 1 in 10 mil.,




In the previous experiment we were dealing with
the rates for further "adaptors" and "mutators" within a
single drug-resistant clone - that to 5 streptomycin.
In this experiment an attempt was made to compare side by
side on streak plates the behaviour on subsequent sub¬
cultures of the two clones themselves - "adaptor clone" and
"mutator clone% and that was done for pairs of colonies
from the three levels of streptomycin resistance 5 ^Ag,
10 l^g, 50 ^-g.
Materials
E, coli No: 86 drug-resistant colonies were
selected from previous experiments, first-day large colonies
providing the outright "mutants", and small late growers
the so-called "adaptors". Overnight broth cultures were
grown of these pairs for the three degrees of resistance -
5> 10 and 50 |Ag* streptomycin, and also the original
sensitive strain.
Method
Standard loopfuls of the sensitive strain and the
three degrees of resistant "mutants" were streaked side by
side with the corresponding three "adaptors" 'A' on 4
MacConkey Agar plates containing 0, 10, 50 and lOGi^g/ml
streptomycin respectively.
TABLE32
FREQUENCYOFRESISTANTINDIVIDU LSNVARIOUSST AINPESCHER CHIACO I






The growth after 24 hours at 37°C showed that
the resistant progeny at 24 hours are virtually identical
for both types of resistant colony apart from some minor
inconsistency at 10^vg» where the "true mutator" gave a
confluent growth and the "adaptor" seemed to show some
partial reversal of drug-resistance. The fact that both
"mutator" and apparent "adaptor" continued to breed
resistant strains suggests that both in fact originate in
genotypie mutations.
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CHAPTER 9. ANOMALOUS FINDINGS AND FALLACIES
1• OVERLOADING OF ANTIBIOTIC
27A 271
Maass and Johnson 3 estimated that each
staphylococcus binds some 750 molecules of penicillin thereby
weakening the residual antibiotic in a solution* It seemed
likely that a similar quantitative loss occurs with
streptomycin in contact with coliform bacilli, and the follow¬
ing experiment shoivs that this is so, and that very high
colony counts (500-1000 colonies) are false evidence of
drug-resistance•
EXPERIMENT 32*
The clone of £» coli communis No* 1094 "Resistant to
25*000 |Ag" ivas taken from previous experiments and maintained
in nutrient broth containing streptomycin 80 ^g/ml, An
overnight subculture in this medium was adjusted to Brown No. 4
opacity (3*000 mil* organisms/ml)• After 2 hours' agitation
in a vial with glass beads, half the inoculum was diluted 1 in
100 the remainder being kept undiluted.
Identical MacConkie Agar plates containing 25*000 ^vg/ml
streptomycin hydrochloride were poured, and 0.1 ml inocula of
the two different strengths of culture pipetted onto each, using
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Fig: 34, The spuriously high count of "resistant" colonies caused
by overloading an agar plate containing 25,000 jmg./ml, of
streptomycin with an excessive inoculum of the clone E,
colt No: 1094 "Resistant to 100 fxg,"
Left: Using optimum inoculum (0,1 ml, of 1% overnight
broth culture) the yield is 3 truly mutant colonies.
Right: Using one hundred times this amount the yield is
many more than 300, and the colonies show no
uniformity in size, suggesting that the appearance
of many is due to mere exhaustion of the
streptomycin in the plate.
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separate sterile pipettes, the spreading also being done by
separate sterile angled glass-rod spreaders. After over¬
night growth at 37°C the resulting colonies are shown in
silhouette in Figs 34• It will be seen that the colony
counts were 3 for the 1 in 100 dilution; but approximately
750 for the undiluted culture. Moreover the colonies on
this overloaded plate were of many sizes and even in clusters.
EXPERIMENT 33.
In order to confirm that this latter high count is
in fact spurious, subcultures were tested as follows* Four
MacConkie Agar plates containing Oj 1000j 10,000} and
25#000 jug/ml of streptomycin respectively were prepared, and
overnight cultures made to give inocula from colonies from
the two plates of the previous experiment. These were grown
in broth to which streptomycin 80 ^g/ml had been added, and
after 12 hours the two cultures were carefully adjusted to
an equal turbidity, Brown Opacity Tube No. 4*
'A* is the clone from one of the 3 mutants in the
left-hand culture (Fig: 35) end ,B' is from one of the 750
suspect colonies of the right-hand culture. 'A* and 'B'
are streaked in parallel on the four media and grown overnight
at 37°C. The results (Fig: 35) show that while both are
streptomycin - dependant as they do not grow on the plain
218
Fig: 35 Streak sub-cultures from the plates of the previous experiment.
'A' is from the colonies of the left-hand plate (Fig: 34),
'B' from the right-hand one, The two inocula have been
incubated, on agar plates containing 0; 1,000; 10,000; and
25, 000jg./ml. streptomycin.
'A' is seen to be truly streptomycin-dependant and highly
resistant (to 25,000 ^g./ml.)
>B', however, is streptomycin-dependant as it will grow on
the control plate; but is only moderately resistant
(- to 10,000 wg.).
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control plate, and both are to some degree streptomycin-
resistant, only the »A* strain is truly resistant to 25,000/ug/ml.
The 'B' strain in isolation falls short of this, being
apparently fully resistant to 1000 jug/ml and partially to
10,000 ^g/ml.
The experiment, though crude, shows that to obtain
resistant mutants, upon whose drug-fastness we can rely,
isolated colonies are essential, and probably the ideal count
lies between 10 and 100, as too small a number on the other
hand will introduce other errors.
2. DETERIORATION OF ANTIBIOTIC
A somewhat similar phenomenon of artificially high
colony counts occurs where antibiotic plates are not freshly
prepared or where experiments are unduly prolonged.
Streptomycin is heat-labile especially above 60°C, and 60% is
lost e.g. during the inspissation of Loewenstein-Jensen medium.
The loss is, however, very much smaller at 37°C, and for periods
of a few days, such as we are using, are largely offset by the
alkalinity of the MacConkey Agar, for streptomycin is twelve
times more potent at pH 8 than at pH 6.5» However if the
cultures of any of the previous experiments are incubated for
any longer period there will be a combined loss of drug by
deterioration and also by absorption by the growing resistant
colonics.
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Fig: 36. The underlying mecJiantsm of the phenomenon seen in Fig. 34.
Satellites of low drug-resistance are growing round each
large highly resistant colony.
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EXPERIMENT 34«
Figs 36 shows the result of keeping a 1000 jug/ml
streptomycin - containing plate from Experiment 5 showing
13 resistant mutants for a week at 37°C, and then photograph¬
ing the resulting growth by transmitted light. It will be
seen that there are still the 13 original true mutant
colonies now grown to giant size. But scattered over the
medium are fully a hundred much smaller colonies, generally
less than a tenth the size. They are particularly numerous
in the area where 3 of the large mutants lie closely together
and one may speculate whether such "setellitism" implies that
the area has been denuded of streptomycin thus enabling
weaker bacilli to grow. There must also be the effect of
time on the lability of the streptomycin itself, and elsewhere
on the medium this factor must presumably predominate.
EXPERIMENT 35.
To confirm that the main colony nMn is a true 'First
Day Mutant', and that the small satellite colonies "S" appear¬
ing around the sixth day in the vicinity are, as it were,
opportunists, subcultures were prepared as follows.
Overnight cultures in broth containing 80
streptomycin were made of one of the giant colonies from
Experiment 16, and from one of the minor colonies adjacent
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Fig: 37, Further confirmation of the explanation advanced in Fig: 35,
Streak sub-cultures have been made from the large main
colonies ('M') and from the satellite colonies ('S'),
Incubation of the streaks on agar plates containing 0; 100;
1,000; 10,000; and 25,000 ixg./ml, streptomycin shows that
their viabilities are quite different, 'M' is truly
streptomycin-dependant and highly resistant (to 25,000 jxg,),
while 'S' is only streptomycin-dependant and moderately
resistant (to 10,000 y~g,/ml, streptomycin).
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but discrete. These were carefully adjusted to the same
turbidity (Broxvn No. 4) and streaked in parallel on
5 MacConkey Agar plates containing respectively 0j 100;
1,000; 10,000} and 25*000 pg/ml. of streptomycin. After
overnight incubation at 37°C the results are seen in Fig: 37*
photographed by transmitted light. Both clones are again
truly streptomycin-dependant and resistant; but while the
main colony "M" grows best at 25*000 ^g, diminishing with
lower strengths of drug, the satellite "S" grows best at
100 jxg diminishing at higher strengths.
The conclusion is once again that heavy inoculation
of antibiotic plates gives falsely high resistant counts as
weak mutants are presumably helped by strong ones using up
the available drug.
3. SIMULTANEOUS DIVERSE ?IUTATI0NS
A further complication which tends to be overlooked
when pre-occupied ttfith the single phenomenon of drug-resistance
is that this mutation, or rather group of mutations, is only
one facet of a whole host of mutations affecting morphological
characters such as pigmentation, virulence, nutrition and
biochemical properties. If one assumes that these phenomena
also are subject to variation of all degrees and in different
directions simultaneously, it is possible to realise the
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enormous diversity to which even simple bacteria could
evolve.
For our present purposes only the commonest co¬
existent mutations are likely to obtrude. And perhaps the
commonest is <S' to 'R' type of colony associated with loss
of virulence, and, in the case of E. coli such as we have
been using, producing the distinctive traditional rough
colonies from smooth. With Salm. typhi-murium these mutants
comprise some 2% of the population, and for E. coli they seem
quite as common (See Fig: 38).
4. NON-MUTATIONAL MULTIPLE DRUG-RESISTANCE
Mention must also be made of a rare phenomenon,
multiple drug-resistance which has appeared as a single
jr o
transmissable characteristic in Japan . The explanation
is that certain Escherichia possess "Resistance Transfer
Factor" or R.T.F., which they convey by transduction to other
Escherichia and even to Shigella, making them resistant to
e.g. streptomycin, tetracyclines, chloramphenicol, and
sulphonamides. Although R.T.F. has a frequency of about
1 in 10 it is not a mutation, and the streptomycin-resistance
it confers is of lotv degree never exceeding 25 ^ug./ral. It
is ineffective in bile, as in our MacConkey's media, and is
more readily conveyed in the lag phase than in our rapidly
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Fig: 38, Rough and smooth colonies of the strain E, coli, N.T.C,
No: 86, seen on MacConkey Agar, Although itself a
mutation, it is not to be confused with the variation in
size on antibiotic-containing plates, seen in Fig: 35,
due to the different rates of growth which results from
drug-resistance probably by adaptation as well as by mutation.
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multiplying bacilli* For these reasons we have felt able
to disregard the factor in our experiments.
APPLICATION OF MUTATION KATE EXPERIMENTS TO MYCO. TUBERCULOSIS
It appears from the foregoing experiments with E, eoli
that resistance to streptomycin arises from the cumulative
effect of mutations which occur so constantly that their
numbers can be predicted. For practical purposes it is enough
to know that the regularity of such mutations in any strain
would justify deductions based on a suitable laboratory test.
The "Elope Diffusion" sensitivity test for Kyco. tuberculosis
described in the next Chapter affords a means of providing
gradients of potency of streptomycin so that colonies of
tubercle bacilli of varying resistance can appear and be counted.
By analogy with the results seen in the E. coli
experiments it is probably the subsequent multiplying
potentialities of the common low-resistance colonies which
are the hazard, not the isolated highly resistant one which
they so vastly outnumber. For example, having examined the
cultures from a case of tuberculosis after four weeks'
incubation for zones of inhibition broadly indicating the
sensitivity of the bacilli, a search is made with a hand-lens
for minute single colonies within the zone, if necessary the
vials being re-incubated for a further fortnight to help their
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recognition. The onset of widespread resistance in the
strain is foretold by the recession of the inhibited zones
or by a scatter of resistant colonies within these zones*
To be of clinical value the results of such a test
should, of course, be available prior to, or at least at an
early stage in, drug treatment, and the "Slope Diffusion"
test on the first sub-culture will often give a just visible
zone after only one month from the taking of the specimen.
PART III.
DRUG-RESISTANT TUBERCULOSIS
AS A *NEW DISEASE*
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CHAPTER 10, THE GROWING PREVALENCE OF DRUG—RESISTANCE
AMONG TUBERCLE BACILLI; AND ITS ASSESSMENT
In contrast to the experience with staphylococci,
in which resistance to antibiotics is generally attributable
to infection from a nasal carrier with an already drug-fast
strain ^8, 171^ possibly even ones of natural occurrence
the problem in the chemotherapy of tuberculosis has been
quite different up to the present time. Strains of tubercle
bacilli, in the great majority of cases, have been initially
sensitive to such drugs as streptomycin, p-amino-salicylie
acid, and isoniazidj but have tended to acquire resistance
305while undergoing treatment , and evidence is accumulating
that the change is a lasting one 433^
Clinical relapses after an initially favourable
response to streptomycin have been recognised as a major
hazard in the treatment of pulmonary tuberculosis and
aq/l
tuberculous meningitis . Such relapses are most usual
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in pulmonary tuberculosis during the second and third month
and can be correlated with the more or less abrupt emergence
of resistant strains of bacilli in the cultures submitted to
streptomycin-sensitivity tests. In tuberculous meningitis,
381
however, proved cases of in vitro resistance are rarer •
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No doubt some of these resistant cases date back
to the era of single-drug therapy; but expectations that
combinations of drugs would completely eradicate the risk
appear to have proved unduly sanguine. There are well-
authenticated cases of meticulously conducted courses of
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multiple drug therapy merely inducing resistance . It
seems clear that the need for periodical drug sensitivity
3
tests on every case will increase rather than diminish even
with combined drug-therapy, and with a lengthening list of
drugs there is urgent need for a drastic simplification
of method.
But in addition there is the likelihood that cases of
tuberculosis, which show initial resistance to streptomycin,
will also become increasingly prevalent, and this emphasises
the need for routine sensitivity tests to include new cases.
To be of value the results of any sensitivity tests should,
of course, be available prior to, or, at least, at an early
stage in streptomycin treatment, and the ideal plan would
seem to be to test the diagnostic cultures of cases on entry
to hospitals or sanatoria, and to record the findings for
reference. Moreover recent research has indicated that it
may well be possible by combining streptomycin with some other
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therapy, such as p-aminosalicylic acid or the sulphones ,
to reduce the chances of resistant variants developing. The
"Elope Diffusion" method, which will be described, offers a
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simple and rapid test suitable for routine use in small
laboratories, end by giving an indication of the occurrence
of resistant variants, as well as of the general level of
sensitivity, the test may suggest the probable response
to drugs*
It is generally accepted that the onset of drug
resistance has been due to the multiplication of rare
naturally occurring resistant bacilli, which supersede the
original sensitive majority of bacilli as the latter are
eliminated 81' 127* 496* 497 (Fig: 39).
Early identification of these rare resistant bacilli
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is important as drug combinations can retard their emergence *
The rationale of these measures is based on the likelihood
that bacilli which possess more than one such natural drug
insusceptibility will be in still greater rarity} but double
or even triple chemotherapy, to be effective, must be given
before any such resistant strain develops predominance, for
once this occurs to one drug its admixture confers no advantage
over the alternative drug given alone.
SENSITIVITY TESTS CURRENTLY IN USE
The M.R.C. - Dubos Method
This method makes use of visible turbidity in the
liquid culture medium of Dubos as an index of growth. To wet
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Fig: 39, A single large resistant colony of Myco, tuberculosis
strain H37 Rv surviving on a LowensteinrJensen slope
with 100 fX.g,/mL, of streptomycin at the base.
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the lipoid cell-membrane of the tubercle bacillus
give a submerged growth sorbiton monodeate ("Tween 80")
10 <?is added , and to offset the antagonistic effect of this
AO R
detergent the medium is enriched with bovine serum
albumin 1^3j 382^ ^Chat the Tween 80 is itself
bacteriostatic can hardly be doubted ^ Ziehl-
Neelsen film of a Dubos culture shows that many of the
bacilli have lost their acid-fastness in whole or in part
by the action of the detergent.
The technical procedure involves culturing on solid
medium, and then usually three successive subcultures in
Dubos medium to obtain a more and more diffuse growth. The
7'
third subculture is distributed in eight bottles containing
j '
doubling dilutions of streptomycin or other drug, and the
minimum amount of the drug required to inhibit completely
this diffuse growth, and give a clear solution, is determined.
The stock culture H37Rv is tested in parallel as a control.
Unfortunately the method is impracticable for small
laboratories as it may take two months and some three
successive cultures to obtain the turbidity used as an index
of growth, and at each subculture there is a risk of
contamination, and not least of danger to the worker.
However the test is quantitatively most precise, and when
required, for example for evaluating a new drug, time and
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even a subculture can sometimes be saved by shaking the
cultures daily. For this purpose a wooden board drilled
with holes an inch deep to hold bijou bottles may be
made to fit the Kahn shaker. Each bijou contains two
sterile 5 mm beads in Dubos medium, and thirty minutes
shaking gives a suspension which is incubated as the first
subculture. The boards can be stacked in the incubator and
hold the bottles sufficiently firmly to allow daily rocking
by hand to accelerate further diffuse growth.
But a much more serious objection is that tests in
liquid media give no indication of mixed sensitive and
resistant bacilli and their relative numbers. Crofton and
81
Mitchison by testing individual colonies from the same
culture from a case under treatment have shown that there
may be different degrees of resistance present. It is
therefore essential to make the inoculum for any test truly
representative by drawing the loop over a wide area of the
primary culture. But even if we are satisfied with our
random sampling the method only gives an overall picture of
the sensitiveness or resistance of the patient's strain at
the time of the test, and no indication of its future state.
It could not, for instance, discriminate between a large
number of moderately resistant bacilli partially inhibited
and multiplying slowly, and a few highly resistant bacilli
totally uninhibited and multiplying fast.
Fig: 40, Holt and Oruikshahk's method of showing drug-resistance
in Flyco, tuberculosis.
A Lowenstetn-Jensen slope with 100 ^g./ml. of
streptomycin incorporated before inspissation is shown
on which 13 resistant colonies are growing.
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Fig: 41. Another possible method of showing drug-resistance in
Myco. tuberculosis. A Lowenstein-Jensen plate with
100 ^g./ml. of streptomycin in the gutter has been
inoculated with 3 strains - reading downwards, sensitive,
moderately sensitive and resistant.
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Only a method employing isolation on solid culture
media can hope to isolate the different colonies which may be
present together in a single patient's strain (Figs: 4° and 41)•
Karlson & Needham's Method
In this American method egg-nutrient agar had 1, 10 &
lOOj^g/ml. of streptomycin added at 50°C and subculture gave a
broad indication of resistant bacilli.
Holt & Cruikshank's Method 2 ^
Subcultures are made on Lowenstein-Jensen medium in
which drugs in various strengths have been included, and the
lowest concentrations giving complete inhibition, or not
more than 20 colonies, are usually accepted as effective.
The streptomycin can be added either by mixing with the medium
before its solidification, with allowance for 60$ loss of
potency on heating, or by allowing the solidified slope to
absorb streptomycin solution uniformly over its surface while
lying horizontally.
Tests employing slopes, such as these, reduce the
risk inseparable from the use of liquid medium, of resistant
bacilli which may have been comparatively scanty in the
inoculum multiplying to dominate the final result. But „here
is still the impossibility of distinguishing between inhibited
growth and inadequate or even absent inoculum, and the choosing
of an end-point of say 20 colonies is somewhat arbitrary, for
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these 20 resistant colonies may, as previously explained,
be the very ones in which we are interested - the progenitors
of a future resistant strain* Nevertheless the methods are
very convenient especially for the non-antibiotic drugs
isoniazid and P.A*S* Tubercle bacilli resistant to these
drugs appear to be equally resistant in vitro to "Nupasal-213"
(o-hydroxybenzal isonieotinyl hydrasone) and "Dipasie"
(isoniazid-p-aminosalicylate) respectively, as the following
experiment shows:-
Resistance to Isoniasid, P«A*S*, and their derivatives
Six strains partially, and seven wholly resistant to
isoniazid were found to shotv identical degrees of resistance
to "Nupasal-213". Five strengths of each drug were used —
0.2, 1, 5» 10, and 50 per ml.
Fifteen strains resistant to P.A.S., isoniazid, or
both were tested similarly against P.A.S., isoniazid, and
"Dipasic" ( a drug combining the other two). Right sensitive
to P.A.S. were also sensitive to "Dipasic". Four partially,
and one wholly resistant to P.A.S. were also resistant to
"Dipasic" to a comparable degree. The two remaining strains
in their greater resistance to "Dipasic" than to P.A.S,
apparently reflected the influence of isoniazid to which they
were wholly resistant.
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This suggests that strains of tubercle bacilli
resistant in vitro to isoniazid show identical resistance
to "Nupasal-213", and that strains resistant to P.A.S.,
and/or isonizid will also be resistant to "Dipasic".
Additional tests with these proprietory drugs do not, there¬
fore, seem justified 71' 108* 243» 341> 432' 433» 457#
THE SLOPE DIFFUSION METHOD
The Slope Diffusion Test introduced twelve years ago437
has been found to give consistent results, and has several
advantages in the modified form now described . It depends
upon the fact that if the antibiotics, e.g. streptomycin or
vionycin are placed in suitable strength at the foot of a
Lowenstein-Jensen slopw, diffusion will occur for up to two
inches. There appears to be a gradient in this diffusion
diminishing towards the neck of the vial so that some visible
growth of Hyco. tuberculosis can survive to define its limits
after about three weeks. That it is diffusion and not
capillary spread is suggested by the phenomenon occurring
equally well when the bottles lie flat. For the sane reason
the originally suggested name of "Vertical Diffusion Test"
is inappropriate.
Such a short gradient of diffusion occurs only with
the macro-molecular compounds such as the sulphates or chlorides
TABLE 33








Streptomycin CaClg complex 1493
Dihydro streptomycin chloride 693







of antibiotics, whose molecular weights are between 50G-1500
(See Table 33). Ihe method is impracticable in small vials
for e.g. p-aminosalicylic acid (P.A.S.), isoniazid (I.N.H.)
and pyrazinamide (P.Z.A.), presumably because their
molecular weights of about 150 are so small that rapid
diffusion occurs throughout the whole slope. For these the
usual media with the drugs incorporated may be retained, in
the case of pyrazinanide, incidently, acidification to pil 5
being necessary to ensure full potency. Alternatively a
modified test using specially long tubes may be employed as
described below.
Sensitivity to oxytetrscycline and cycloserine can
be tested by the Slope Diffusion Methodj but as these drugs
in the usual strengths are only tuberculostatic, not
bactericidal, freshly made slopes should be used and read
as soon as growth is apparent to the naked eye. Cyclo¬
serine is also very unstable in neutral or acid mediumj but
in practice the egg slopes are sufficiently alkaline.
Kanamycin and Fucidia (Fusidic acid) have also given reliable
tuberculostatic zones on diffusion slopes.
Methods
Lowenstein-Jensen slopes are prepared in universal
containers or 1 oz. screw-capped vials, and the condensation
water is poured off before adding to the foot of the slope
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Fig: 42, The Slope Diffusion Test for the Streptomycin-sensitivity
of Myco, tuberculosis. Culture of H37 Rv, a typical
sensitive strain, showing 1" zone of inhibition above
50^.g./ml, of streptomycin, in which no resistant mutants
are yet visible.
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1 ml. of a solution of 2% agar, to which streptomycin 5°^^g»/ml»
or 200 pg./ml. pf viomycin, cycloserine or other tuberculostatic
antibiotics has been added at about 60°C. The bottles are
stood upright while the agar sets, and the caps marked to
identify the antibiotic J they retain their potency for at
least a month in the refrigerator. The greater dose of
viomycin cycloserine etc. needed is due apparently to their
221 AQ(i
lower strength and lesser stability than streptomycin ' '
For use the slope is evenly spread all over with
inoculum, preferably a primary Lowenstein-0 ensen culture
emulsified in 1 ml. of Dubos medium, and it is then incubated
for 3-4 weeks. Sensitivity is shown by the zone of inhibition
extending fully half way up the slope in most cases initially
but receding with subsequent specimens as resistance develops.
The stock culture H37Rv is grown as a control with each batch
of tests as a typical sensitive strain (Fig: 42). It is
important to use full 1 oz. vials. Any smaller size will not
display the residual growth which contrasts with the inhibited
lower zone. Moreover tubercle bacilli being aerobes small
bottles probably discourage growth.
The total time required for a sensitively test by
this method is 6-7 weeks; but where urgent reporting is
paramount it has been found practicable to duplicate the
diagnostic cultures with these diffusion slopes inoculated
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directly with sputum after concentration, although the
results are not, of course, so clear cut as with an evenly
spread subculture.
METHYLENE BLUE MEDIUM FOR DISTINGUISHING VIRULENCE
Animal inoculation, the most generally reliable
test of virulence in suspected tubercle bacilli 3^7^
open to fallacies from isoaiazid-resistant organisms which
while increasingly responsible for human tuberculosis 435
can be of low pathogenicity to guinea-pigs and mice '4* 22^#
Alternative tests of virulence include "cording" of bacilli
07
in cultures and their ability to absorb dyes in
solution 104# 207^ inconsistencies occur from mixed
1 On
strains v which can only be separated by isolation on
solid media.
In spite of reports of its toxicity 333# 440^
methylene blue can replace the malachite green in Lowenstein
Jensen and will detect the dehydrogenase of virulent
strains ^2, 194 ^ g cc. of 1% aqueous methylene blue
are added to each 100 cc. of medium, and the slopes kept in
air-tight vials to prevent later re-oxidation, virulent
tubercle bacilli including those resistant to isoniazid will
stain dark blue while saprophytic mycobacteria and gram
negative contaminants remain colourless 436^
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STREPTOMYCIN-ANTAGONIST MEDIUM
Where the patient has already been on streptomycin
therapy, culture of the Infecting organism is usually
unsuccessful unless a streptomycin-antagonist10,12,100,121,144
264,353.365,366,373,374,421# ls added to the medium- Ke
employ Lowenstein-Jensen slopes in which 2 sag. cysteine
hydrochloride per ml. of the medium is added before pouring.
During subsequent heating the powerful reducing action of the
cysteine may bleach the malachite green but on standing with
the bottle caps screwed down the dye becomes more blue than
before. When growth has been achieved on the cysteine medium
the organisms are inoculated onto the streptomycin-containing
bottles for subsequent sensitivity tests. Using this method,
one specimen from a case which had had nine months' treatment
was successfully grown after five abortive attempts on ordinary
medium.
Drug Concentrations on Slope Diffusion Media
All the tuberculostatic drugs used in the Slope
Diffusion test are crystalloids, and diffuse readily from the
agar at the foot of the slope. Presumably the subsequent
spread is up the surface of the egg medium; penetration is
unlikely to any appreciable extent as the egg lattice is
already saturated with water.
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Estimation of drug-loss on gradient
By using a sterile cork borer plugs were punched
out at 4" intervals up the slopes which had been stored in
the refrigerator for a week. These were placed on agar
plates and time allowed for diffusion before inoculating
with the test organism, Esch, coli N.T.C, 1094* It was
found that SO ^g, streptomycin had dropped to about 10 g,
at |n, the estimate being obtained by a comparison of
inhibitory zones with those from plugs containing known
amounts of drug. This £n up the slope is the usual point
where equilibrium is reached between a growing strain of
sensitive Myco, tuberculosis and the diffusing antibiotic.
Loss of potency of streptomycin during incubation
This is the other possible variable affecting the
antibiotic during the test, and biological assays were
therefore made of streptomycin kept at 37°C as follows:»
Test organism: Klebsiella pneumoniae sensitive
to 1 i^g,/m'±» streptomycin in glucose broth.
Test concentration of drug: Streptomycin
hydrochloride 16 ^Ag./ml, in water.











It was concluded that there would be no appreciable
loss from this cause during the first fortnight of the test.
THE LONG-SLOPE DIFFUSION TEST
Schmiedal and later Kunz and Rudnick showed
that similar diffusion zones do in fact occur with the drugs
isoniazid and p-aminosalicylic acid) but that they are too
extensive to be visible within the confines of a 1-oz. bottle.
Using 30 pg. of I.N,II. or 100 ^g. of P.A.S. in 1 ml. agar
at the foot of a Lowensteln-Jensen slope in a sufficiently
tall container such as a 7 x |" boiling tube with a rubber
stopper, zones of inhibition of some 10 cm. are seen with
"fully sensitive" strains, (but see Chapter 6, page
concerning P.A.S. and Figs J 43 and 44). We use specially
made 6 x 11/16" screw-capped test-tubes for these drugs,
and also for ethionamide, 100 fxg, of which gives a comparable
10 cm. zone. Pyrazinamide, even in a concentration of 10 mg.,
was ineffective. The demonstration of heterogeneity in the
strain and especially of resistant mutants is seen with these
drugs as with the antibiotics, and this further advantage is
described in the next Chapter.
Obtainable from Johnsen & Jorgensen, Trident Glass 'Works
Herringham Road, Charlton, London, S.E.7.
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Fig: 43. Schmtedel 's Long Slope modift cation of the Slope
Diffusion Test. Using tubes 6" long the method can
be used for isoniaztd (33j^g./ml. at foot of tube),
as seen in the three left-hand examples, and P.A.S.
g./ml.), as seen in the two right-hand tubes.
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Fig: 44. A close-up photograph of Fig: 43, Note that while the
inhibitory sones for isoniazid are clear-cut. those for
P.A.S, apparently show three steps of (a) confluent growth
at top, (b) semi-confluent growth in the mid-tube, and
(c) scanty colonies below,
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Tsukamura identified two P.A.S,-resistant genotypes:-
(i) Resistant to l-8u<g.t with a frequency of about 2 per
100,000. 1
(it) Resistant to 5-100i^g., with a frequency of about 1
per 100 million.
The three steps could, therefore, be consistent with this
interpretation:-
(a) Unrestricted growth due to sub-minimal drug.
(b) Growth restricted to the two resistant genotypes,
(c) Growth restricted to the highly resistant genotype orly.
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Results of Slope Diffusion Sensitivity Test
Tables 34 (first line) and 35 show the results from
100 newly isolated tuberculous cases for the culture's
sensitivity to streptomycin and vioiaycin respectively, while
Table 36 is the suggested interpretation for these and other
tuberculostatic drugs. In the case of streptomycin a zone
of inhibition of f" or more indicates average sensitivity,
while less than \n implies resistance, and it will be seen
from Table 37 that there is good correlation between these
readings and those given by media incorporating the drug.
The Slope Diffusion method has the advantage that the
surviving growth in the upper part of the bottle confirms
that inoculation and incubation have been adequate for the
test} but of greater importance is the overall diminution
of the zone of inhibition which is proportionate to the increase
of drug-resistance. This is seen in Table 34 where tests were
made in series some years ago, after successive months of the
single drug therapy then in vogue with streptomycin. But over
and above all this the Slope Diffusion Test lends itself to
our present studies, because the gradient provided for the
concentration of the drug is especially conducive to the
emergence of resistant mutants of widely varying degree (Fig! 45)•
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Fig: 45, Slope Dtffuston Tests with streptomycin against strains
of Myco, tuberculosis.
Left: A resistant culture due, in this case, to
numerous mutant colonies of different degrees of drugr-
resistance.
Right: A partially sensitive culture. There is §"
inhibited zone above 50jxg,/ml, of streptomycin; but
this has a margin of weaMy resistant mutants giving
a "frayed edge", and there are in addition 2 highly
resistant mutants near the base on the right.
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TABLE 34
RESULTS OF SLOPE DIFFUSION SENSITIVITY TESTS ON STRAINS OF
MYCO. TUBERCULOSIS WITH 50 ixg. STREPTOMYCIN
Months of Resistant Moderately Sensitive Very Total
treatment sensitive sensitive
with ( <}" (2*-§* ( >l£*
streptomycin. inhibition) inhibition) inhibition) inhibition)
0 3 13 32 17 65
1 1 6 8 3 18
2 1 5 11 17
100
TABLE 35
RESULTS OF SLOPE DIFFUSION SENSITIVITY TESTS ON STRAINS OF
MYCO. TUBERCULOSIS WITH 250 ^g. VIOMYCIN, UNTREATED CASES.
Reststant Moderately Sensitive Very Total
sensitive sensitive
( < i* ($•-§• ( >li"
inhibition) inhibition) inhibition) inhibition)




SUGGESTED INTERPRETATION OF ZONES,
(Read after 3 weeks' incubation).
Drug Gone, in 1 ml, agar
in ^g.


















S « Sensitive, S - » moderately sensittve, t,e, becoming resistant,
S t m only slightly sensitive, i,e, resistance imminent.
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TABLE 37
COMPARISON OP STREPTOMYCIN SENSITIVITY TESTS ON 100 UNTREATED CASES
BY THE METHODS OP SLOPE DIFFUSION AND INCORPORATED SLOPE
(3 js-g./ml. STREPTOMYCIN).
Resistant by both tests
(under and over SO colonies respectively). 9
Sensitive by both tests
(over and no colonies). 75
Moderately sensitive by both tests
(i"-§" and under 20 colonies). 8
Moderately sensitive by diffusion, sensitive
by incorporated slope. 6
Sensitive by diffusion, moderately sensitive
by incorporated slope. 2
Contradictory results (resistant/sensitive or
sensitive/resistant). 0
TABLE 38
INITIAL SENSITIVITY TO STREPTOMYCIN OF 58 STRAINS OF MYCO.
TUBERCULOSIS ISOLATED BET. TEN 1948 AND 1950
Concentration of








INCIDENCE IN GLASGOW DURING 1955-1956 OF RESISTANCE
TO FOUR TUBERCULOSTATIC DRUGS
Newly diagnosed Hospital oases
cases prior to previously
treatment treated
Sensitive to I.N.H., streptomycin, P.A.S.
and viomycin 106 126
Resistant to




I.N.H. and streptomycin - 30
I.N.H. and P.A.S, - 1 *
I.N.H. and vtomycin
Streptomycin and P.A.S. - 6
Streptomycin and viomycin - 4
P.A.S. and viomycin
I.N.H., streptomycin and P.A.S. - 8
I.N.H., streptomycin and viomycin - 7
P.A.S,, streptomycin and vtomycin - 1
P.A.S., I.N.H. and viomycin
Streptomycin, I.N.H., P.A.S. and viomycin - 1
117 263
@ A130 resistant to "Nupasal-213" in 13 cases tested.
* Also resistant to "Pipasic
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USE OF SERIAL SLOPE DIFFUSION TESTS
FOR STUDYING STREPTOMYCIN-RESISTANT MUTATIONS
Welch has suggested that the real significance
of persistent growth of organisms after the administration
of drugs is that it portends the coming of drug-resistance.
In tuberculosis one can go further and say that the most
significant feature of in vitro tests during chemotherapy
is that there is growth at all - a fact which tends to be
overlooked. The persistence of tubercle bacilli after
treatment with streptomycin 1 gm. daily was shown by us in
the following series in 1960:-
Cultures were made from pooled three early-morning
sputa from 100 cases, and 36 yielded no growth at all.
Prior to treatment 64 strains grew and were sensitive.
After 1 month 27 of these still grew and were sensitive.
» 2 months 7 " " " " " " "
11 j n 3 " " " " " n n
11 ^ 11 2. H " " " » « «
ti tj n 1 " " " " " "
Originally strains of Myco. tuberculosis showed little
variation in the degree of streptomycin-sensitivity• Thus of















Fig: 46. The Frequency Distribution of the initial sensitivity
to streptomycin of the 58 strains of Myco. tuberculosis
recorded in Table 38. Note the almost symmetrical
curve around, the value of § ag./ml.
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were sensitive to between 1 and 4 pg/ml, (Table 38 and Fig: 46),
while subsequent progress under the single-drug therapy of
this period revealed a steepening curve of streptomycin
resistance, as shown by the graph of three cases (Fig: 47)•
The "single-step" rises seen here are in marked contrast
with the more familiar "multi-steps" of penicillin resistance,
and are, of course, the outcome of the cumulative mutations
occurring with streptomycin which we have described in the
earlier Chapters (Part 2).
Initial resistance to a tuberculostatic drug may occur
spontaneously; but this is rare. More commonly it is the
outcome of therapy, either in the patient himself or by
82
infection from a treated case . That this is no inconsider¬
able risk in a populous area, especially with streptomycin and
isoniazid, is shown by Table 39• The implications of these
several varieties of mutant resistance will be discussed more
fully in the next Chapter.
The particular merit of the Slope Diffusion Test for
our present intention is that, affording as it does for all
practical purposes an almost infinite gradient of streptomycin,
mutants of varying resistance will appear, and can be studied
with a lens as they do so between the fourth and sixth week
of incubation. Occasionally a lack of the customary abrupt¬
ness between growth and inhibition indicates insusceptible
Increasing resistance to streptomycin in Dubos
medium of three strains of Myco. tuberculosis follow¬
ing streptomycin treatment.
Fig: 47, The so-called "StngL e-step" curve characterising the
onset of streptomycin-resistance, which contrasts
with the more gradual "Multi-step" pattern seen
with penicillin.
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clones of low degree of resistance being sufficiently
numerous to portend imminent general resistance5 but more
commonly there are isolated resistant colonies within the
zone of general inhibition as seen in the illustration
(Fig. 44). Drug-containing media will also be used in the
studies which follow; but supplementary, and aimed at
isolating these mutant colonies - the harbingers of resistant
populations of tubercle bacilli.
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CHAPTER 11. THE GENESIS OF AN EPIDEMIC DISEASE -
DRUG-RESISTANT TUBERCULOSIS
The Source of Resistant Tubercle Bacilli
NATURALLY RESISTANT STRAINS OF MYCOBACTERIA
Mention ivas made in Chapter 6 of the suggestion of
12?
Fairbrother that penicillin-resistant staphylococci were
in fact the primitive type, and that the emergence of such
drug-resistance now was in fact merely a reversion to the
original saprophyte by the more specialised, and therefore
penicillin-sensitive, modern parasite. Staphylococci found
since in the wilds of New Guinea 375^ could not possibly
hove encountered penicillin therapy, and yet are penicillin-
resistant, appear to bear this out.
One inevitably speculates whether a similar phenomenon
is in fact operating with resistant tubercle bacilli, and in
looking for naturally drug-resistant strains one is confronted
by a curious group of Mycobacteria occupying the borderland
between saprophytism and potential pathogenicity. These are
the " Atypical Mycobacteria" which appear sporadically, and of
which we have found ten examples over a decade, all at least
in association with infections. All had apparently co-existed
in the body with Mycobacterium tuberculosis, or had themselves
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been implicated in chronic insidious diseases strangely
reminiscent of the protean manifestations of tuberculosis,
though of far lower virulence#
THE ANONYMOUS MYCOBACTERIA AND THEIR RELATION TO THE
TUBERCLE BACILLUS
During the last ten years this group of so-called
"Atypical Tubercle Bacilli" have been recognised repeatedly
IQO 370
in association with human disease. Runyon ' ,
classified them into four groups
I Photochromogens• Yellow or red on exposure to light.
II Scotochroxnogens. Similarly coloured even in the dark.
III Uncoloured pleomorphic 'Battey Strains'.
IV Rapid growers, even at room temperature, and uncoloured.
All are relatively drug-resistant, in fact it is this
feature rather than abnormal morphology or the colour of the
18I
colonies which has attracted attention to them • Group I
resist 1 ^g. I.N.H., and 10 ^g, P.A.S., while the other groups
are still more resistant especially to iscniazid. Besides
this, all four groups are non-pathogenic to guinea-pigs, but
they may be virulent to mice, though we have not found them
so, and this additional feature of experimental avirulence
they share with isoniazid-resistant strains of undoubted
Myco. tuberculosis from cases of human disease. Some have
supposed therefore that these newly discovered Anonymous
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Mycobacteria evolved from tubercle bacilli as a result of
drug treatment 474^ particularly as the chronic lesions in
which they were found, and their situation, e.g. in the
lungs and neck glands, would be regarded otherwise as





This man had been on a 40% pneumoconiosis pension for
12 years, and in May 1962 a new opacity was noted in his
chest X-rays in the left upper lobe.
He was admitted for investigation. Repeated sputum
examinations for tubercle were all negative. The question of
a bronchial carcinoma was raised, especially as the hilar
glands became more prominent. Although bronchoscopy was
negative a left pneumonectomy was carried out.
Discovery of Chromogenic A.F.R.
Histology (report 1674/62) confirmed the presence of
advanced, simple pneumoconiosis and the lesion in the upper
lobe was found to be an area of progressive massive fibrosis
showing central cavitation.
Necrotic material from the centre of the cavity
produced a growth of an acid fast bacillus which was found to
be resistant to P.A.S. and I.N.A.H. and which became pigmented.
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Subsequent Tests
The culture was found to be sensitive to Streptomycinj
but resisted 10 P.A.S. and 50 ^.g I.N.H* It grew on
ordinary Lowenstein-Jensen, and on L-J \*ith 5% sodium salicylate,
at 37°C appearing in 11 days. No growth occurred on nutrient
o
agar, nor at 22 C on L-J. Growth assumed a butter yellow
colour in the dark after 3 weeks. Catalase + +, Oxidase ~.
Classified as a Scotochromogen - i.e. Group II.
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WILLIAM PEAT (Udston Hospital)
A Case of Pulmonary Fibrosis with a Chromogenic Bacillus.
History 1952 Found to have extensive pulmonary
fibrosis and positive sputum. Sputum
became negative untils-
1954 Sputum again positive and has remained
positive ever since despite continuous
treatment with P.A.S., Streptomycin
and I.N.A.H.





November - Sensitivity (Hairmyres)
Streptomycin
)
P.A.S. ) All resistant
I.N.A.H.
Viomycin - Sensitive
? atypical acid fast bacillus.




A pleomorphic beaded alcohol and acid-fast bacillus
which did not grow on nutrient agar nor at room temperature.
Eugonic growth on Lowenstein-Jensen after 15 days at 37°C and
on the same medium with 5% Sod. salicylate. Colonies assumed
a canary yellow after 3 weeks incubation in the dark.
Catalase ++, Oxidase -. Culture resistant to P.A.S. 10
I.N.H. 5 juigf and partially resistant to 100 ^g, and 50 ^g.
respectively! but sensitive to Streptomycin.
Classified as a Scotochromogen (Group II)#
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DAVID CASEY
Cervical Adenitis apparently due to a Scotochromogenic
Mycobacterium•
History
This 5-year old boy reported in May 1961 with a
submandibular swelling. X-ray of the chest was equivocal,
and it was decided to excise the swollen gland. The pus
contained no acute pyogenic organisms but numerous acid-fast
bacilli.
Laboratory Tests
The bacilli were Gram +, beaded, acid- and alcohol-fast
but somewhat pleomorphic. Culture, which required 37°C,
yielded a butter yellow growth even in the dark. Lowenstein-
Jensen was preferred but some growth was obtained on nutrient
agar after 3 weeks. The strain was sensitive to Streptomycin 3
^g, but resisted 50 ^g isoniazid and 10^ jAg P.A.S. (It was
also sensitive to viomycin, cycloserine, sofrainyein and
erythromycin; but resistant to dipasic 5 terramycin,
ethionamide, penicillin, neomycin, polymyxin, and sulphanilamide.)
It w-as Catalase and Oxidase -. Inoculated guinea-pigs showed
no lesions after two months, nor did they react to old tuberculin
i.d. The organisms was classified as a Group II Scotochromogen.
Subsequent History
The child was discharged after 5 months bed-rest
in a sanatorium. His Mantoux Test was only weakly + to
1/100 O.T., and X-ray of the chest showed only one small
apical focus*
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MISS JOYCE HAY (25 years)
Pulmonary Tuberculosis
Found to have active pulmonary tuberculosis in
October i960 -
Sensitive to Streptomycin 3 j^S't P«A.S. 2 ywg., I.N.II. 1 /^g.
Treated with all three and then Pycamycin with good
response and all sputa and laryngeal swabs negative for tubercle
since January 1961.
Discovery of Chromogenic A.F.D.
In March 1961 she was referred to the urologist for
pain on micturition and haematuria.
A.F.B. found on culture of urine, and as she was a
teacher she continued to be excluded from employment.
This culture was resistant to -
Streptomycin 30 ^g., P.A.S. lOO^vg., I.N.H. 56
Subsequent Tests
This high degree of overall resistance prompted further
tests, and the strain was found to grow readily even on nutrient
agar and at 22°C, giving after a fortnight a white growth
changing to rosy pink on exposure to light. It was oxidase +
and catalase ++, and was classified as a (Group I) photochromogen.
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MISS DEIRDRE DUFFY
A case of Chronic Paronychia associated with a
colourless atypical Mycobacterium.
History
At the age of 23 a chronic granuloma invaded the
whole of the soft tissues of the terminal phalanx of the
right little finger (See Figs 48). Amputation was considered
but her employment as a telephonist and her hobby as a pianist
encouraged search for a remedy. There was even a suggestion
that her infection was amphibian tuberculosis as she kept
tortoises I
Laboratory Investigations
Direct films were negative; but culture of the tissue
on both Lowenstein-Jensen and nutrient agar grew white granular
colonies in 3 days at 37°C and more slowly at room temperature,
which were microscopically long beaded acid and alcohol-fast
bacilli. They were catalase +. oxidase and decolourised
neutral red and methylene blue. They liquified gelatin and
fermented lactose and sucrose without gas. Growth was a
pellicle on broth, black hemispheres on tellurite, and crenated
L.F. colonies on MacConkey Agar (see Fig: 49)* The bacilli
were avirulent to guinea-pigs and mice. They withstood 5%
sodium salicylate, and they resisted the tuberculostatic drugs
Fig: 48. Paronychia of right little finger in the case of
Deirdre Duffy. Infection was due to Myco. fortuituni.
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Fig: 49, Myco, fortuitum growing on MacCohhey Agar after 3 days
Case of Deirdre Daffy,
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streptomycin 30 jAg., P.A.S* 100 ^-g., I.N.H. 5 ^g., and also
cycloserine, and pyrazinamide, besides penicillin* However
in vitro sensitivity to sulphonamide and oxytetracycline enabled
these drugs to be used systemically with slow resolution.
The organism was classified, because of its rapid
growth, as in Runyon1s Group IV, while culture on MacConkey's




This lady aged 67 Had acne rosacea on her face, and,
because of Lewandowsky's classical contention of its tuberculoid
nature, a biopsy was cultured.
Laboratory Investigations
Culture on nutrient agar at room temperature gave a
rugged white growth in 2 days, which consisted of beaded acid-
and alcohol-fast bacilli but which were short and pleomorphic.
Growth on tellurite gave black hemispheres, and on broth a
pellicle, and it also occurred on medium with 5% sodium
salicylate but not on MacConkey Agar. The culture was catalase +
but oxidase -. it decolourised neutral red and methylene blue,
and it gave no sugar fermentations and only slight liquefaction
of gelatine. It was avirulent to guinea-pigs and mice. The
tuberculostatic drugs streptomycin 3° ^g»» P.A.S. 100^g.,
I.N.H. 5 cycloserine and pyrazinamide were resisted as
well as penicillin and sulphonaiaide: but the bacilli were
sensitive to chloramphenicol and soframycin.
Tentative classification was in Runyon's Group III,
largely because of the pleomorphic morphology.
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MISS KATHLEEN MCKENZIE
Another rosacea-like rash of face and chest, which had
persisted 10 years on the face but only a few months on the
trunk.
Laboratory Investigations
Direct films were again negative; but culture on agar
in the dark gave orange crusts in 3 days at 37°C and in a week
at room temperature. The other tests resembled those on
T. Muir's strain except that the bacilli formed a deposit in
broth and were much more proteolytic in gelatine. Again
there was no virulence to animals, and resistance to
tuberculostatic drugs exceeded 30 streptomycin, ICC yug.
F.A.S., 10 i+g, I.N.II., besides vioiaycin, cycloserine and
ethionamide as well as penicillin and sulphonamide; but
erythromycin, chloramphenicol and soframycin were again effective.
The organism was classified as a scotochromogen, Runyon Group II.
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GEORGE PENMAN
A case of Cervical Adenitis associated with a
Photochromogen.
This 25-year old salesman had had his right cervical
glands swollen for 7 weeks. Culture of the excised gland
yielded buff-coloured crusts in one week on nutrient agar at
room temperature which deepened to a pink colour in the light.
Supplementary tests resembled those on T, Muirj but there
was no proteolysis of gelatine, and drug-resistance again
included 30 ^g. streptomycin, 100 ^.g. P.A.S., 5/^g. I.N.H.,
cycloserine and ethionamide as well as penicillin and
sulphonamidej but erythromycin and soframycin, and, to a
lesser extent, chloramphenicol and oxytetracycline were effective.
The organism was classified as a photochromegen,
Runyon's Group I.
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GEORGE BROWN AND ROBERT FAULDS
These two strains were noted among sputum cultures
because of their intense resistance to I.N.H. exceeding SO^g.j
though they were sensitive to streptomycin, P.A.S., and
viomycin. The growth was slow at 37°C, taking 2-3 weeks,
and while Brown's culture was orange in the dark, that of
Faulds was uncoloured even in the light. Both were catalase -,
and both grew on agar as well as Lowenstein-Jenseru The
bacilli were acid- and alcohol-fast but very pleomorphic.
They were classified respectively as a scotochromogen of
Group II in the case of Brown, and a Battey strain of Group III
in the case of Faulds.
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Runyon has pointed out, however, that nobody has ever
isolated chromogenic Mycobacteria from actual cultures of
tubercle bacilli as has been done with the merely I.N.H.-
resistant strains, and that remarkably distinctive as the
latter are from the parent tubercle bacilli, the distinction
is trifling compared with the utterly different pigmented and
pleomorphic Anonymous Mycobacteria.
A 1A
Wolinsky comments that these organisms were
noticed occasionally even before the advent of tuberculostatic
drugs, and he suggests that the increasingly frequent discovery
now is due to three factorss-
1, Ordinary tuberculosis is decreasing.
2. Increased interest leads to their recognition.
3• Lengthy cultural procedures for drug tests for tubercle
bacilli fortuitously favour the recognition of these
rarer Mycobacteria too.
If the chromogens were in any way constant in treated
tuberculosis cases the Slope Diffusion Test should contribute
to their recognition by providing gradients of drugs with the
tubercle bacilli inhibited} but we have found no pigmented
colonies in the inhibitory zones even when cultures have been
left for weeks at room temperature.
281
Nevertheless there is a curious tendency commented
o OQ
on by others ° for these abnormal Mycobacteria to occur
sporadically among routine Lowenstein-Jensen cultures, and
especially in crops during certain months of the year, and
their role in disease, let alone their relationship to true
tuberculosis, remains an enigma.
NATURALLY-RESISTANT STRAINS OF TUBERCLE BACILLI
Mycobacterium bovis has been recognised for some
years to be relatively more resistant to P.A.S. than the
human type. Natural isoniazid-resistant strains of tubercle
bacilli also appear to be not uncommon in Africa and India,
and sometimes this is associated with avirulence.
Natural Streptomycin-resistance in Myco. tuberculosis
Figure 39 showed a single large colony of Myco.
tuberculosis growing luxuriantly on Lowenstein-Jensen medium
with 100 ^Ag. of streptomycin at its base. If we accept that
drug-resistance arises from the multiplication of these pre¬
existing mutants it is not unreasonable to assume that
occasionally a strain will be found in which they are already
in the majority from the first encounter. Such a circumstance
will confer natural drug-resistance and cases have been
described for streptomycin also; but unlike isoniazid they
are extremely rare. The following example was described by
the author in 1950s
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Natural Streptomycin-resistant Tuberculosis in a Newborn Child^7
This baby, who was born prematurely and breast-fed
by an untreated tuberculous mother, developed miliary
tuberculosis of the lungs, and an enlarged liver and spleen,
when only eight weeks old# Daily injections of Streptomycin
for three months, totalling ll| Gm., were unavailing, and death
occurred after increasing pulmonary consolidation#
Gastric washings were obtained at the outset and just
before death, and Hyco# tuberculosis was cultured from both.
The first specimen showed no apparent inhibition by 6 yiAg/ml.
of Streptomycin in bubos medium, the highest concentration
used. As the control iI37Rv was sensitive to ^ ^g/ml# the
relative degree of resistance was not less than tivelve times
that of the control culture. It was realised that a
sensitivity test with a wider range than usual would be
necessary, and the Slope Diffusion Test was therefore used in
addition to study the resistant mutants which seemed likely to
be present.
The results of the Dubos and Slope Diffusion Test on
the cultures from the baby before and after treatment, compared
with the control culture H37Rv were as follows:-
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TABLE 40





Inhibitory Zones Resistant Mutant
at 4 weeks Colonies at 6 weeks
(cm.)
H37Ro





Baby O'D after treatment >6 Nil Unaotmtabl e
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It will be seen that even though the initial
Streptomycin-resistance was high, it was much enhanced by
three months1 Streptomycin therapy just as occurs in the vast
majority of cases which have initial sensitivity. The final
intense resistance is shown in the photograph, where the baby's
strain obtained prior to death is compared with H37kv, both
streaked on a Lowenstein-Jensen plate at right angles to a
gutter containing Streptomycin 100 ^.g/ml, solution, the sealed
plate being incubated at 37°C for two months (Fig* 50).
In May 1948 when this infant was infected, Streptomycin
had not become available for general hospital use in Britain,
the supply being restricted to a few research units. It was
therefore most unlikely that infection had come from anyone
harbouring tubercle bacilli rendered resistant by therapy.
Post-mortem was refused, and the mother, who was the probable
source of the infection, unfortunately refused treatment and
left for Eire before any of her sputum could be obtained for
culture.
As long ago as 1947 ^ and 1948 it was shown that
the susceptibility to streptomycin was by no means uniform
throughout a strain of tubercle bacilli, and the Slope Diffusion
Test indicates clearly that the initial resistance of this case
as shown by the Dubos method is not attributable to a homogeneous
culture but really represents a very high proportion of resistant
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Fig: 50. Comparison of the resistant strain from Baby O'Donnell with
the sensitive strain HS7 Rv of Myco. tuberculosis on a
Lowenstein-Jensen plate with a gutter containing 100 jj^g./ml.
of streptomycin.
The growth of the control culture (H37 Rv) has been
restricted to one edge of the plate, while the resistant
specimen has grown uninhibited up to the margins of the
gutter on both sides.
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nutants, which by overgrowth come to dominate the final result.
On the solid slopes this takes between four and six weeks and
can be observedj but in the liquid culture of Dubos with its
more rapid and all-or-nothing growth such distinctions are
not detectable.
The full extent of the potentialities for drug-
resistance of the tubercle bacilli from this baby was shown
by a subculture of the confluent growth on the above gutter-
plate, which was found to be resistant in turn to no less
than 1,000 ^g./ml. on a repetition of the test with a stronger
streptomycin solution. This and the previous experiments
suggested strongly that the progressive development of
resistance in Myco. tuberculosis depends on mutants, just as
was seen with strains of Esch. coli in Chapter 8. It seemed
possible that the actual numbers of resistant and sensitive
tubercle bacilli in a strain could be estimated, therefore,
by an analogous technique using plate counts.
P
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EXPERIMENT 36 Plate Counting of Resistant Colonies of
Myco tuberculosis•
1. Estimate of the number of resistant bacilli in Strain H37&V.
A one-month old Dubos culture of the control strain
H 37Rv (Opacity Brown No' 2 tube) was homogenised by 3 hours
shaking at 6-10 beats per second with two g" glass beads.
A standard 4 nun. loopful of a 1/50 dilution was spread widely
on 8 sets of Lowenstein-Jensen plates containing 1, 10, and
100 ^g./ml. streptomycin respectively, and a similar standard
4 nun. loopful of a 1 in 100,000 dilution was spread on 2
plain Lowenstein-Jensen plates to give total counts of the
o
inoculum* All were incubated at 37 C for 6 weeks.
Inoculum Counts
16 38 Average 27
Number of bacilli per loopful of original culture =
Average count X Dilution ®
2,700,000
Resistant Colony Countss-
Concn. of Counts Average
Streptomycin
100^g./ml 00000000 0
10 ^g./ml 00000010 0.125
1 ^g./ml. 94 202 120 210 190 150 250 154 171.25
Dilution = 50 in each case.
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Therefore in an inoculum of 2,700,000 bacilli there are:-
Resistant to 100 ^g, nil
" n 10 jxg, 6.25
" 1 8,562.5
Which gives a very approximate rate for resistant
tubercle bacilli in strain Il37Rv oft-
Resistant to 100 ^g. nil in 2f million
w K 10 ^g, about 1 in 400,000
" "1 ^g. about 1 in 3*000
2. Estimate of the number of resistant bacilli in patient's
strains
A count of the proportion of resistant colonies of
Myco. tuberculosis in the strains from the baby before and
after treatment was made in a similar manner, suspensions
from the solid cultures being attempted by prolonged shaking
in Dubos medium as in the previous experiment. Owing to
the tendency of tubercle bacilli to re-adhere such a count
can only be a conjecturej but estimates of the resistant
organisms in the two specimens were made by spreading standard
4 mm. loopfuls of a 1 in 20,000 dilution on 10-cm plates
containing 40 ml. Lowenstein-Jensen medium with 0, 10, and 100
jjLg./ml. streptomycin respectively. Multiplying by the dilution
factor was therefore unnecessary as only approximate direct
ratios xvere being attempted, and estimates of the resistant
bacilli in the two specimens were as follows:-
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Initial Specimen
Resistant to 10 j^g./ml.









which compares with the very rough estimates of 1 in nearly ^
million resistant to lG^g./ml#, and 1 in nearly 2f million
resistant to 100 ^g./ml. in the typical "sensitive" strain H37Rv.
adhesiveness of Mycobacteria probably makes supposed counts
of bacilli based on the number of colonies quite misleading
except for broad comparisons of gross resistance and sensitivity
as in the example above# However small, symmetrical and
discrete^ the colonies are much less likely than Esch# coli
to be from a single organism# There seems little to be gained
by plate counts, therefore, over the generalisations possible
from counting resistant mutants as seen in the Slope Diffusion
Test#
It must be emphasised, however, that the strong mutual
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EMERGENT RESISTANT MUTANTS
Apart from the relatively rare naturally occurring
resistant Mycobacteria which we have described, one must
presume that all drug-fast strains originated during treat¬
ment from surviving mutants. The discovery that penicillin-
resistant staphylococci come from mutants suggested, of course,
that a similar accommodation could occur in any bacterial
species exposed to widespread use of a chemotherapeutic drug.
With tubercle bacilli resistant to streptomycin, isoniazid or
P.A.S. emerging among cases under treatment as described in
the last Chapter, it is inevitable that they are now being
reported throughout the world among tuberculous cases when
first diagnosed. Token use of isoniazid in India and
Nigeria for both prophylaxis and large-scale treatment has,
for instance, provided a huge pool of live tubercle bacilli
which have "experienced the drug". It xvould seem that the
eventual control of the disease may have been sacrificed to
immediate expediency.
The advantages of solid media for sensitivity tests
on tubercle bacilli were described in the last Chapter.
» -no
Mitchison and others ° however, showed that the actual
'minimum inhibitory concentration' or 'M.I.C.' of a strain
could vary between laboratories from such factors as differing
preparation and storage of media, and though their work was
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with sensitive strains of Mycobacterium bovis such variations
are inevitable in any supposedly quantitative biological test
such as Mycobacterial sensitivity tests are. Cruickshank and
© fs
Stet^art therefore suggested that resistance ratios would
be a more reliable index than absolute values. Strains are
cultured on eight slopes incorporating doubling dilutions of
a drug, the control strain H37^v., being treated exactly
alike, and the minimum inhibitory concentration is expressed
as a fraction or multiple of that of the control strain.
There are, hoivever, contrary arguments for absolute
values as the criteria of resistance when performing serial
tests on the same patients' strains very frequently and even
monthly. The specimens by their numbers act as "internal
controls" as with Wassermann Reactions read similarly in bulk,
in fact minor inconsistencies in the control I137&V., itself
are eliminated, and that the results are sufficiently
reproducible is shown by a comparison of 295 such tests with
resistance ratios which shows 85% correlation (Table 41)«
For our special purpose of studying the development
of resistance through mutants we have used a combination of
the Slope Diffusion Test and incorporated media throughout
a decade. The Slope Diffusion Test gives the overall
sensitivity of the bacterial population to an antibiotic in




IN EASIER* GLASGOW, 1963.
Assessed Additionally




Sensitive 153 — 153
Resistant to
Streptomycin 15 2 17
P.A.S. 3 1 4
I.N. ft. 7 2 9
Viomyctn 2 «•» 2
Cycloserine - - -
Ethionamide «*» - -
Strept. & I.N.H. 23 12 35
Strept. tt P.A.S. 6 2 8
P.A.S. & I.N.N. 4 2 6
Strept. & Vio. 1 - 1
Strept., P.A.S., I.N.H. 21 9 30
Strept., I.N.H,, Ethionamide 2 - 2
Strept., I.N.H., Cycloserine 1 - 1
Strept., P.A.S,, I.N.H., Vio. 4 2 6
Strept., P.A.S,, I.N.H., Cyclo. 5 2 7
Strept., P.A.S., I.N.H., Efhion. 2 2 4
Strept., P.A.S,, I.N.H., Cyclo,, Vio. 2 - 2
Strept., P.A.S,, I.N.H., Cyclo,. i'thton 1 - 1
Strept., P.A.S., I.N.H., Vto„ Ethton 5 1 6







graduated, and this has a particular application when
matching strains in those suspected of cross-infection#
Its use will be seen in the family outbreaks described later
in this Chapter, and especially strikingly in the almost
certain occupational cross-infection seen in the case of
Rinaldi and Baume.
It was shown in earlier Chapters that strains of
bacteria were heterogeneous, and in Chapter 10 the point
was made, as by others 211, 317* 352, 411> 439^ that
a mixture of sensitive and resistant tubercle bacilli will
appear at least partially resistant by ordinary tests * ,
be have followed the emergence of resistant mutants by two
methods# One is by counting the colonies on media
incorporating the same concentrations of a drug, streptomycin,
P.A.S., or isoniazid, month after month. 3^g*/ial.,
streptomycin, 2 ^vg./ml., P.A.S., and 1 ^g./ml., isoniazid have
been found empirically to be the usual thresholds for isolating
significantly resistant mutants. For streptomycin and
isoniazid the amounts are related to attainable blood levels
of the drugs; but for P.A.S., they are a compromise with
A 2.2.
reports that even lot* resistance is clinically significant •
The other method, which tve are inclined to think is
more perceptive, at least for streptomycin-resistant mutants,
is to read the £lope Diffusion Test's main growth at 4 weeks'
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incubation, and then re-examine at 6 weeks for the presence
of resistant colonies in the inhibitory zone. The results
are read as the height of the zone in inches plus the
mutant colony count thus:- 14" 6. Table 42 shows 12
strains investigated by this method and also by that of the
Resistance Ratios in parallel. It will be seen how a
relatively few mutants can drastically influence the Ratios:-
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tabm 42
signi»icancf op rfsistant hofamts in twnim
mug~se:nsitivi?r tfsts with sm ptomycin
Case Date Resistance Ratio Slope Diffusion
Jn, Anderson 24/1/64 16X Res, $" + 3 * Sens ®
Robt, Ptsher 28/1/64 2X m Gens, 1" * 1 m Gens -
Patrick Plynn 8/11/63 IX ex Gens, i* ♦ 0 m Gens a






1* + 6 * Sens *
Robt» Gibson 27/11/63 16X m Res, f" * 8 » Sens •














* 2 » Sens s
+ 4 m Sens £
Jas. MeGowan 6/21/63 8X m Res. #» * 10 * Sens »
Pat McLusky 12/3/63 16X m Res. *» ♦ 14 m Sens -
Andrew Sal es 12/10/63 8X m Res. i" * 6 " Sens »






i" * 0 m Sens -
Abbreviations: Res « resistant, ? Res. ® doubtfully resistant ( in
Resistance Ratios)t Sens » sensitive,
Sens - and Sens * » diminishing, and greatly
diminishing sensitivity, respectively (by Slope
Diffusion).
Name




AComparisonfResistancetiondSlopDiffusionMe h ds to showthefuturesignificanceftMut ntC u tsh latterasreadtsix>/>eeks.
Ratios: S.D: Ratios: S.D: Ratios: S.D.:
July/Dec.'62 13/6
1"+4rn=Se s- 1/11 16XmRes. +10mRes. l/ll 2XaSens £"+1mSens«
Jan./June'63 12/4
4X»Res. 1"+=Sens+~
July/Dec.'63 27/9 8X«Res. *3»Sens- 6/7 8XaRes. 0"aRes. 12/7 16X»Res. +6aRes.
Jan./June'64 25/2 16XaRes. +1aSens- 24/3 16.YaRes. 0"aRes. 17/3 16XaRes. 0"aRes.






IXaSens §" +0aSens 19/1 (a)32XaRes (b)16X«Res 0"«Res
31/12
2XaSens





















4*+1aSens"3"Sens—+5*Sens 24/615/4(a)4X*7Res4X=»?Res(b)16X»Res +o-Sens—0"**Res 11/429/11 IX=SensIXSens§"+0**Sens+«Sens 22/525 2230/ 16Xs>Res16X=Res16X«Ses 0*=Ses0"atSes0*mRes 10/431/711/2 16Xa*Res16XasRes16X«■Sesi"+0«Ses/?+2*Res§*2»S ns 2/223/38XtRes16Xa®Seaf* +J«Sens-1atens
Nam
July/Psc.162
13.JanetMcComack28/10 Ratios:32X»e S.P:09mReg 24.lectorMcDonald Ratios: s.D: 25.JanesMc&iee2 /9 P.attoa:SSX»Res S.D:O9=»Reg 26.ThomasMcintosh Ratios: S.Dt 27.JanesMcNcmara Ratios:2X»Sen s.D; 18.JanesMilln Ratios: S.D: 29.MegnyHurra Ratios: s.D:





20,Corneltu3Petrie 21,MalcolmStewart 22,MargaretT ylor 23,JamaTrovers 24,DavidMcDougall
July/Dec,'62 8/8
Ratios' S.D: Ratios: S,D: Ratios: S.D: Ratios: S.D:




(Comparehusb nd EricWithers*Ratto :
S.D:
July/Dec.'63
Jan,/June'64 18/3 16X=*Res 0"*=Res
13/118 2
16XmRes1 =*s




Abbreviations:Dayndm nthfte tregiv nhus:—"6/7" Thesensitivityt 8wereperformed,bonrb thm t ods,asrpo sibleatsix-monthljiinterva s, Q-T"Ratios"»ResistanceR tioTests. "S.D"=lopeDtffusionTestsad cribedinChapter10,threadingofthezonefinhibitionbe nggiventhusi ches:-'f"'followedbyacountfthereststantcolonieswithinth tzonereadupsixwe l-tsus:-'+4 Resultsaregiv nth s:-'Sen '»Sensitive 'Res'mResistant '?Res'=Doubtfullyresistant( yRatiosMethod)ens«.=Dtminishtngsensitivity ar*d-' „Greatlydiminishingsensitivity
(bySlopeDtffustn)
*Mr.andrs.Withershaprobablybeensimult neouslyi f ctedt years previouslywhenstayingthh rb o er,M .S arer,w oadd efr m tuberculosis.Thereisnr cordofanyt tsnibacilli.I1963 EricWithershadelapsedaft rmanyyea 'qui scence,whi hnowappears tohaveregained.Misw fh sbe nmoreol scontinuouslyill.Th abovetestinterestingaimplyhatisrelapsewanotuperinf ction fromhiswife,aitcouldhavbeenithbacillihab nsresistant hermo er centspecimens.
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COMMENTARY ON TABLE 43
This table shows the advantages of the Slope
Diffusion Test read at four weeks and again at six weeks,
when particular note is made of the emerging mutants. By
using both tests, Resistance Ratios and Slope Diffusion, and
carrying out a series at roughly six-monthly intervals, the
consistency of the results in the Slope Diffusion Test can
be seen.
Wholly or Partially Sensitive Strains
It will be seen that Cases No: 4, 9# and 17 were
consistently sensitive by both the Resistance Ratio and
Slope Diffusion methods and that the latter test also
revealed no mutants to mar this interpretation. In No: 22,
however, while both tests are satisfactorily sensitive on
three successive occasions, the Slope Diffusion with its
additional reading at six weeks shows an ominously progressive
rise in mutants. In Nos: 7 and 12 their presence probably
explains the discrepancy between the two tests, Slope Diffusion
breaking down the "resistance" of the Ratios into an overall
sensitive growth with a few mutants arising month by month,
and in No: 19 the abrupt transition from sensitive to resistant
in the Ratios is foretold in the Slope Diffusion by the
presence of mutants and a dwindling zone of sensitivity.
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Resistant Strains
Similarly \vith the resistant eases for, while Nos: 5#
10, and 13 are overwhelmingly resistant by both methods, in
Nos: 2, 14» 18, 243 and 25 the Slope Diffusion Test shows
that the onset is more gradual than the Ratios alone would
suggest, being preceded by a diminishing zone of inhibition
and often a rising mutant count as well. In Nos: 15 and 16
such analysis of the Slope Diffusion Test suggests that
resistance is in fact more borderline than the broad picture
of the ratios would suggest.
Strains in Transition
The more or less gradual transformation from
sensitivity to resistance is seen in Nos: 3# 6, and 8 by both
Resistance Ratios and Slope Diffusion methodsj but the Slope
Diffusion discloses the same phenomenon in Nos: 1, 21, and 23#
and in Nos: 1, and especially 21, the rise in mutants is seen
preceding diminishing sensitivity. In Nos: 11 and 2D this
critical discrimination of the Slope Diffusion Test shows by
alternating results that resistance is by no means finally
established*
By recognising and reporting in this way the
significance of these resistant mutants on both our Slope
Diffusion Tests and also on media incorporating the drugs,
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we have gone some way to i eet Canetti's objections to the
usual tests. His ingenious "Proportion Method" involves
making successive dilutions of the inoculum of tubercle
bacilli to obtain counts of the resistant colonies at three
weeks, so that, for instance, 1% of the population resisting
4 pAg. streptomycin, 0.5 ^g, P.A.S., or 0.2 ^g. isoniazid, or
proportionately higher counts at lower concentrations, tvould
indicate clinical resistance to these drugs. Such an
elegant test is as precise as any yet devisedj but it is
unfortunately hardly practicable for a busy hospital laboratory,
in particular as regards the safe preparation of the inoculum
dilutions.
It has been claimed that to report sensitive organisms
at all among resistant ones may mislead as the benefits of the
drug will not be lasting; but where other drugs are already
less effective, even transient benefits are justified if only
as a prelude to surgery. That the combination of the Slope
Diffusion Tests, with Mutant Counts included, gives a realistic
assessment is shown by the serial results for the long-term
eases given in Table 43 . The clinical correlation is
demonstrated in more detail in the following example, aptly
termed a "salvage case", in which a combination of Slope
Diffusion Tests and colony counts on drug-incorporated media
have been employed throughout.
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EMERGENCE OF DRUG-RESISTANT MYCO. TUBERCULOSIS IN AN INDIVIDUAL
Tuberculosis is unique among infectious diseases in
that its chronic nature and intractibility under treatment
lend themselves to providing a perfect site for the parasite's
evolution in a single host over many years. In such an
ecological niche repeated imitations can occur, and, in an
extreme example such as the following case five years
may suffice to breed bacilli resistant in more or less degree
to all the ten currently available drugs.
A Case of Extreme Multiple Drug-resistance
Miss Helen Chisholm was a factory machinist whose
sister had died of pulmonary tuberculosis in 1947• Two
years later, when she was 23, a haemoptysis showed that she
too had the disease in the right upper lobe but two months in
hospital appeared to give quiescence.
A year and a half later radiography showed activity
again and spread to the left upper lobe. Two months were
again spent in hospital with collapse therapy, and then 18
months at home on streptomycin and P.A.S. 41 Gm. of
streptomycin were injected, aimed at controlling the left
lung infection before surgery on the right side. But now,
in toy 1953* another haemoptysis showed cavitation on the
left side, and isoniazid and P.A.S. replaced the streptomycin
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and P.A.S. Four months later the sputum was negative, and
quiescence tvas again assumed. Next year the cavitation had
increased, streptomycin and P.A.S, were again introduced and
a total of 5° Gra. streptomycin were given at home during 1954*
In 1956 Hiss Chisholm married Mr. Anderson, who died
the next year of pneumonia after influenza, leaving her a
daughter. The subsequent winters cf 1957* 1958 and 1959
were all spent in hospital with detiorating health. During
these years there were in vitro resistance of the tubercle
bacilli to streptomycin and iscniazid, and also increasingly
though to a lesser extent to P.A.S,, and the accompanying table
shows how the lowering of sensitivity to all three drugs is
due to the accumulation in each case of resistant mutants.
By 1959 cycloserine had replaced the earlier drugs
as the accompaniment to P.A.S., and in June 1959 viomycin was
added too and gave some improvement with rest at home. In
August the P.A.S. was stopped because of nausea; but was
hastily resumed in November when two large cavities appeared
at the right apex. It will be seen in the table how the
Slope Diffusion Test with cycloserine reveals that this drug
too had lost its effect, the tubercle bacilli being only
moderately sensitive to it and to P.A.S., and quite resistant
to streptomycin and isoniazid (11.11.1959 )• Ihe untimely
three months' stoppage of P.A.S. could have contributed to
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this emergence of cycloserine-resistance; but fortunately
viomycin retained its effect. The patient felt well during
I960; but the sensitivities of the bacilli remained the
same, and the cavities growing steadily bigger spread by
September also to the right side.
During 1961 resistance to viomycin began to appear
and was explicable by the increasing counts of resistant
mutants shown in the table, though this was offset to some
extent by a transient return of sensitivity to P.A.S. in
March, and to cycloserine in May and June, presumably due
to over-riding back-mutations. By June 1962 the patient
had been alternating between bed at home and in hospital
with a variety of drugs such as ethionamide and pyrazinamide,
and the tubercle bacilli were now, after 14 years, resistant
to no less than 8 drugss- streptomycin, isonaizid,
pyrazinamide, viomycin, cycloserine, terramycin, ethionamide,
and kanamycin. P.A.S. and Dipasic, which still showed some
in vitro effect, were then used, and in the next month, July,
a new antibiotic Fucidin providentially arrived from Denmark,
where early in vitro tests had suggested some tuberculostatic
action. 1^ Gm. were given daily, and by October the bacilli
were not only still sensitive to fucidin, but showed reversion
of sensitivity to cycloserine and partially to viomycin and
kanamycin. The list of ineffectual drugs, however, now
included P.A.S. and Dipasic, the two drugs used with the fucidin.
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TABLE 44
SIX YEARS' DRUG-SENSITIVITY TESTS
ON TUBERCLE BA.CILLI FROM HELEN ANDERSON
(OVERALL SENSITIVITY BY SLOPE DIFFUSION; MUTANT COUNTS ON mUG"CONTAINING MEDIA).
nate Streptomycin P.A.S. I.N.N. Vtomyctn
mutants mutants mutants mutants
30 100 2 10 10 0 1 5 10 5 o It
'56 Oct. R 0" DO S 2" R 0" CO s §"
'57 Aug. - - - - - -
'58 May _ _ 8 _ — MM
July - - S — 1" OO 3 - ~ CO -
Sept. - CM 12 - - - OO S - f
Oct. - — 12 » 11 - — - - 2
'59 Sept. _ 20 «•* 1 — _ s §*
Nov. — - 50 m* 50 20 mm — - -
'60 Mar. 4 10 5 _ a.
Nov. S 12 - 30 3 - - MM - 6
Dec. 30 3 - 20 10 - - - MM 6
'61 Jan. - 50 30 _ ait m. S
Feb. - 5 3 Mb 1 - - - -
Mar. - 15 - 10 MM - R 0* 30
Apr. 8 3 - 0 -■ - 50 - 50
May R 0" CO 30 - 40 6 - - OO
June mm - 30 - 4 5 - - OO - 100
Aug. - - Mb 3 - 50
Sept. - 100 MM 36 0 - CO Co - 100
Oct. - 30 - 1 - 100
Nov. - 50 ~ 12 5 - - 25








- 4 0 s 1"
20 2 mm CO MM 3
S if OO 50 s i. ir8 6
S ♦ £»*■* 4 7 1 ttt - oo
MM 20 12 mm - CO 10 - 30
( Resistance Ratios at this date 2nd. Nov. 1962:-
Streptomycin 32X, P.A.S. 32X, I.N.N. 800X, Vtomyctn 4X,
Ethionamide 16X, as resistant as control culture N37 Rv.
Cycloserine IX, i.e. sensitive).
R » resistant, S « sensitive, S - = moderately and S t = only slightly
sensitive respectively. - » result as before.
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Summary
Mrs. Andersons story has been given in detail
because her infection coincided with the discovery of the
tuberculostatic drugs, and her subsequent fifteen years'
history is that of the chemotherapy of tuberculosis.
Drug-sensitivity tests on the tubercle bacilli were
not done for seven years by which time streptomycin- and
isoniazid-resistance was already present. The table shows
the sequence of events in the eight years since, and
demonstrates how by using the quantitative £lope Diffusion
Test and by counting resistant mutant colonies, the
mutational origen of the drug-resistance can be unequivocally
proved.
Isoniazid-resistance has continued irreversibly in
the whole eight years since 1956, and streptomycin-resistance
has been similar except for temporary remissions early in
1961 - evidence that back-mutations, though infrequent, do
occur with streptomycin in contrast to isoniazid. P.A.S.-
sensitivity has declined steadily since 1958, and a similar
story of rising resistance has made the population of tubercle
bacilli also immune at various times to vioraycin, cycloserine,
Dipasic, and ethionamide.
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The Rise of Drug-resistant Tuberculosis
EMERGENCE OF RESISTANT TUBERCLE BACILLI IN THE COMMUNITY
Tuberculosis has always been relatively common in
Scotland, and there was a two-thirds increase during the last
war. After the war the fall in incidence lagged far behind
that of the rest of Western Europe.
That there was still a big reservoir of undetected
tuberculous infection in Glasgow could hardly be doubted, just
how big could only be shown by the Mass Radiographic Survey
which took place in 1957 in five weeks 714*915 people
were examined, and those with X-ray evidence of disease were
just over 156, one third of these being active cases. But
these 2,565 active cases were by no means evenly distributed.
A rate of 0,15% for the University contrasted with 2% for the
prison, 3% for a mental hospital, and no less than 10% among
the 7,000 dwellers in Lodging Houses. In 1962 twenty new
cases were still being found in Glasgow every week, and
typically half of these had missed the Mass Survey, and more
than half came from the lodging houses. 40% had positive
sputa, and one in eight bilateral cavities.
In the same year as the Mass Survey drug-resistant
tuberculosis was already giving cause for concern. Bruce,
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Cuthbert and Ritchie ^ had found 125 cases, 59 of them
resistant to more than one drug* Twenty were untreated
cases, and five had been in contact with a treated case.
Tinne had found among 106 newly diagnosed cases in the
city 9 resistant to streptomycin, and 1 each to P.A.S. and
I.N.II., while among 263 cases already being treated more than
half harboured resistant strains, in one case resistance being
to no less than four drugs (Table 39 ).
Reports of primary drug-resistance in tuberculosis
for 1957 and the two following years were very similar for
other cities as far apart as Madras (8%), Strasbourg (11$), and
21*
Athens (11$), and at an international conference in I96I
nine countries agreed that their primary resistance rates of
3 to 11$ had become general.
RESISTANT CROSS-INFECTIONS IN FAMILIES
The insidious onset of tuberculosis may make the
source extremely difficult to trace; but where several cases
occur in one family there was always the presumption that one
had infected another. This now receives strong support when
the pictures of drug-resistance in the strains exactly match
or could formerly have matched, having regard to the very long
incubation period of the disease, on which, incidentally, this
sheds new light. The folloiving four family outbreaks exemplify
this, in one case the family dying out with the resistant infection.
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FAMILY 1. MRS. ODGER AND 1IER TWIN DAUGHTERS
(Fig: 51 and Table 45)
Mrs. A. Odger, the mother of three daughters, was
infected with tuberculosis in the left lung in 1944• This
responded to a thoracoplasty in 1945 with subsequent P.A.S.
and I.N.H., but by May 1954 the infection had spread to the
right lung with cavitation.
Streptomycin, P.A.S. and I.N.H. for two years, and
then Streptomycin and P.A.S. or dipasic or both during 1957
again produced quiescence; but in June 1958 the bacilli
were found resistant to Streptomycin and I.N.H. Streptomycin
P.A.S. and dipasic continued to be used, however, until
August I960 when a report of the culture's resistance to
Streptomycin, I.N.II. and dipasic forced a substitution of
cycloserine and ethionamide, with six months in hospital.
In the winter of 1961 unchanged resistance to the
three primary drugs induced the use of viomycin, cycloserine
and dipasic, and in June 1962 ethionamide had to replace
cycloserine which in turn had become useless. In Feb. 1963
resistance to Streptomycin, I.N.H., P.A.S. and dipasic, and
intolerance to cycloserine and ethionamide have dictated
kanamycin and pyrazinamide as the current treatment.
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MRft AMK1E ODGEK
June '5J: t^ug"- sensitive Tuberculosis
J<m, '58 > 6i rejo-resistant Tuberculosis




Kiss Helen Odger Mrs. Martfya Tagg&rt
Oct, N.ov, 'bo:brug- sens.Tuberculosis
heo. 'bO ~ sSejDi, 'bL Negative.
Jan Early focus. It,apex
(Vug-sens. Tuberculosis.
Fig: 51. Family tree of the Odgers.
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Two of the daughters are twins. One, Miss H, Odger,
was passed fit in the 1957 Mass X-ray Campaign; but had a
cavity in the right upper lung in Oct. i960. Happily the
bacilli were fully sensitive, and six months Streptomycin,
P.A.S. and I.N.II., followed by continued use of the latter
two drugs, have yielded negative cultures for over two years.
The other twin, Mrs. M* Taggart, was well until
29 Jan. 1963# when haemoptysis disclosed an early lesion in
the upper left lung with scanty tubercle bacilli. Her
tubercle bacilli also were fully sensitive to Streptomycin,
P.A.S., and I.N.H.
There would seem to be a strong presumption here that
both daughters were infected by the mother who had been an open
case of tuberculosis for nearly 20 years. If this is accepted
cross-infection must have occurred in both girls prior to June
*
1958, after which the mother's bacilli were no longer of this
sensitive pattern. This would give a latent period of over
4 years in the case of Mrs. Taggart, before her first early
lesion was detected radiographically.
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TABLE 45.
TUBERCULOSIS IN THE ODGER FAMILY
MRS. ODGER
Streptomyctn P.A.S. I.N.H. Viamyctn Cycloserine
7.6,57 §" » Sens- 3" » Sens 1" » Sens §" » Sens
3/3 0/3 0/1
39.1.58 £* » Sens» 3" « Sens± 1» « Senst 1" * Sens
1/30 6/3 6/1
15.8.58 0" » Res. 1§* » Sens- 0" » #es. §* » Sens.
S/JO 56/2 oa/l
4/20 2/5
4,5.60 0" "Res. 1&* mSens- 0" "Res. 1* "Sens. ^3" "Sens,
30/30 15/3 3/5
30.5.61 0" " Res. 3" » Sens. 0* »Res. J-* » Sens- §* » Sens-
°°/J0 0/2 20/5
81.9.63 0" " Res. §" « SensZ 0* » Ses. 2" » Sens, 1" + 3 ® Sens-
co/30 15/10 oo/i o/5o
5/100 10/5
33X " Res, 16X " Res. 8X » Res, 3X " Sens. 8X » Res.
88.1.64 0* »Res, * Sens" 0" * Res. §*+4m Sens- 0" • 2es.
°°/50 40/20 cxj/2 00/50
7/200 5/5 25/200
6/250
26X » Res, 16X » Res. 33X" Res, 33X" Res, 8X » Res.
17.4,64 0" "Res, §" " Sens" 0* "Res, £"+4* Sens* 0* "Res.




TUBERCULOSIS IN THE ODGER FAMILY.
MISS HELEN ODGER
Streptomycin P.A.S. I.N.H, Vtomyctn Cycloserine
14.10,60 1"+10 - Sens- 2" * Sens- if** Senst §" - Sena l£" - Sens.
6/50 8/2 10/1
MRS. MARTHA TAGGART NEE ODGER.
6.2.63 §* m Sens 2" « Sens. 2" « Sens 1* - Sens, 2" ® Sens.
0/3 0/2 3/1
9.5.63 £" m Sens- 2" - Sens. 1§* « Sens - Sens. 1§" - Sens.
0/3 0/2 0/1
4X - Sens <2Z ® Sens <flX * Sens IX * Sens, IX » Sens.
LEGEND:
The tests were performed in parallel on each of the dates shown,
which are at 3 - 6 months' intervals. The results are quoted under each
drug as follows: -
1. The zone in inches of inhibition by Slope Diffusion Test.,
+ mutants, if any, within zone in the case of vtomyctn and
cycloserine tests whtch were kept stx weeks for this.
J'or the other drugs, read at 4 weeks, mutants were studied by:-
2, The mutant count on drug-incorporated slopes. To simplify
the table only the crittcal level has been given. As a
rule this has meant quoting the htghes drug-concentratton
at which resistant mutants were seen thus:-
*4/10" « 4 colonies on 10^g./mlt
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Sometimes, however, abrupt changes have Justified quoting
the concentrations at lower levels also•
The first interpretation is based on both the results of
1, and 2, and is abreviated as follows:-
Sens « sensitive, Res « resistant, Senst * moderately t.e.
diminishing sensitivity, Sens* * rapidly diminishing sensttivtty.
3, Where available, that is during the last two years, the results
of Resistance Ratios are given with their interpretation thus
"16X * Res." means 16 times as resistant
as the control culture 1137 Rv,
SUMMARY OF TABLE 45
It will be seen how progressive deterioration in
sensitivity to all five drugs occurred in Mrs. Odger's strain
over seven years, preceded in each case by the appearance of
resistant mutants. This gives the first two tests used in
conjunction a prognostic significance in a chronic case of this
sort. No reversion to sensitivity was seen, except to a limited
extent in the case of P.A.S.
This progressive deterioration was not repeated in the
twin daughters, whose strains show a pattern of overall
sensitivity which implies infection was transferred in the
earliest years, if, as one assumes, it came from the mother.
Helen's moderate degrees of resistance to three drugs suggest
cross-infection could have been in early 1958, while Martha's
full sensitivity must date back, even earlier.
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FAMILY 2. THE STUDENT BROTHERS
(See Fig: 52 and Table 46)
Graham T., a 22-year old Glasgow medical student, was
found to have tuberculous cavitation of the right apex when
examined after a haemoptysis in March 1961. Cultures of his
tubercle bacilli were resistant to 100 p.g, streptomycin and
„|
5 yw-g. isoniazid, and partially to P.A.S. (10 and two
months later a further culture was unchanged• Sixteen months•
treatment with cycloserine and ethionamide successfully
arrested the disease giving repeatedly negative sputa.
In the course of a check on his family it was found
that a brother, Robert T., in Falkirk had also had pulmonary
tuberculosis, and that his cultures of tubercle bacilli in
February and March 1959 were also resistant to streptomycin
and isoniazid. It was interesting that he, too, had been
treated, quite independently, with the same drugs - cycloserine
and ethionamide - and with equal success. But still more
interesting for our present investigation is the fact that
Robert's sputa had yielded negative cultures for at least a
year previous to Graham's first symptoms.
Richard I
Spring" bp Strep.-&r/
IN H - res. Tuberculosis
treated with Cycloserine fc/ ^as.
Spring bl Negative
Grahana T
Spring" 'lo 1 Streji— &r/
IWH-res, Tuberculosis
treated with Cycloserine
K\s. July 'bl Megativc-
Fig: 52. The two student brothers with drug-resistant tuberculosis.
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TABLE 46
SHOWING ERADICATION OF INFECTION BY CYCLOSERINE AND ETHIONAMIDE
IN SPITE OF MULTIPLYING MUTANTS ALREADY RESISTANT 70 STREPTOMYCIN,
P.A.S, AND I,N,H, WHEN FIRST SEEN,
Strepto- P,A,S, I,N,H, Viomyctn Ethion- Cyelo-
mycin amide serine
6, 3,61 S,D, 0* » Res, §■* » Sens- 0* - Res, -$* - Sens 2" - Sens 2"-Sens
Mutants: 10/30 3o/2 °°/5 -
Drug 5/100 15/10
Concn, 6/joo
8,5,61 S,D, 0" - £es. » Sens- 0" - Res, §" - Sens 2*-Sens §*mSens
Mutants: 40/30 20/100 o°/5 - ...
Drug 5/100
Cone,
28,7,61 and since: No growth.
S,D, » Slope Diffusion Test, Res, - resistant. Sens - sensitive,
- » no mutants seen.
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FAMILY 3. EXTINCTION OF A FAMILY BY TUBERCULOSIS
(See Fig: 53 and Table 47)
If we regard successful parasitism as the survival of
a micro-organism in its host, in the next example the drug-
r sistant tubercle bacilli have over-reached themselves and
failed. The father, mother and married daughter all died
from the disease; but who was the originator was never
discovered.
Mrs. Sarah Craig harboured tubercle bacilli already
resistant to isoniazid and streptomycin when cultures were
first tested in August 1956. Between February 1957 and
July 1958 there was reversion to sensitivity to isoniazid;
but in November 1958 both drugs were again ineffective and
death occurred in September 1959 at Belvidere Hospital from
isoniazid- and streptomycin-resistant tuberculosis.
Meanwhile in February 1958 both parents were examined
and both had isoniazid-resistant but streptomycin-sensitive
tuberculosis. This pattern persisted in the cultures from
the father, hilliam Laurie, and by April 1958 he was dead in
Gartloch Mental Hospital. The mother, Ellen Laurie, survived
three years, dying in Robroyston Sanatorium in February 1961.
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bRJUG ASSISTANT













Return. o£ 1NH - sens. Feb. '5~j to July 68
bleb £ept, i^sO) M belvedere o£
1KJ H - res ^ vStrep. - res. I,B,















8' « Sens 0* « Res 1}" » Sens
V'o/iSo 50/10/5










I'm Sens- I'm Sens §" -
30/8 0/1
8/10







Mrs. Filer. Laurie, her mother
17. 8.58 1' m Sen-
8/10
0/30
I'm Sens - 0" » Res
15/8 °°/l
0/10 0/5
William, Laurie, her father
17. 8.58 ,, 1' m sens
0/3
1' mmSens * 0' m Res
1/8 30/1
0/5
S.D. m Slope Diffusion Test, Res. » resistant, Sens * sensitive,
m no mutants seen.
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FAMILY 4. THE 0'NEILS
Synopsis
Infection of a girl with tubercle bacilli with
multiple drug-resistance by the mother before the latter's
death (Table 48).
Mrs. Cecilia O'Neil, the mother of four children,
was put on streptomycin in Nov. 1951 for tuberculous infiltration
of the right lung. By Oct. 1953 both lungs were affected and
by May 1954 there were cavities in the right. I.N.H. and
P.A.S. were then added to the Streptomycin for some months
until a hospital bed became available in Sept. 1954. The
patient then continued on Streptomycin and P.A.S. until March
1955 when isoniazid was added. In March 1956 the Streptomycin
was discontinued following a report that the bacilli were
resistant to Streptomycin and I.N.H., sensitive to P.A.S. and
viomycin. In 1957 Nupasal replaced I.N.H. (to which it is,
however, only an analogue) and in 1958 Cycloserine was used
instead with P.A.S. She asked for her discharge to attend
her large family, and this was accepted with misgiving because
of the kno\m mental disturbance with cycloserine. Later in
1958 use of Streptomycin, P.A.S. and I.N.H. was again attempted.
By Oct. 1959 Mrs. 0'Neil's tubercle bacilli were
resistant to 3® f^g. Streptomycin and 5 M-g. I.N.II., besides
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being partially resistant to P.A.S. (lOyKg). By March I960
resistance to lOO^g. streptomycin, 5 Kg. I.N.H. and 100 ^g.
P.A.S. was reached, and during the next four months resistance
to 5|Ag. Dipasic and 100 ^g. Viomycin followed. By Jan. 1961
cycloserine resistance completed the picture.
During the last months of I960 she was being treated
with ethionamide and P.A.S.; but could not tolerate the
former drug. Moreover she realised only too well that she
had infected he" eldest daughter Sadie who was nursing her, and
she threatened suicide. She was admitted to a mental hospital
and all chemotherapy was stopped; but in Feb. 1961 she had a
haemoptysis and died almost instantly.
The daughter, Sadie, was a weaver. X-rays had shown
a healthy chest in March 1958; but cough and lassitude in the
winter of 1959-1960 led to a diagnosis of active bilateral
disease with right mid-zone cavitation, and the admission of
mother and daughter together into hospital. Her sputum
culture taken the same day as her mother's, 16.2.60, was an
exact replica in drug-sensitivities, namely completely
resistant to Streptomycin 30pg. and I.N.H. with only
partial sensitivity to P.A.S. In the following months
resistance to dipasic and cycloserine ensued even more rapidly
than in her mother's bacilli, though sensitivity to viomycin
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was retained. In August and Sept. I960 there was some
reversion to sensitivity to Streptomycin and cycloserine
while she was being treated with P.A.S. and kanamycin. The
kanamycin brought on Monilial vulvitis, and in August I960
viomycin was used with ethionamide and P.A.S.
Sadie took her mother's death with fortitude, and
made steady progress until May 1961 when deterioration in
the right lung prompted the addition of pyrazinariide to her
drugs. In August 1961 we obtained our first negative
culture, then a positive, then in Oct. a second negative.
After two months' convalescence at Irvine the patient has
spent 1962 at home on P.A.S., pyrazinamide and ethionamide
and is making very slow but steady progress.
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TABLE 48.
INFECTION FROM DYING MOTHER WITH
TUBERCLE BACILLI SHOWING MULTIPLE DRUG-RESISTANCE
MRS. CECILIA 0 'NEIL
Streptomycin P.A.S. I.N.H.
5*3,56 Slope Dtffusion 0* » Res. 2* « Sens. 0" » Res.
Mutants/Drug 50/30 6/2 °°/l
Concn: 0/100 0/10 0/5
16.4.58
0" »2es. 2" "Sens* 0" * Res.
30/30 30/2 oo/i
0/100 20/10 oo/5
9.7.58 " 0* *>Res. §* * Sens* 0* "Res.
20/30 °°/lO oo/l
0/100 30/100 20/5
16.2.60 * 0" * Res, §■* * Sens* 0" * Res.
00/30 100/10 o°/5
30/100 10/100 7/100









MISS SADIE 0 'NEIL
TABLE 48 (cont)
Streptomycin P,A,S, I,N,N,
16,8,60 Slope Diffusion: 0" •Res 1" »Sens- 0* ® Res.
Mutants/Drug 20/30 00/2 °°/l
Concn: 0/100 20/10 0/5
5.8.60 " 0" » Res. « Sens* 0" - Res.
20/30 50/10 °°/l
O/lOO 15/100 vo /5
5,12,60 " 0" m Res, * Sens« 0" ■ Res.
4/JO . | 15/20 00/5
5.5.61 * £* - Jena± 0* - Res.r
61/JO 50/2
10/10 °°/5
3,7,61, 8,8,61, 7,9,61, 5,10,61, and 2,11,61, , , , No growth,
LEGEND:
Res, » resistant, Sens, « sensitive, Sens- » moderately
sensitive. Sens» * oniy slightly sensitive. These estimates are based
on both the Slope Diffusion Test's zone of inhibition and also on the count
of mutant colonies on the series of slopes incorporating drugs, Eor
clarity only the critical levels of these have been quoted. Thus "30/2
20/10"
for P,A,S, means that there was a count of 30 colonies on 2^g,/ml, 20 on
10^g,/ml,, and none on a higher concentration.
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SUMMARY
It will be noticed that shortly before the death
of the mother her daughter became an open case of tuberculosis
also, and that her initial resistances to drugs matched the
final ones of the mother. Resistance to I.N.H. proved
irreversible in both subjects, as has been our general
experience. With the other two drugs, however, there is a
tendency to fluctuation back and forth in the degree of
resistance, preceded in each case by a rise or fall in the
mutant count. In the case of P.A.S, these never exceeded a
countable number, and this is reflected in the Slope Diffusion
Test, where a residual zone always remained with P.A.S, This
agrees with reports suggesting that P.A.S-resistance, in fact,
is never absolute.
TIIE ECOLOGY OF DRUG-RESISTANT TUBERCLE BACILLI
Early American reports of streptomycin-resistant
tuberculosis, or its absence, may have induced a false sense
of security based as they were on experience in sanatoria.
1 AP
Thus in 1949 Furtos and Doane announced that they had
treated 385 cases safely together. But only a year later
Arany and Lewis ** , when describing a similar group of 368
cases treated unscathed in open wards, admitted that three of
the sanatorium employees had become infected, one with
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streptomycin-resistant bacilli. This suggested that while
there might not be much risk of resistant organisms causing
superinfections, the position was totally different with
primary disease. The following case is probably an instance
of this among business associates} though it remains a
tantalising enigma who first infected the other.
Bernard Rinaldi, the 52-year old proprietor of a
public house in South-eastern Glasgow, was admitted to hospital
in June 1963 with pulmonary tuberculosis. This had been
diagnosed radiologically as an extensive bilateral infection,
which had caused an haemoptysis} but he admitted that for two
years he had been unable to work because of "chronic bronchitis".
A week later Rinalds's 61-year old barman, Lewis Bohme, was
occupying the adjoining bed. He, too, had had chronic
bronchitis for many years} but had showed no evidence of
tuberculosis until the previous month. Moreover he had been
under more or less continuous medical attention with sputum
examinations and X-ray examinations, and it xvas following an
attack of left basal pneumonia in May 1963 that he was found
to have extensive cavitation on the opposite side.
Sputa from both, taken on the 19th. and 27th. June
respectively, grew tubercle bacilli with the following
characteristics:-
TABLE 49
INITIAL DRUG-SENSITIVITY TESTS ON TUBERCLE BACILLI
PROM A PUBLICAN AND HIS BARMAN
B. Rinaldi 19,6.63 Cult: 20758





32 : em 16* Res.
P.A.S. 1 : 2 8 : mm 8X Res.
I.N.ff. 0,06 : 0.125 0.25 : 0.5 4X?Res.
Viomycin 16 t 32 64 : 128 4X? Res.
Cycloserine 8 : 16 8 : 16 IX Sens.
Ethionamide 10 : 20 10 : 20 1 X Sens.
L. Bohme 87,6,63 Cult: 21849





32 : 16 X Res.
P.A.S. 0,85 : 0.5 8 : - 32X Res.
I.N.ff, 0,3 : 0.6 1 : 50 32 X Res.
Viomycin 16 : 32 32 : 64 2X Sens.
Cycloserine 8 ! 16 8 : 16 IX Sens.
Ethionamide 10 : 20 20 : 40 2 X Sens.
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TABLE 49 (Cont.)
By Slope Diffusion + Mutant Counts on drug-incorporated media:-







Streptomycin * 1/30 Sens.-
P.A.S. 20/2, 10/10, 0/100 Sens -
I.N.H. o• °o/l, 0/5 Res.
Vtomycin l" 0 Sens.
Cycloserine 0 Sens.
Ethionamide l£* 0 Sens.







Streptomycin t 0 Sens.-
P.A.S. "*S 30 Sens.-
l.N.H. 0" oo Res.
Viomyctn 1" 0 Sen3.
Cycloserine ll" 0 Sens.
Ethionamide 2#* 0 Sens.
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The close correspondence between the two sets of
results is at once apparent; but it is particularly striking
by the second method. Partly this is because a shift in
the degree of sensitivity to P.A.S., and I,N,H,, has occurred
in the control culture 1137 Rv between the tests on the two
men, which were not performed together, and such slight
changes, inseparable from a biological 'control' are reflected
inevitably in the ratios.
Some 5-6 weeks later on 7•8.1963 both patients again
yielded positive cultures, which were not tested for
sensitivity. Meanwhile triple drug therapy had begun, 200 mg.
isoniazid and 15 G. P.A.S. being given daily, and f G,
streptomycin thrice a week. After six months both men were
discharged, with pyrazinamide 2^ G. replacing the isoniazid,
Rinaldi had begged to be allowed to supervise his languishing
business from bed at home, and a positive sputum in January
1964 gave these results:-
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TABLE 50
SUBSEQUENT DRUC-SENSITIYITY TESTS ON TUBERCLE BACILLI PROM B. RINALDI
Culture No, 433/64 By Resistance Ratios: - 7,1.64
H37 Ru Test Culture Resul ts
Streptomycin
n
2 : 4 38 • *"• 16 X Res,
P.A.S, 0,5 : 1 8 ; - 16X Res,
I.N.ff, 0,03 : 0,06 1 ; 50 32 X Res.
Viomyctn 16 ! 32 32 : 64 2x Sens.
Cycloserine 8 : 16 8 : 16 1 X Sens.
Ethionamide SO : 40 SO : 40 IX Sens.
and by Slope Diffusion + Mutant Counts on drug-incorporated media:-





























It will be seen by comparing successive tests that
the results for isoniazid, and viomycin (which was not used
for therapy), are more consistent by the Slope Diffusion and
Mutant Count method, and that this procedure also shoivs clearly
the deterioration in the counts of resistant mutants with both
streptomycin and P.A.S.
Lewis Bohme had also been discharged prematurely;
because he soon lapsed on his treatment, the residual cavity
enlarged, and in May 1964 he was readmitted to hospital.
The more severe disease in his case, following a well-
authenticated earlier history of no tuberculosis, suggests
that he was the victim, and that Rinaldi was the source of
his drug-resistant infection.
THE ttORLDV.IDE EMERGENCE OF DRUG-RESISTANT STRAINS
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McDermott " has pointed out that in the world
problem of drug-resistant tuberculosis, isoniazid and
streptomycin are at present the drugs that aiatter, isonizid-
resistance being the key problem.
Ten years ago the vast majority of tubercle bacilli
were still highly sensitive to these drugs as we saw in the
case of streptomycin in Table 38 ; but only five years later
in 1958 the International Union Against Tuberculosis 354
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concluded that drug-resistant bacilli were already a risk in
17 countries and that the average incidence was 6.5%» By
2ii
June 1961 the 14th. World Health Assembly announced that
important as the loss of effectiveness of the drugs was to
the patient, it was "not nearly so important as the spread
of drug-resistant Mycobacteria in the community" •
In this chapter we have seen that drug-resistant
tuberculosis is virtually a new disease. Its apparent
restriction to primary cases rather than to superinfection
of those already phthisic suggests, at least, that there is
as yet no accompanying exaltation of virulence. Slope
Diffusion Tests show that it arises from mutants of the
classical disease, and, if mutagenicity also increased the
virulence, then indeed the small groups of cross-infections






CHAPTER 12. NATURAL SELECTION AMONG PARASITES
In the seventeenth century Sydenham already
looked forward to the time when his work would "be finished
by posterity, and the whole series of epidemics be exhibited
to view as they shall succeed each other for the future".
The more credulous Sir. Thomas Browne a few years earlier
had written: "Some think there were few consumptions in the
old world, when men lived much upon milk; and that the
ancient inhabitants of this island were less troubled with
coughs when they went naked and slept in caves and woods, than
men now in chambers and featherbeds .... Some will allow no
diseases to be new, others think that many old ones are ceased:
and that such which are esteemed new, will have but their
time". However irrational compared with Sydenham, his
observations seem now to have been curiously prophetic, because
through all the rise and fall of epidemic periodicities there
are quite clearly certain long-term trends suggestive of a
slow evolution.
For our studies of the rise and fall of epidemics
have confirmed the remarkable fact that many such fluctuations
return at most exact intervals, and that the number of these
precise repetitions is far greater than could be explained
by mere coincidence. This sug ests that the relationships
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between host and parasite, disturbance of which precipitate s
epidemics, must be the subject of some regularly recurring
natural phenomena.
No doubt the changing seasons, and alternating
events like school terms play a part; but the-fcre still remain
unexplained the most conspicuous cycles - those long waves
extending over years or even decades.
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Pasteur originally supposed that there were
present in nature mixtures of virulent and attenuated organisms
in varying proportions, Later, convinced that the virulence
itself could vary, he realised with disquiet that here could
be the reason of the spontaneous appearance of diseases such
as smallpox, syphilis and plague in the past, and of the rise
of the great epidemics, if only an explanation could be found
for what he called the "cosmic influences" controlling these
^AO
universal effects. He could only suppose that a property
inherent in the oxygen of the air would eventually limit
epidemics, which arose by successive passages in lower animals
preceding transfer to man.
We have shown in Chapters 7 and 8 that bacteria
exposed to antibiotics to which they are susceptible will be
inhibited except for a few resistant mutants which survive
to grow on. By experiments with known numbers of bacteria
339
the proportion of such mutants in any population of
organisms could be calculated, and such experiments showed
that these mutations were occurring at a definite fixed
rate, constant for any one species, and therefore predictable.
As "back-mutations" can also be seen in the reverse direction,
we could have here those basic phenomena of cyclical change
and counter-change which are needed to explain the mysterious
fluctuations of epidemic disease.
Of course there must be a host of separate distinct
mutations, affecting such diverse characteristics as altered
colonial morphology and virulence as well as resistance to
antibiotics, occurring in all directions and to all degrees
simultaneously. Probably all that our strongest drugs can
do is to interfere with the back-mutations so that the to and
fro equilibrium of natural mutations becomes for a time one
way only. It could follow, too, that any bacterium by the
mere spread by its multiplication could be a menace, because
virulent mutations happening at a fixed rate will likewide
be a relatively frequent occurrence. If drug-resistant find
virulent organisms are alike so largely children of chance,
one may well wonder whether any of the so-called harmless
commensals, which abound in sputum for instance, can safely
be ignored.
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THE ORIGIN OF PARASITIC MICRO-ORGANISMS
Microscopic unicellular fossils have been claimed
70 2 57
with some authority * "J/ in meteorites, which would
envisage living primaeval organisms back in unimaginable
aeons of time. Burnet less equivocally, has pointed
out the remarkable resemblances between all living matter,
in that all creatures possessing protoplasm have the same
twenty-eight amino-acids constituting the proteins, although
an almost infinite number are theoretically possible. This
makes man and bacteria, and for that matter viruses, more
alike than unlike. He further makes the point that
"practically all animals live at the expense of some other
organism", so that even a protozoan lives on bacteria and
algae. Thus parasitism, as generally understood, is only
a matter of degree.
Xalabarder and Cullell by extensive use of electron
microscopy have staunchly maintained that extrusion and
fusion of nuclear protoplasm regularly occur between bacteria
in the lag-phase, which they therefore regard as the decisive
step in the growth cycle rather than the accepted binary
fission of subsequent logarithmic reproduction Such
as interchange of protoplasm, if it really does occur with
any regularity, would enormously facilitate mutations. But
even Xalabarder admits that there is a lack of such tropism
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and fusion of the two nuclei when contiguous bacteria are
of different species ^9^
10
Burnet noted the significant fact that when
"bacteria produce disease, the region primarily involved
is almost always that which normally harbours those harmless
bacteria which the pathogenic type resembles. Obvious
examples are the meningococcus morphologically indistinguish¬
able from other Neisseria in the pharynx, and the Shigellae
and Salmonella® so like the other Enterofcaeteriaceae in the
gut. In fact it seems to be almost the rule for pathogens
to have their counterpart in some co-existing commensal.
There is Borrelia refringens to match Borrelia vincenti and
Treponema calligyrum matching Treponema pallidum. The same
parallelism is seen with parasitic protozoa. Entamoeba
histolytica and the harmless Entamoeba coli are a comparable
pair, and here the much larger size allows some suggestive
observations. In acute amoebiasis Entamoebae histolytica
are big, engorged with blood cells, and rarely encysting.
But in the 'carrier' state of the host smaller amoebae
appear, "E. dispar or minuta" and it is said that they live
on bacteria, seldom exceed 10 in size and are prone to
log
encyst . If the large amoebae do not in fact encyst,
they must derive from the smaller ones, and it has been
suggested that the transformation may well be a mutation,
and that the two apparently different species are but one.
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Other living creatures, such as bacteria, are necessary
for the survival of B. histolytica in vitro, and it may
be that bacterial infection predisposes to human amoebiosis
and explains the effectiveness of anti-bacterial treatment
in the acute disease
Zinsser quoted by Burnet ^ has postulated that
where infection is always quickly fatal to the host, as with
the Rickettsiae of typhus in the louse, one must assume that
the parasitism is of only recent times and that adaptation of
the parasite to the host is still far from complete. By
contrast some viruses, such as Herpes simplex in the human
mouth, have evolved such a perfect equilibrium that they are
tolerated throughout the normal lifetime of the host. Examples
could be found of all degrees between these extremes, with
the viruses on the whole better adapted to parasitism than
the bacteria* Perhaps the pathogenic Neisseria represent a
transitional stage. Their characteristic presence in the
cytoplasm of polymorph cells is generally ascribed to
phagocytosis prior to destruction; but both they and the
white blood cell often look healthy enough, and the profusion
of cocci in one polymorph when others round it are unoccupied
may imply the first steps in intracellular parasitism.
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DISCONTINUOUS CHANGE
The doctrine of monomorphism, that bacteria
multiplying by binary fission stay true to type in shape,
growth and functions, dates back to the time of Koch*
Within a decade Eisenberg had shown such things as involution
forms ^* ^78 awj 1906 Neisser suggested that the
abnormal shapes of £* coli mutabile were due to mutation.
Most of the variationists, those who accepted this view,
concluded that such mutations as the change from smooth to
rough in bacterial colonics were transient departures from
the normal; but a few, the cyclical variationists, detected
a certain purposiveness in these modifying cultures, and
suggested that such serial transformations must lead in a
certain direction.
CQ
If we agree with Burnet that "growth, reproduction
i'
and mutation are the fundamental characteristics of life, we
must accept that evolution, the outcome of successive
mutations is inevitable from life itself. Sexual reproduction
in higher animals allows continuous variation so that no two
individuals are quite alike, and on the wide choice which this
offers will ultimately depend survival in an ever-changing
world. Among bacteria the genetic unions, whether by
lysogenic conversion, transformation and transduction as
described in Chapter 5# or by the direct cell fusion and
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interchange of Xalaborder quoted above, must only seldom
occur* Even spontaneous mutations and the selection of
successful variants is relatively rare; but, because of
the huge number of individuals concerned, evolution is
achieved, and hence bacteria are remarkable for their
plasticity and apparent ease of adaptation.
Evolution depends on successive mutations, and is
fortuitous in so far as these are chance occurrences. An
example of evolution in our own day is the loss of scent
this century by musk. Epidemics represent these successful
mutations in a parasite, giving increased virulence etc.,
and if they continue to succeed they will establish as a
new type and hence a distinct ne*v species may evolve.
Possible examples of this "discontinuity" in
historical times are mumps orchitis changing to primarily
parotitis, infantile paralysis changing to adult polio¬
encephalitis, the rise of herpes zoster rather than chickenpox,
and perhaps syphilis from syphiloids. Many pathogens have
commensal counterparts e.g. Shigellae and the Paracolon
bacilli, Anthrax Bacilli and the anthracoide, Meningococcus
and N. catarrhalis, Bcrrelia vincenti and refringens,
Diphtheria Bacilli and the diphtheroids.
I
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THE EVOLUTION OF A NEW BACTERIAL SPECIES
Until 1946 bacteria, living an apparently asexual
existence with vegetative multiplication, were regarded as
lying outside the main stream of biological evolution.
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In that year Lederberg and Tatum working with E. coli
showed that two biochemically distinct strains when mixed and
cultured together produced progeny of the order of one in a
million possessing the characters of both. More recently
actual sexual differentiation has been shown in E. coli, and
the male-determining gene "F" has even been transferred to
other species so that E. coli, Salmonellae and Shigellae
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have been crossed with each other as well as among themselves •
It seems reasonable to suppose that some bacteria must possess
in their protoplasm sexual differentiation with all its
genetic consequences fundamentally comparable to that in
higher creatures.
Ravin has pointed out that although mutations
occur at random "the living universe is not a vast community
of genetically interacting organisms". For if it were the
whole merit of achieving adaptation by selection would be lost
again as the better variants would be just as fugitive as the
more poorly adapted progeny among the maze of further mutations.
In higher creatures there are "isolating mechanisms" which
limit breeding for practical purposes to the same species.
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Flowers bloom in their proper season, animals mate only
with their like, and so on. Similar isolating mechanisms
must occur among bacteria to limit the randomness of their
mutations, and they have been shown to exist. Excessive
conjugations are limited by the incompatibility of very
unlike pairs, transductions are segregated by the specificity
of the phage responsible, and rejection of incompatible D.N.A.
from an unsuitable partner would prevent transformations which
were too bizarre.
The isolating mechanism which limits mutants from an
infinite variety to a finite number of species has been shown
to be itself induced by mutation and recombination. If two
differing bacterial populations from a common stock continue
side by side they may well remain just a heterogeneous
population. But if each is adjusting to a distinct
ecological niche, the isolating mechanism will ensure that
they continue to be differentiated. If it is advantageous
to evolution the isolating mechanism, and the mutations which
it controls, will persist and must ultimately create a distinct
new species. We have here an example of •cybernetics1 in
that we are studying an automatically self-regulating
system 338' 46S.
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RHYi'HMIC BESIAVIOUR IN LIVING CREATURES
72Professor Cloudsley-Thompson ' , after ten years*
study of the clock-like regularity of phenomena in crustaces
and other arthropods, concluded that rhythmic phenomena
permeate all aspects of life* Among parasites especially
J aA
periodicity is remarkably precise • The recurring bouts
of fever in malaria may occur on alternate or every third
day according to the life-cycle of the Plasmodium responsible}
but the acme of the fever when there is the maximum disintegra¬
tion of infected blood cells always occurs between 6 and 8 a.m.
in a day worker. A change of working hours by the host is
promptly reflected in a change of rhythm by the parasite.
Why this should be so, or indeed how all the plasmodia keep
in step anyway, is a complete mystery.
In Asiatic filariasis the maximum migration of
microfilariae from the lungs to the peripheral blood takes
place around midnight, while in African loa loa the timing
is noon. Probably these rhythms are linked to the life
cycles of the associated insect vectors. Female mosquitoes
needing blood to mature their ova bite by night or around
dawn, while the vector of loa loa is the mango fly biting in
the heat of the day. But thisstill does not explain the
timing mechanism within the parasite. Possibly the drop in
oxygen in the blood during sleep is detected, or rainor
temperature changes, or the rise in waste products; but this
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is but speculation, one can only marvel at what Cloudsley-
Thompson terms "biological clocks" in nature. Intermittent
emergence of mutations implies a similar periodicity, and
this thesis shows how their rhythmical recurrences are not
only possible but are in fact inevitable.
T1IE BALANCE OF NATURE
AO 262 A7?
Recent work * * ' /J suggests that recombination
among bacteria depends in the first instance on chance
collisions between comparable organisms, and only subsequently
on all the highly specific genetic transfers which we have
described. in such randomness preceding specificity there
might be thought to be an anelogy with the very specific
natural selection which succeeds supposedly chance mutations.
But are any living organisms in reality creatures
of chance? Equilibrium between existing species is a
natural tendency of the world in which we live, and this
must imply, in the case of a parasite and its host, a constant
mobilis in mobile 07 , Disturbance of this equilibrium
could result from a major change in one partner or lesser
changes in both. The resulting imbalance will be "disease"
in that host, and if it persists as a gross imbalance
favouring the parasite an "epidemic" may result. Permanent
successful change will mean evolution towards a new species
as envisaged by Darwin.
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The Lederbergs postulated that bacteria adapt
to new environments by "spontaneous mutation and population
selection". If, by spontaneity is meant unrestrained
freedom, our experiments with E« coli and Myco. tuberculosis
show, on the contrary, that bacterial mutations are highly
ordered in number and frequency. If the mutation rates of
bacteria are fixed in time so must be the appearance of
their dependant characters, and rising at regular intervals
like beats will be major phenomena like drug-resistance,
virulence and epidemicity, in fact the pulsing progress of
evolution itself.
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